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i 
SUMMARY 
 
Surface waters are essential for human life, to supply of drinking water and as an important 
resource for agricultural, industrial and recreational activities. However, tonnes of pollutants 
enter these surface waters every year. Amongst the substances discharged into the 
environment, a large number are known to be mutagenic, forming part of a complex mixture 
of effluents found in municipal waste waters from domestic and industrial waste water 
treatment plants and in surface runoff from agricultural land . Moreover, these surface waters 
contain many unknown compounds. Consequently, water pollution can be a serious problem 
for public and aquatic ecosystem health. Effect-directed analysis (EDA) is a tool to identify 
chemicals responsible for the observed toxic effects. It is based on a combination of chemical 
and biological analysis. The chemical analysis enable the separation and isolation of toxicants 
from complex samples, while the biological analysis enables the “tracking” of the toxicants 
during the separation of the chemicals, which allows decreasing the complexity of the sample 
in focusing only on chemicals causing the biological effects.  
Among planar aromatic compounds such as azaarenes, polyaromatic hydrocarbons (PAHs), 
keto-, nitro-keto-, hydroxyl-, amino- and nitro-PAHs, as well as quinones and hydroxy-
quinones there are many known environmental mutagens often present in surface waters in 
complex mixtures and at low concentrations. Planar aromatic compounds may be sampled by 
selective adsorption to blue rayon (BR). The first part of the thesis work presented here aimed 
to provide a specific fractionation method for these compounds applicable in effect-directed 
analysis. This procedure relies on three fractionation steps: (i) solid phase extraction using 
mixed-mode cation- and anion-exchange sorbents, (ii) reversed-phase HPLC polymeric C18 
column and (iii) reversed-phase HPLC phenyl-hexyl column. Based on 47 analytical 
standards and a BR extract tested with the Ames fluctuation test, the ability of the method to 
recover and isolate mutagenicity is shown. Standard group recoveries ranked from 37% 
(quinones) to 85% (keto-polyaromatic hydrocarbons and amides) and these chemicals were 
separated satisfactorily, with little overlap between neighbouring fractions. The recovery of 
the BR mutagenicity was over 75 %. As the sample mutagenicity was mainly present in only 
7 of 50 fractions (neutral compounds in fractions N-2-6, N-2-7, N-2-8 and N-7-12 and acidic 
compounds in fractions A-2-9, A-2-10 and A-8-9), this three step fractionation method has 
been shown to be a reliable method to decrease sample complexity in order to identify polar 
planar compounds responsible for mutagenic effects. 
The aim of the second part of the EDA study was to develop and apply an identification 
strategy to handle the data produced by liquid chromatography-high resolution mass 
spectrometry (LC-HRMS) and to identify chemicals that are responsible for the mutagenic 
effects in selected fractions. This was done in two steps: (i) Reference standards were 
analysed in order to understand their ionisation behaviour by electrospray (ESI) and 
atmospheric pressure chemical ionisation (APCI) and their MS/MS fragmentation behaviour 
with the aim of deriving rules that can be used for the unknown identification, and (ii) the 
method was then applied in the frame of a target-, suspect compounds- and non-target-
screening for two mutagenic environmental fractions, N-2-8 and N-7-12 (target-and suspect-
compounds-screening for this latter). Typical losses associated with certain chemical classes 
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(e.g. nitro-, hydroxyl-, keto-PAHs) were determined for both APCI- and ESI-, positive and 
negative mode. As a larger range of compound groups (particularly nitro compounds) could 
be ionised in APCI, this technique was used to identify unknowns of interest in original 
sample screening. The target screening based on the exact mass and retention time of the 
reference standards did not provide any hit and hence, no compounds were identified in the 
two fractions. The suspect-screening strategy based on the exact mass of the compounds 
enabled the identification of pigment yellow 1 in fraction N-7-12. Finally non-target screening 
was applied, which relied on (i) the determination of the empirical formula based on the exact 
mass of the parent ion, its isotopic pattern and its MS2 fragmentation, (ii) the selection of the 
candidates based on the comparison of MSn fragments of the unknown and compounds 
present in chemical database such as ChemSpider or PubChem, and (iii) the match of the 
physico-chemical properties of the unknown compound with candidates. This strategy 
enabled to identify and confirm the presence of benzyl(diphenyl) phosphine oxide in the 
fraction N-2-8 and to propose a list of 92 candidates, including 46 aromatic amines..  
The aim of the third part of this study was to apply two different approaches to further 
decrease the candidates list, containing 92 candidates for fraction N-2-8. This was done by 
applying (i) retention prediction in reversed phase liquid chromatography calculating the 
Chromatographic Hydrophobicity Index (CHI) using Linear Solvation-Energy Relationship 
(LSER), which is based on the Abraham equation and (ii) the mutagenicity prediction of 
aromatic amines on the basis of the stability of corresponding nitrenium ions as the ultimate 
electrophiles attacking the DNA. Applying the LSER model, the list of candidates was 
decreased to 22. The mutagenicity prediction method identified nine amino-candidates as 
mutagens, 24 amino-candidates for which the mutagenicity could not be predicted and 
thirteen as non-mutagens. In combining the results of these two methods, 22 compounds 
remained on the list. For two of them, the retention prediction and mutagenicity were positive, 
while for the 20 other the retention was in agreement with the prediction, but no mutagenicity 
was predicted. Hence, these two methods allowed to drastically decrease the number of 
candidates.   
The methods described in this thesis work provide a good basis with new criteria for 
candidate selection (acid/base property and APCI/ESI ionisation behaviour of the different 
compound classes, which can be used in any identification procedure) for EDA studies of 
planar mutagens in water samples. Two approaches (LSER and mutagenicity prediction) 
showed their efficiency in reducing the number of candidates. As general considerations, the 
LSER approach can easily be included in EDA studies as a pre-step for confirmation. 
Furthermore, this work showed that new tools are needed to improve the identification 
procedure, which requires databases (e.g. self-made databases for target and suspect-
compounds screening), analytical and separation techniques (e.g. ionisation and 
fragmentation, to gain even more information regarding the analytes to be identified), as well 
as certain software tools (e.g. helping in the adduct formation prediction).  
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ZUSAMMENFASSUNG 
 
Oberirdische Gewässer haben für das menschliche Leben, insbesondere für die 
Trinkwasserversorgung und als wichtige Ressource für Landwirtschaft und Industrie sowie 
für Freizeitaktivitäten eine große Bedeutung. Dennoch gelangen jedes Jahr Tonnen von 
Schadstoffen in diese Gewässer. Unter den Substanzen, die in die aquatische Umwelt 
gelangen, sind eine große Zahl bekannter Mutagene, die als Teil komplexer Mischungen aus 
häuslichen und industriellen Abwässern, sowie im Oberflächenabfluss landwirtschaftlich 
genutzten Flächen gefunden werden. Daneben sind diese Gewässer aber auch einer Vielzahl 
unbekannter Verbindungen belastet. Folglich kann die Verschmutzung des Wassers eine 
ernste Gefahr für die Volksgesundheit und das Gewässermanagement sein. Die Methode der 
Wirkungsorientierten Analytik (EDA) erlaubt es, Chemikalien zu identifizieren, welche für 
beobachtete toxische Wirkungen verantwortlich sind. Es basiert auf einer Kombination von 
chemischen und biologischen Analysen. Die chemische Analyse erlaubt die Trennung und 
Isolierung von Schadstoffen aus komplexen Proben, während die biologische Analyse 
ermöglicht, die Komplexität der Probe zu verringern, indem man sich nur auf die Fraktionen 
fokussiert, welche die Stoffe enthalten, die für die biologischen Effekte verantwortlich sind.  
Unter der Gruppe der planaren aromatischen Verbindungen, wie z.B. Azaarene, polyzyklische 
aromatische Kohlenwasserstoffe (PAK), Keto-, Nitro-Keto-, Hydroxyl-, Amino-und Nitro-
PAKs sowie Chinone und Hydroxy-Chinone, gibt es viele bekannte Umweltmutagene, die oft 
in niedrigen Konzentrationen und in komplexen Gemischen in unseren Oberflächengewässern 
vorkommen. Solche planar-aromatischen Verbindungen können durch selektive Adsorption 
an Blau-Rayon (BR) als Sammelmatrix beprobt werden. Der erste Teil der hier vorgestellten 
Arbeit zielte daher darauf ab, ein spezifisches Verfahren zur Fraktionierung dieser 
Verbindungen im Rahmen einer Wirkungsorientierten Analytik zu entwickeln. Dieses neue 
Verfahren basiert auf drei Fraktionierungsschritten: (i) Festphasenextraktion unter 
Verwendung von gemischten Kationen- und Anionenaustausch-Sorptionsmitteln, (ii) 
Umkehrphasen-HPLC mit einer polymeren C18-Säule und (iii) Umkehrphasen-HPLC mit 
einer Phenyl-Hexyl Säule. Basierend auf 47 Analysenstandards und einem BR-Extrakt, 
welche mit dem Ames-Test überprüft wurden, wurde die Fähigkeit des Verfahrens zur 
Extraktion und Isolierung von mutagenen Proben gezeigt. Die Methode erzielte 
Wiederfindungen von 37 (Chinone) bis 85% (Keto-polycyclische aromatische Kohlen-
wasserstoffe und Amide) und trennte die Chemikalien zufriedenstellend auf, mit wenig 
Überlappung zwischen den benachbarten Fraktionen. Die Mutagenität in der BR-Probe war 
im Wesentlichen in 7 der 50 Fraktionen zu finden (neutrale Verbindungen in Fraktionen N-2-
6, N-2-7, N-2-8 und N-7-12 und sauren Verbindungen in Fraktionen A-2-9, A- 2-10 und A-8-
9) und konnte zu 75% wiedergefunden werden. Es konnte gezeigt werden, dass die 
entwickelte Drei-Stufen Fraktionierungsmethode zuverlässig war, um die Proben-Komplexität 
zu verringern und die polar-planaren Verbindungen als verantwortlich für die mutagenen 
Wirkungen zu identifizieren. 
Das Ziel des zweiten Teils der hier vorgestellten Studie war die Entwicklung und Anwendung 
einer Identifikations-Strategie anhand von Flüssigchromatographie - hochauflösenden 
Massenspektrometern (LC-HRMS) erzeugten Daten, um die für die mutagene Wirkungen 
 iv 
verantwortlichen Chemikalien in den ausgewählten Fraktionen zu identifizieren. Dies wurde 
in zwei Schritten erreicht: (i) Analysestandards wurden gemessen, um deren Verhalten im 
Elektrospray Ionisation (ESI) und Atmospheric Pressure Chemical Ionisation (APCI) Modus 
hinsichtlich ihrer MS2-Fragmentierungsverhalten zu verstehen. Dies hatte zum Ziel, sich 
Regeln zu erarbeiten, die man für die Identifizierung unbekannter Substanzen verwenden 
kann. (ii) Diese Methode wurde dann im Rahmen einer Target-, Suspect- und Non-Target 
Screening Analyse für zwei mutagene Fraktionen angewendet, N-2-8 und N-7-12 (Target und 
Suspect-Screening für die Letztere). Typische Verluste in einigen Stoffklassen (zB Nitro-, 
Hydroxyl-, Keto-PAKs) wurden sowohl für APCI und ESI im positiven und negativen Modus 
zugeordnet. Da ein größerer Teil der mutagenen Stoffklassen (insbesondere Nitro-
verbindungen) auch in APCI ionisiert werden können, wurde diese Technik verwendet, um 
Unbekannte in den Screening-Proben zu identifizieren, während die Informationen aus dem 
ESI Modus dazu verwendet wurden, um die Anwesenheit oder Abwesenheit von bestimmten 
funktionellen Gruppen in der molekulare Struktur der unbekannten Verbindungen zu 
bestätigen. Das Target-Screening, basierend auf der genauen Masse und Retentionszeit der 
Analysestandards, ergab keinen Treffer, und somit wurden zunächst keine Verbindungen in 
den beiden Fraktionen identifiziert. Das Suspect-Screening, basierend auf der genauen Masse 
der Verbindung, ermöglichte die Identifizierung von Pigment Yellow 1 in der Fraktion  
N-7-12. Schließlich wurde eine Non-Target-Screening Methode angewandt, welche auf 
folgenden Schritten aufgebaut ist: (i) Bestimmung der Summenformel anhand der exakten 
Masse des Mutter-Ions, sowie anhand dessen Isotopenmusters und ihrer MS2-Fragmentierung; 
(ii) Auswahl der Kandidaten basierend auf dem Vergleich von MSn Fragmenten der 
unbekannten Verbindungen mit denen, die in chemischen Datenbanken wie z.B. ChemSpider 
oder PubChem vorhandenen sind, und (iii) Überprüfung der Übereinstimmung der 
physikalisch-chemischen Eigenschaften der unbekannten Verbindungen mit denen der 
Kandidaten. Mit dieser Strategie konnte das Vorhandensein von Benzyl (diphenyl) 
phosphinoxid in Fraktion N-2-8 identifiziert und bestätigt werden und eine Liste von 92 
Kandidaten vorgeschlagen werden. 
Das Ziel des dritten Teils der Studie war es, anhand zweier unterschiedlicher Ansätze die 
Anzahl der 92 Kandidaten für die Fraktion N-2-8 zu verringern. Dies wurde folgendermaßen 
erreicht: (i) Vorhersage der Retenzionszeit in Umkehrphasen-Flüssigchromatographie anhand 
des so genannten Chromatographischen Hydrophobizitätsindex (CHI) unter Verwendung der 
linearen Solvatation-Energie-Beziehung (LSER), die auf der Abraham Gleichung beruht, und 
(ii) Vorhersage der Mutagenität von aromatischen Aminen auf der Grundlage der Stabilität 
entsprechender Nitrenium Ionen - Zwischenprodukte, welche letzten Endes den elektrophilen 
Angriff auf die DNS auslösen. Durch die Anwendung des LSER Modells konnte die Liste der 
Kandidaten auf 22 verringert werden. Die Mutagenitäts-Vorhersage wiederum identifizierte 
neun der Amino-Kandidaten als potenziell mutagen, während für 24 Amino-Kandidaten die 
Mutagenität nicht vorhergesagt werden konnte und weitere dreizehn Kandidaten als nicht-
mutagen identifiziert wurden. In Kombination der Ergebnisse dieser beiden Methoden blieben 
22 Verbindungen auf der Liste. Für zwei von ihnen waren sowohl die Vorhersage der 
Retention als auch der Mutagenität positiv, während für die anderen 20 Substanzen zwar die 
Retentionszeit übereinstimmte, aber keine Mutagenität vorhergesagt wurde. Diese beiden 
Methoden erlaubten somit eine drastische Verringerung der Zahl der Kandidaten. 
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Die in dieser Arbeit beschriebenen Methoden bilden eine gute Grundlage für die Auswahl von 
Kandidaten anhand neuer Kriterien (Säure-/Base-Eigenschaften und APCI / ESI Ionisation 
Verhalten von verschiedenen Stoffklassen, die in praktisch jedem Identifikationsverfahren 
verwendet werden können) für die Wirkungsorientierte Analytik von polar-planaren 
Mutagenen in Wasserproben. Zwei Ansätze (LSER und Mutagenitätsvorhersage) waren 
geeignet, der Zahl der Kandidaten zu reduzieren. Als allgemeine Anregung kann der LSER-
Ansatz leicht in EDA-Studien als Vorab-Schritt für die Bestätigung von Unbekannten 
integriert werden. Des Weiteren konnte diese Arbeiten zeigen, dass neue Werkzeuge benötigt 
werden, um das Verfahren der Stoffidentifizierung zu verbessern, wie z.B. Datenbanken (z.B. 
selbst erstellte Target und Suspect-Screening Datenbanken), Analytische- und Trennverfahren 
(z.B. Ionisierung und Fragmentierung, um noch mehr Informationen über den zu 
identifizierenden Analyten zu gewinnen), sowie bestimmte Software Anwendungen (z.B. für 
die Bestimmung der Summenformel). 
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CHAPTER 1: INTRODUCTION 
 
1.1  Chemicals in freshwater resources 
 
Surface waters are essential for human life, they supply drinking water and are an 
important resource for agricultural, industrial and recreational activities. However, tonnes of 
pollutants enter surface waters every year. Domestical, agricultural and industrial effluents 
contribute significantly to the contamination of surface waters [1]. Industries produce a wide 
range of chemicals, including pesticides, pharmaceuticals, dyes, solvents, plasticizers, 
antioxidants and surfactants [2]. In general, industrial wastewaters have high concentrations 
of organic pollutants. Furthermore, these chemicals exhibit a large diversity of functionality in 
their molecular structure and thus different properties (e.g. solubility, volatility and 
lipophilicity) affecting their fate and behaviour in the environment. They also exhibit different 
acute and chronic toxicity.  Wastewater effluents have pronounced toxic effects on aquatic 
organisms [3-6] at different trophic levels (e.g. algae, plants, crustaceans and fish) [7] and on 
human consumers of drinking water and fish.  Thus, water pollution can result in serious 
public health and aquatic ecosystem problems [8].  
In Europe, the Water Framework Directive (WFD-2000/60/EC), effective from 2000, 
aims to reduce chemical pollution of surface waters [9]. This directive establishes guidelines 
for water pollution by prioritising substances that are highly toxic for the aquatic 
environment. According to the Annex II of the Directive 2008/105/EC, this list contains 33 
substances or groups of substances (e.g. biocides, plant protection products, metals, 
polyaromatic hydrocarbons, polybromated biphenylether). These priority compounds are used 
to assess the organic contamination of aquatic systems. However, about 60 million 
compounds are known and registered in the Chemical Abstract Service (CAS). The number of 
these compounds that are of potential environmental concern is unknown but, it clearly 
exceeds the number of chemicals that can be regulated and monitored individually. In 
addition, numerous transformation products further enhance the complexity of the chemical 
mixtures present in water. Organic pollutants can react in aquatic environment, for example 
through reactions involving hydrolysis, photodegradation, oxidation, or metabolisation.  
These transformation reactions lead to the creation of numerous transformation products that 
in most cases nothing is known. Furthermore, some of the transformation products can be 
more persistent and/or more toxic than their parent compounds [10]. This may be highlighted 
by the highly mutagenic phenylbenzotriazoles that form from dinitrophenyl azo dye during 
the industrial process and disinfection at sewage plants [11,12]. It is also possible that 
genotoxic compounds can be generated by the interaction of chlorine and organic components 
that are naturally present in surface waters (e.g. fulvic and humic acids) [13]. Thus, it is 
evident that the impact assessment of chemicals on the water system cannot solely be done on 
the basis of the priority substances.  The identification of toxic compounds in complex 
chemical mixtures is a new challenge in environmental analytical chemistry that must be 
addressed.   
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1.2 Importance of planar mutagens in the environment 
 
A wide range of industrial effluents that enter surface waters have been associated 
with mutagenic effects, including those from organic chemical manufacturers, metal refining 
operations, dye manufacturers, petroleum refineries and pulp and paper mills [5,14]. Thus, 
humans, terrestrial organisms and aquatic organisms are exposed to a large variety of 
naturally-occurring and man-made mutagens. Amongst these, nitrosamines (e.g. N-
nitrosodymethylamine) [15] and polycyclic aromatic compounds [8,16] are classes of 
chemicals well known to include potent mutagens. The abundant presence of polycyclic 
aromatic compounds with few rings in the environment is cause for concern. Several 
heterocyclic amines, which are emitted into the atmosphere through combustion of various 
materials such as wood, grass, garbage and petroleum, as well as into the terrestrial and 
aquatic environments through domestic and industrial waste [17], are identified as mutagens 
[17,18]. Nitro-aromatic compounds are another group of chemicals that include potent 
mutagens such as nitropyrenes and nitrobenzenes.  Their use in pharmaceuticals, dyes, food 
additives, pesticides, and explosives result in their wide distribution in the environment [19].   
Monitoring the effects of organic environmental pollutants is an on-going challenge 
for researchers.  A large battery of bioassays is now available to assist in this task. 
Compounds contributing to surface water mutagenicity are often present at very low 
concentrations and their presence can vary temporally [16,20,21]. Furthermore, trace 
mutagens in water co-exist with a multitude of other chemicals. These may be present at 
greater concentration masking mutagenic effects (e.g. by reducing bioavailability or by 
cytotoxicity) [22]. Thus, passive samplers or extraction devices that are selective for specific 
groups of mutagens are required to assess mutagenicity using bioassays and subsequent 
chemical analysis [13,23].  
 
1.3 Objective 
 
The overall objective of the present thesis was the development of an integrated 
approach to identify mutagens in contaminated river waters. The approach was tested at the a 
site on the River Elbe that is downstream from the industrial area of Pardubice (Prelouc, 
Czech Republic) where dye, explosive and pharmaceutical industries release effluents. 
To fulfil this objective, the present thesis will present:  
 
(i) The scientific background of the approach and the individual tools used in the 
development and application of the different methods (Chapter 2). 
 
(ii) The establishment and application of integrated tools for the sampling and 
isolation of planar polycyclic mutagens from surface waters and development of an effective 
fractionation procedure for these compounds (Chapter 3). Blue rayon passive sampling, ion 
exchange solid-phase extraction, RP-LC fractionation and Ames testing for mutagenicity were 
the major tool utilised. 
 
(iii) The development of analytical tools for the analysis of planar mutagens using an 
LTQ-Orbitrap, with the aim of providing a list of candidate compounds in mutagenic fractions 
(Chapter 4). The optimisation of the LC-MS method using chemical standard is described 
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followed by two procedures to identify contaminants present in fractions N-2-8 and N-7-12. 
The first approach was target identification, using a chemical library composed by the 
chemical standards used for methods development and compounds produced in the sampling 
site. The second approach was identification of unknowns based on fragmentation studies of 
the standards by ESI and APC using search and fragmentation prediction in 
ChemSpider/PubChem. 
 
(iv) The development of a chemical-analytical approach to prioritise and decrease the 
number of candidates (Chapter 5). The chemical method used chromatographic retention 
prediction of candidate structures in comparison to measured retention of the analytes. The 
biological approach was based on nitrenium “theory” energy to predict the mutagenicity of 
the candidates. 
 
Finally, this thesis concludes with the discussion of future research directions for the 
field. 
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CHAPTER 2: SCIENTIFIC BACKGROUND 
 
2.1 Effect-directed analysis 
 
One of the difficulties encountered in understanding the biological effects of exposure 
to organic pollutants is the multitude of contaminants at trace concentrations that combined 
with numerous natural compounds that are present in surface waters. Although chemical 
analytical techniques have advanced detection methods for most target analytes in trace 
concentrations, major challenges cannot be addressed by analytical chemistry alone.  The 
complexity of environmental samples which typically contain tens of thousands of 
compounds precludes the analysis of all individual compounds. Also, the need for 
understanding the how concentrations of target analytes affect the hazards and risks of the 
complex mixture. To address these limitations, bioassays can be utilised to detect and quantify 
the effects of complex mixtures. However, they provide no or very limited information on the 
individual substances causing the effects. Thus, only the integration of chemical-analytical 
and bioanalytical techniques allow the identification of which components of a mixture 
significantly contribute to the toxic effects. This requires effect-directed complexity reduction 
by combined fractionation and biotesting aiming at an elimination of non-toxic fractions from 
the sample. Such combinations of chemical and biological methods are becoming more 
common (as seen in [24] with about 10 publications in 1990 and over 300 in 2008).  
Effect-directed analysis (EDA) is the most prominent non-target approach to identify 
toxicants in the environment and has been applied since the late 1970s [5].  The method has 
been improved significantly. However, EDA is still far from being applicable in routine 
monitoring and success rates are still well below what is required. Therefore, the development 
and integration of novel promising analytical and prediction tools into EDA is urgently 
needed. 
Since its development EDA has been applied to complex mixtures from different pools 
of aquatic systems [25-30]. The principle of EDA is presented in Figure 2-1 [31]. EDA 
involves stepwise fractionation procedures to separate the compounds according to their 
physico-chemical properties (e.g. hydrophobicity, planarity, polarity, molecular size and 
presence of functional groups). At each fractionation step, bioassays identify the active 
fractions.  The non-active fractions can then be discarded from further processing, enabling 
the prioritisation of the most active fractions. These fractionation procedures can involve as 
many steps as necessary to simplify the fractions for chemical analysis and structure 
elucidation, which are increasingly integrating predictive computer tools.  The most 
commonly used techniques for the identification step are chromatographic methods coupled 
with mass spectrometry. Nuclear magnetic resonance (NMR) or infra-red (IR) are often not 
suitable for the analysis in EDA as the amount and purity of compounds are often insufficient 
[22]. Finally, the tentatively identified compounds need to be confirmed as the cause of 
toxicity. This includes the confirmation of the molecular structure e.g. by comparison with 
analytical standards and the confirmation of the contribution to toxic effects [22].  
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loss of sodium bisulphate. This reaction is illustrated in Figure 2-3. One gram of dry cotton 
contains 10 µmol of CPT. 
N
N
N N
N
N
N
N
C u
-
SO 3 Na
Na O 3S
SO 3 Na
SO 2NH SO2-CH2-CH2-OSO3Na
+ Cellulose - OH
NaHSO4
N
N
N N
N
N
N
N
C u
-
SO 3 Na
Na O 3S
SO 3 Na
SO 2NH SO2-CH2-CH2-O-Cellulose
 
C.I Reactive Blue 21    Copper phthalocyanine trisulsulphonate-fibres 
 
Figure 2- 3: Synthesis of blue fibres (redrawn from [16]) 
 
In order to increase the concentration of CPT in the support and therefore the number 
of binding sites for contaminants, amorphous rayon fibres, which is an artificial fibre, was 
used to carry the CPT ligands. Rayon fibres can be efficiently washed with solvents. With the 
same synthesis process as blue cotton, about three more CPT was bound to the rayon than 
bound to the cotton (30 µmol of CPT /g of dry rayon).  
More recently, blue chitin [16], which is the powder version of the blue rayon, was 
developed. Chitin is a poly-N-acetylglucosamine and can be stained with copper 
phthalocyanine trisulphonate (CPT) pigments in its powder form [16] and has an even greater 
concentration of CPT than blue rayon (40 µmol of CPT /g of powder). Blue chitin is suitable 
for preparing a packed column [33].  
CPT complexes are very stable and cannot be released without the use of solvent 
mixtures [34]. When used in situ, the adsorption process is dependent on concentration and 
the velocity of the water stream [35,36]. The pigment itself is not sensitive to light and 
temperature, but the adsorbed compounds can be, and care has to be taken following 
exposure. 
Hayatsu [16] tested the recoveries of planar compounds with different numbers of 
aromatic rings. In general, recoveries are good (between 60 and 100 %) for compounds with 
three or more fused aromatic rings, decreasing with decreasing numbers of fused rings as seen 
in Table 2-1.  CPT, shown in Figure 2-3, has a large planar structure and the mechanism of 
adsorption to the blue fibre is directly related to the planarity of compounds. Planar chemicals 
in solution form a 1:1 complex with CPT based on strong π-π interactions between the 
extensive heterocyclic aromatic system of CPT and the aromatic ligands. The increasing 
polarisability of the ligands due to an increasing aromatic system or specific substituents 
results in greater dispersion forces (dipole-induced dipole interactions) and thus greater 
stability of the complexes. However, the stabilisation effect of substituents can be disturbed if 
coplanar interaction is hindered [37]. Thus, large aromatic compounds will form more stable 
complexes with CPT than small aromatic compounds. However, there are some exceptions, in 
which the geometry of the substituents may be involved. For instance, actinomycine D and 
carminic acid, which both contain three fused rings, have poor recoveries in comparison with 
other compounds with three fused rings. This can be explained by the presence of non-planar 
substituents causing a steric distortion of the aromatic molecule, decreasing the π-π 
interactions and thus the stability of the complex [37]. In contrast, 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine and quercetin have high recoveries (95 %) despite containing 
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only two aromatic rings in their structure. In this case, the aromatic ring substituent is directly 
linked and conjugated to the two ring structure, such that the size of the planar molecule is 
comparable to a three ring system [16]. Therefore, blue fibres are specifically able to adsorb 
planar compounds, with the best recoveries expected for compounds with more than three 
fused rings.  
 
Table 2- 1: recoveries of compounds by blue cotton [16] 
Number 
of rings 
Example (recovery) Example exceptions Recovery 
(from-to %) 
≥ 5 Benzo(a)pyrene (95%) 
 
 85 -95 
4 1-nitro-pyrene (80%) 
NO2
 
 80-100 
3 2-amino-3-
methylimidazo[4,5-f] 
quinolone (90%) 
N
N N
NH2
CH3
 
Actinomycine D (25%) 
N
O
CH3
NHO
NH2
O
CH3
NH O
NH
O
CH3
O
O
N
O
CH3 CH3
H
O N
CH3
O
N
CH3
CH3CH3
NH
O
CH3
O
O
N
O
CH3CH3
H
ON
CH3
O
N
CH3
CH3 CH3
 
Carminic acid (40%) 
O
OH
OH
OH
OH
OH
OH
OH
O
O
OH
OH
O CH3
 
60 - 95 
2 Adenine (10%) 
NH2
N
N
N
H
N
 
 
2-amino-1-methyl-6-phenylimidazo[4,5-b] 
pyridine (95%) 
N
NN
NH2
CH3
 
Quercetin (95%) 
O
OH
OHO
OH
OH
OH
 
0 - 35 
1 Histidine (2%) 
NH2
N
N
HOH
O
 
 
 0 - 35 
0 Nitrosodimethylamine 
(0%) 
CH3N
CH3
NO  
 0 - 20 
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- Solid phase extraction 
The blue fibres can also be used as a sorbent for solid phase extraction to concentrate 
the planar compounds from sampled waters. They can be used in two different ways:  
 
(i) Drop in flask: water is collected and bottled at the sampling site. Fibres packed in a 
plastic net are immersed in the bottle (e.g. 1 g of BR/L of sampled water [34]), which is 
manually shaken for 30 min. The net is then taken out of the bottle, the fibres are rinsed with 
distilled water, dried by blotting the fibres onto a paper towel and kept for extraction in the 
laboratory. This method can be used in the field [34] to avoid transporting samples, or in the 
laboratory [52].  
 
(ii) Fibres in column: the blue rayon/cotton is packed in glass columns. Water samples 
are collected and passed through the column. The recommended ratio of BR (g) per litre of 
sample is from 0.2 to 0.5 g for treated water and 1 g per litre for raw water [13]. The flow 
rates ranged from 10 mL/min [53] to 50 mL/min at room temperature [13,39,54,55]. After 
passing the sample through the column, the blue rayon is removed from the glass column, 
washed several times with distilled water to remove suspended matter and non-adsorbed 
compounds [13,39,54], dried with a clean paper towel and kept for extraction. The blue rayon 
can also be kept in the column [55], rinsed with distilled water and dried using airflow. 
 
2.2.1.3 Hanging method vs. solid phase extraction method 
 
In general, there are advantages and disadvantages to both passive and active sampling 
methods. Drawbacks to traditional water sampling methods are: (i) insufficient volume of 
water to satisfy the detection limit requirement of analytical methods, (ii) the water sample 
represents only the contaminants present at the time of sampling, such that episodic events are 
often missed, (iii) the need of repetitive sampling in order to estimate the time-weighted 
average (TWA) concentration of the pollutant of interest, which are essential in risk 
assessment of chemical stressors, and (iv) repetitive sampling can be physically, logistically 
and financially difficult [56]. However, these shortcomings are overcome by the use of 
passive sampling methods, that have the advantages of: (i) devices used are generally simple 
and reliable, (ii) low cost as only one device is necessary at a given sampling location, (iii) 
provide TWA concentrations of the contaminants of interest, (iv) concentrating ultra-trace 
levels of contaminants, enabling sufficient sampling requirements for the detection limit of 
the analytical methods and (v) no large volumes of water have to be transported.  The main 
drawbacks of the passive samplers are that: (i) they do not enable the calculation of toxicant 
concentration in water, as it is not possible to calculate the amount of water sampled, and 
hence provide only semi quantitative concentrations (e.g. BR concentrations are given in the 
form of g of chemical/g of BR [30]), (ii) to predict TWA concentrations they require 
calibration at appropriate temperature ranges that will be encountered in the field deployment 
for each targeted toxicant [57], and (iii) the uptake rate can be disturbed by water turbulences, 
water temperature and biofouling [21].  
In effect-directed analysis (EDA) studies, both sampling methods can be used as long 
as there is enough material for fractionation, biotest and then identification of the chemicals 
responsible for the toxic effects.  In the case of BR, the hanging method has the advantages of 
passive sampling over conventional sampling (water collection and extraction). As the blue 
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fibres are placed for a longer period of time (24 hours), the analytes are accumulated.  The 
result is time-weighted average concentration, which eliminates the risk of non-detection due 
to variations within 24 hours. Furthermore this technique proved to be an efficient, reliable, 
easy and convenient method to concentrate polyaromatic mutagens in water and thus was 
chosen to collect the sample used in this thesis work. 
2.2.1.4 Extraction of the chemicals adsorbed on blue fibres. 
 
Compounds adsorbed to the blue fibres, either from the field or from columns, can be 
recovered by elution with hydrophilic organic solvents, most effectively with 
methanol/ammonia mixtures (50:1, v/v). Ammonia may help to dissociate the complex by 
coordinating itself to the central metal of the ligand [16].  The pieces of blue fibres are 
immersed in this methanolic mixture and agitated for at least 30 minutes, then repeated with a 
fresh methanolic mixture. The extracts are then combined and evaporated. 
 
2.3 Mutagenicity testing of surface waters 
2.3.1 Ames bioassay 
 
There are many tests for detecting the mutagenicity of surface waters, and bioassays 
with bacteria have proven to be very effective for monitoring due to their sensitivity, low cost, 
reliability and performance within a short time [8]. Amongst these bacteria assays, the 
Salmonella mutagenicity test has been the most widely used to screen mutagenicity in waters 
[8,14,53,58-60]. The Salmonella mutagenicity test was developed by Ames in 1975 [61] and 
its use as well as the number of bacteria strains has been growing ever since. It is based on 
strains of Salmonella typhimurium that carry mutations in the genes involved in histidine 
synthesis and thus require histidine for growth. In the presence of mutagenic agents, 
reversions back to the non-auxotrophic state can occur resulting in growth in histidine-
deficient medium, while non-mutated cells do not grow [61]. Each strain contains a different 
type of mutation in the histidine functional unit of the bacteria genome [61,62]. 
DNA mutation can occur via several mechanisms. Compounds can react with the 
DNA, resulting in the creation of DNA adducts or base deletion, which distort the DNA 
structure [63]. This distortion can disrupt enzymatic DNA repair and replication, increasing 
the chance of erroneous base replacements, deletions or insertion of base pairs [63]. There are 
two types of mutations in the Salmonella strains. Firstly, in base-pair substitutions only a 
single base of the DNA sequence is modified, such as, the replacement of leucine 
(GAG/CTC) by proline (GGG/CCC). Secondly, frameshift mutations occur where a few bases 
are inserted or deleted. Mutation will affect the reading frame of a nearby repetitive C-G-C-G- 
C-G-C-G sequence [64]. The strain TA100 is specially constructed to detect base pair 
mutations while TA98 is sensitive to frameshift mutations.  
Some chemicals (e.g. nitro-compounds and aromatic amines) are biologically inactive 
and need to be metabolised to form active compounds (e.g. by cytochrome P450). Thus, to 
make the Ames test sensitive to these indirect mutagens, external metabolic activation was 
introduced using S9 mix, which contains liver homogenates from rats [61].  
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2.3.2 Different strains of Salmonella and their use 
 
Within the last decade, new strains of Salmonella were engineered on the basis of 
TA98 and TA100 which are particularly sensitive to specific groups of mutagens with certain 
functional groups in their molecular structure (e.g. nitro- and amino-groups). The aim of the 
new engineered strains, such as YG-type strains, is to gain information regarding the 
relationship between the presence of functional groups and mutagenicity. For instance some 
nitroarenes and aromatic amines are highly mutagenic and are widely distributed in the 
environment due to their common use in many industries (e.g. dyes used in textile, paper, 
plastic, pharmaceuticals, cosmetics and food) [65]. These chemicals require several metabolic 
steps to become mutagenic [65-68]. The mechanisms of activation of nitroarenes and aromatic 
amines are presented in Figure 2-5 and Figure 2-6, respectively. The initial step is the N-
reduction (nitroarenes) or N-oxidation (aromatic amines) to the corresponding N-
hydroxylamine, which undergoes N-O bond cleavage to a reactive electrophilic nitrenium ion 
intermediate [65,67,69].  This is a di-coordinate nitrogen intermediate with a single pair of 
electrons and a positive charge on the nitrogen [67]. This nitrenium is the highly reactive 
intermediate able to covalently bind and damage the DNA.  
The YG-type strains over-express nitroreductase- and/or O-acetyltransferase, resulting 
in an increase of metabolisation to the DNA-reactive form and, thus increased mutagenicity. 
 
 
 
 
 
 
 
 
 
Figure 2- 5: Mechanism of nitroarenes activation 
 
 
 
 
 
 
 
 
Figure 2- 6: Mechanism of aromatic amines activation [69] 
 
The YG-type strains are all derivatives of TA98 or TA100.  YG1021 is derived from 
TA98, has elevated nitroreductase activity and is highly sensitive to nitroarenes [68]. YG1024 
and YG1029 were derived from TA98 and TA100 respectively. Both strains have elevated O-
acetyltransferase activity, increasing their sensitivity to aromatic amines [68]. YG1041 and 
YG1042 are also derivatives of TA98 and TA100, respectively and have enhanced levels of 
nitroreductase and O-acetyltransferase activity and are highly sensitive to nitroarenes and 
aromatic amines [70]. Thus, significantly higher mutagenicity in these YG-type strains in 
comparison to TA98 and TA100 is expected where aromatic amines and/or nitroarenes are 
present [8]. This can be observed in Table 2-2, where examples of identified chemicals using 
Nitroreductase - OH-ArNO2 
OH 
H 
ArN 
Mutations 
H ArN
+
 
DNA adducts 
Cytochrome P450 O-acetyltransferase
ArNH2 
OH 
H 
ArN 
Mutations H ArN
+
 
O-CO-CH3 
H 
ArN 
Non enzymatic   
loss of acetate 
DNA adducts 
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the BR sampler and Salmonella strains (TA- and YG-types) are presented. The YG-type 
strains are much more sensitive than TA-type strains as soon as aromatic amines and/or 
nitroarenes are involved in the mutagenicity. The number of revertants is always much greater 
in the YG-type strains than it is in the TA-type strains with and without the S9 mix.  Thus, the 
use of these specific strains can provide information regarding the presence or absence of 
nitroarenes and/or aromatic amines. The second observation concerning the different strains is 
that base pair substitution strains (TA100, YG1029 and YG1042) are not as sensitive as the 
frameshift strains (TA98, YG1024 and YG1041), inducing less revertants than the frameshift 
strains.  
 
Table 2- 2: Molecules found with the blue rayon/cotton or blue chitin with the Salmonella strains   
used. # no CAS Number present in databases. – no mutagenicity detected 
Molecules identified and involved in 
the mutagenicity of a BR extract 
[CAS Number]  
Salmonella strains Mutagenicity 
(number of 
revertants) 
Reference 
2-amino-3-methylimidazo[4,5-
f]quinoline (IQ) [76180-96-6] 
N
N
N
NH2
CH3
 
2-amino-9H-pyrido[2,3-b]indole (AαC) 
[26148-68-5] 
N
H
N
NH2
 
1,4-dimethyl-5H-pyrido[4,3-b]indol-3-
amine  (Trp-P-1) [62450-06-0] 
N
H
N
NH2
CH3
CH3  
TA98 + S9 (1 g BR) 
YG1024 + S9 (0.2 g BR) 
TA100 + S9 (1 g BR) 
YG1029 + S9 (0.2 g BR) 
 
From 161 to 890 
From 502 to 1775 
- 
- 
 
 
 
 
 
 
 
These three 
identified 
compounds 
accounted for 
26% of the total 
mutagenicity of 
the BR sample 
[42] 
1,4-dimethyl-5H-pyrido[4,3-b]indol-3-
amine (Trp-P-1) 
 
1-methyl-5H-pyrido[4,3-b]indol-3-
amine  (Trp-P-2) 
N
H
N
NH2
CH3  
TA100 – S9 
TA100 + S9 
YG1024 – S9 
YG1024 + S9 
YG1041 – S9 
YG1041 + S9 
YG1042 – S9 
YG1042 + S9 
- 
- 
- 
From 0 to 4571 
From 1297 to 
3278 
From 0 to 3185 
From 0 to 1731 
- 
 
[47] 
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Molecules identified and involved in 
the mutagenicity of a BR extract 
[CAS Number]  
Salmonella strains Mutagenicity 
(number of 
revertants) 
Reference 
2-[2-(acetylamino)-4-[bis(2-
methoxyethyl)amino]-5-
methoxyphenyl]- 5-amino-7-bromo-4-
chloro-2H-benzotriazole (PBTA-1) 
N
N
N
Cl
NH2
Br
NH
CH3
O
N
O CH3
O CH3 
TA98 + S9 
TA100 + S9 
 
7300 
223 
[71] 
2-[2-(acetylamino)-4-[N-(2-
cyanoethyl)ethylamino]-5-
methoxyphenyl]- 5-amino-7-bromo-4-
chloro-2H-benzotriazole (PBTA-2) 
[215245-16-2]
 
TA98 + S9 
TA100 + S9 
 
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
8600 
307 
 
93000 
520 
3200000 
39000 
[71] 
 
 
[11] 
2-[2-(acetylamino)-4-[(2-
hydroxyethyl)amino]-5-
methoxyphenyl]-5-amino-7-bromo-4-
chloro-2H-benzotriazole (PBTA-3) # 
N
N
N
Cl
NH2
Br
NH
CH3
O
N
H
OH 
TA98 + S9 
YG1024 + S9 
 
81000 
3000000 
[12] 
2-[2-(acetylamino)-4-amino-5-
methoxyphenyl]-5-amino-7-bromo-4-
chloro-2H-benzotriazole (PBTA-4) # 
N
N
N
NH2
Br
NH
CH3
O
NH2
Cl
 
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
19000 
310 
7800000 
15000 
 
[43] 
2-[4-[bis(2-acetoxyethyl)amino]-2-
(acetylamino)-5 -methoxyphenyl] -5-
amino-7-bromo-4-chloro-2H-
benzotriazole (PBTA-5) #
N
N
N
NH2
Br
NH
CH3
O
N
Cl
O
CH3
O
CH3
O
O
 
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
56000 
387 
723000 
1580 
 
[48] 
 
 
Br
Cl O
O
NN
NH
N
N
NH2
N
CH3
CH3
CH3
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Molecules identified and involved in 
the mutagenicity of a BR extract 
[CAS Number]  
Salmonella strains Mutagenicity 
(number of 
revertants) 
Reference 
2-[2-(acetylamino)-4-[bis(2-
hydroxyethyl)-amino]-5-methoxy-
phenyl]-5-amino-7-bromo-4-chloro-
2H-benzotriazole (PBTA-6) #
N
N
N
NH2
Br
NH
CH3
O
N
Cl
OH
OH
 
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
17900 
146 
485000 
953 
 
[48] 
2-[2-(acetylamino)-4-(diethylamino)-5-
methoxyphenyl]-6-amino-4-bromo-7-
chloro-2H-benzotriazole (PBTA-7) #
N
N
N
NH2
Br
NH
CH3
O
N
Cl
CH3
CH3
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
43000 
393 
1430000 
648 
[50] 
2-[2-(acetylamino)-4-[(2-
hydroxyethyl)amino]-5-
methoxyphenyl]-6-amino-4-bromo-2H-
benzotriazole    (non-Cl-PBTA-3) # 
N
N
N
NH2
Br
NH
CH3
O
N
H
OH
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
 
1060 
36 
159000 
640 
[49] 
2-[2-(acetylamino)-4-(diethylamino)-5-
methoxyphenyl]-6-amino-4-bromo-2H-
benzotriazole    (non-Cl-PBTA-7) #
N
N
N
NH2
Br
NH
CH3
O
N
CH3
CH3
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
1520 
512 
178000 
1100 
[49] 
4-amino-3,3'-dichloro-5,4'-
dinitrobiphenyl#   
 
NO2NH2
O2N
Cl Cl  
 
TA98 - S9 
TA98 + S9 
TA100 - S9 
TA100 + S9 
YG1024 - S9 
YG1024 + S9 
YG1021 - S9 
YG1021 + S9 
66000 
1700 
880 
90 
140000 
2900 
7700 
3000 
[46] 
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Molecules identified and involved in 
the mutagenicity of a BR extract 
[CAS Number]  
Salmonella strains Mutagenicity 
(number of 
revertants) 
Reference 
3,3’-dichlorobenzidine      [1194-65-6]
Cl
Cl
NH2 NH2
 
YG1024 - S9 
YG1024 + S9 
YG1029 - S9 
YG1029 + S9 
266000 
189000 
2100 
25300 
[30] 
4,4’-diamino-3,3’-dichloro-5-
nitrobiphenyl
NH2NH2
O2N
Cl Cl  
TA98 + S9 
TA100 + S9 
YG1024 + S9 
YG1029 + S9 
 
8700 
100 
24200 
900 
 
[45] 
 
2.4 Separation in EDA studies 
 
In general, separation in EDA is an important step as it is used to isolate compounds 
within different fractions, but also provides information that can be used during analytical 
identification. 
In order to sequentially reduce the complexity of environmental samples by the 
removal of non-toxic substances, fractionation methods are used. They are based on different 
physico-chemical properties of the analyte including: polarity, hydrophobicity, ability of 
protonation/deprotonation, molecular size, planarity and the presence of functional groups 
[72]. The fractionation provides information on the physical-chemical properties of the 
compounds present in the sample. Such information is then used during the identification 
procedure of the EDA study.   
In most cases, aqueous samples are fractionated using reversed-phase high-
performance liquid chromatography (RP-HPLC) to simplify the samples [72]. RP-HPLC 
separation is predominantly based on lipophilicity, expressed by the octanol-water 
partitioning coefficient (log Kow). Most of RP-HPLC applications are carried out with 
octadecyl silica (ODS) columns [12,30,46,49,73,74]. However, numerous new stationary 
phases with other functionalities have been developed and provide different selectivity to the 
traditional C18 and C8 stationary phases [73,75,76]. For instance, in addition to lipophilicity, 
amino- phases provide acid-base interaction with analytes, cyano- phases provide dipolar 
interactions, phenyl- phases provide π-π interactions, and nitro- phases provide strong dipolar 
interactions [75]. Thus, the different physical-chemical properties of analytes, such as size and 
electron density of aromatic systems, intramolecular steric hindrance or hydrogen bonds can 
be exploited to reach the maximum separation between the different compounds in water [77].  
The main disadvantage of RP-HPLC fractionation is the requirement of additional solid phase 
extraction (SPE) to concentrate the chemicals for analysis or biotesting. The main advantage 
of using RP-HPLC fractionation method is it provides information about lipophilicity of the 
toxic analyte [72].  
Log Kow represents a good model for retention of neutral compound on C18 columns. 
A correlation between the retention time and the log Kow can be used to determine the log Kow 
range of each fraction and thus, assign a log Kow range for peaks within the fraction of 
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interest. During the identification procedure, the log Kow of each candidate can be calculated 
by EPISuite [78] and compared with the determined range of the fraction. Thus, candidates 
can be eliminated or kept depending if their log Kow is within the defined log Kow range of the 
fraction. However, in the case of complex molecules, for which the presence of multiple 
functional groups can involve additional interactions to the lipophilicity, the prediction based 
on the log Kow approach can be less accurate. To address to this limitation another tool, based 
on the Abraham equation [79], can be used and is further described below, Section 2.7.1. 
 
Alternatively or in addition, chemicals in aqueous samples can be separated into acid, 
base and neutral fractions, using ion-exchange separation techniques. This separation 
procedure is based on the ability of chemicals to be protonated and deprotonated according to 
the solution pH. This ability is given by the acid dissociation constant of the analytes (Ka, 
typically expressed by the logarithm form pKa). Thus, in solution at low pH, basic compounds 
are protonated, while neutral and acidic compounds remain non-charged. In high pH 
solutions, acidic compounds are deprotonated while neutral and basic compounds are not 
charged. By adjusting the pH of the solution, chemicals are protonated, deprotonated or 
neutral and can be separated by charge. Laven et al. [80] used serial mixed-mode cation- and 
anion-exchange solid-phase extraction to separate basic, neutral and acidic pharmaceuticals in 
wastewater. The two different polymeric phases used in SPE contain sulphonate anion 
functional groups to selectively interact with the protonated basic compounds at pH 2 or 
quaternary ammonium cation functional groups to selectively interact with deprotonated acid 
at pH 11. By the combination of these two ion-exchange phases the three classes of 
pharmaceutical were successfully separated. 
 
2.5 Analytical methods in EDA studies 
 
In general, identification of unknowns relies mainly on information gained by 
chromatography connected to mass spectrometry.  
Gas chromatography-mass spectrometry methods (GC-MS) have largely contributed 
to the characterisation of non-polar contaminants in different matrices and are often used in 
EDA studies [4,26,81,82]. This is due to the availability, ease of use and reproductibility of 
the method. This method presents also the advantage of a hard ionisation (e.g. electron 
ionisation) enabling the production of numerous fragments and/or easily identifiable mass 
spectra [83]. Large spectral databases (e.g. NIST) are available and suitable to identify 
pollutants. The major disadvantage of GC-MS methods is the limited range of compounds 
that can be analysed. Only compounds that vaporize below about 300°C and are stable up to 
this temperature can be successfully detected, eliminating those with low volatility, thermal 
instability, or high polarity [84].  
Liquid chromatography-mass spectrometry (LC-MS) methods are becoming 
increasingly popular as they extend the investigation of water contaminants to non-volatile, 
polar and highly polar, and thermally labile compounds.  This has allowed the detection of 
chemicals that were not routinely detected historically (e.g. pharmaceuticals, pesticides and 
personal care products) [85]. Many more compound classes can be determined by LC-MS 
than GC-MS because of the broad scope of high pressure liquid chromatography (HPLC), 
including reversed phase, normal phase, and ion exchange [84].  This variety of stationary 
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phases allows for selective, efficient separation without derivatisation. For instance, the use of 
different stationary phases in combination proved to be efficient in separing polyaromatic 
compounds into distinct compound groups according to polarity, planarity and number of 
aromatic rings, in one HPLC run [77].  
LC-MS/MS analyses are performed most commonly with (i) electrospray (ESI), an 
ionisation process that uses electrical fields to generate charged droplets and subsequently 
generate analyte ions by evaporation and (ii) atmospheric pressure chemical ionisation 
(APCI), which is a gas phase chemical ionisation process where the evaporating solvent acts 
as the chemical reagent to ionise the analytes [86]. As a simple rule, analytes that can be 
ionised in solution are more suitable for ESI methods, while other analytes are more suitable 
for APCI [87,88]. Complementary ionisation techniques can be used to cover the widest range 
of identified compounds. In comparison with electron ionisation, ESI and APCI are 
considered as soft ionisation techniques and generally only provide information about the 
molecular weight of substances. However, this can be useful, especially with tandem high 
accuracy mass spectrometry.  This method provides the exact molecular weight of the 
compounds (MS) and the exact mass of fragments (MSn) and thus information regarding the 
substructure of the compounds. LC coupled to high resolution mass spectrometry is an 
efficient technique for identification of pollutants in water.  
There are different instruments that provide high resolution mass spectra including 
time-of-flight (TOF), quadrupole TOF and Orbitrap. Of particular interest, the LTQ-Orbitrap 
MSMS combines the tandem mass spectrometry capability of the ion trap with the high 
resolution and mass accuracy capability of the Orbitrap. This combination provides high-
accuracy mass measurements of the precursor ions and their product ions (MSn), resulting in 
the determination of the m/z of an ion within 5 ppm and covers a wide mass range for 
detection [89]. However this technique suffers from the lack of spectral libraries as the 
libraries existing for GC-MS techniques and identification by LC-MS methods requires 
strategies and the assistance of computer programs. 
 
2.6 Strategies for identification of toxicants 
 
When analysing a mixture that contains known and unknown compounds at low 
concentrations in complex samples, LC coupled to high resolution MS has opened new 
perspectives in chemical identification. In recent years, several strategies were developed to 
identify target and non-target pollutants in environmental samples. There are three types of 
analytical approaches: (i) target analysis based on analytical standards, (ii) suspects screening 
without reference standards, and (iii) non-target analysis for identification of unknowns 
without reference standards [90]. A workflow for these approaches is presented in Figure 2-7. 
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Sampling, extraction, purification
HPLC separation and high resolution mass spectrometry
Target analysis     
with reference 
standards
Target ion list
Exact mass filtering
Matching of measured Rt
with Rt of standards
Matching of measured and 
predicted MS/MS with that of 
reference standards
Non-target screening 
without reference 
standards
Automated exact mass 
filtering and peak detection
Non-target ion list
Elemental formula fit by 
heuristic filtering of 
molecular formula
Structure search in database
Matching of measured Rt
with predicted Rt of 
database hits
Matching of measured and 
predicted MS/MS 
fragmentation of database hits
Suspect screening 
with reference 
standards
Suspect ion list
Exact mass filtering
Matching of measured 
and theoretical isotope 
pattern of suspects
Matching of measured Rt
with predicted Rt of suspects
Matching of measured and 
predicted MS/MS 
fragmentation of suspects
Quantification of targets List of likely present suspects List of likely present unknowns
 
Figure 2- 7: Workflows for the three identification procedures of pollutants in environmental  
samples by using LC-high resolution-MS (redrawn from [90]).  
 
2.6.1 Target analysis approach 
 
This approach is designed to identify known compounds that are present in samples. It 
relies on the use of reference standards for which exact mass, retention time and MSn 
fragments are known (Figure 2-7). The identification criteria for confirmation of a target 
analysis approach using HRMS and an Orbitrap have been discussed by Hogenboom et al. 
[91] and are: (i) LC retention time, (ii) accurate mass of the precursor ion (using a resolving 
power of 100000) and, (iii) fragmentation pattern. Full-scan accurate mass measurements of 
the analytes are compared with theoretical exact masses of standard references. Confirmation 
of the identity is done by comparing the retention time and the fragmentation pattern of the 
analyte to the reference standard.  
Most of the target analysis approaches are applied to water analysis of pharmaceuticals 
[92] and required a self-created accurate mass database. Such methodology allows the 
determination of a large number of compounds in a single analysis, provides information 
about the presence of contaminants in the environment [93] and can be applied in routine 
analysis [92]. The main drawback of this approach is the limitation of the database due to the 
lack of environmental standard references. 
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2.6.2 Suspect compounds screening approach 
 
In contrast to target analysis, the suspects screening approach does not rely on 
reference standards, but on suspect compounds for which specific information, such as 
molecular formula and structure are available. Suspect-compounds can include transformation 
products (TPs) and/or industrial produced compounds that are expected in waste water 
effluents. This approach relies on exact mass filtering followed by the match of predicted 
parameters of the suspected compounds with the parameters of the unknown compounds to 
identify (Figure 2-7). One parameter involved in this approach is retention time in RP-LC 
often using hydrophobicity (log Kow) as a retention predictor. The other is MSn fragmentation 
interpretation and prediction [94]. Both approaches are described in more detail in Section 2.4 
(log Kow) and in Section 2.6.3 (MSn prediction). 
First, the empirical formula allows the calculation of an exact m/z of the suspected ion, 
which is then extracted from the high resolution full-scan chromatogram. Second, in the case 
of a positive match, predicted retention time is compared to the retention time of the 
unknown, and third, in the case of a positive match, the predicted MSn fragments are 
compared with the unknown MSn fragments. This approach was used by Kern et al. [94], who 
developed a procedure to screen for large number of suspected TPs in environmental samples. 
The created list of target TPs included 1794 compounds generated by a rule-based system to 
predict products of microbial metabolism. Using a six-step funnelling procedure (see [94] for 
more details), 19 TPs were identified in surface waters from agricultural areas. 
This approach requires an efficient filtering procedure, due to the large number of 
suspects, comprising rather straightforward and obvious criteria such as absence in analytical 
blanks and the match of the observed isotope patterns with theoretically predicted ones for the 
molecular formula of the suspect [90]. The suspect target screening procedure is highly 
efficient in narrowing down a large number of plausible TPs to those few that are actually 
present in a given environmental sample [94]. 
 
2.6.3 Non-target screening approach (unknown identification) 
 
Identification of unknown compounds is more challenging as the procedure starts 
without any information on the compounds to be detected [90]. There are several unknown 
identification procedures using different software (e.g. [91,95-101]), but three steps are 
common in typical screening workflow (Figure 2-7): (i) an automated peak detection by exact 
mass filtering from the high resolution full-scan chromatogram (e.g. Pitarch et al. [102] used 
the Chromalynx XS software to screen for non-targeted organic contaminants in 
environmental waters, Bataineh et al. [95] used the MZmine software for the identification of 
polar compounds in freshwater sediments), (ii) an assignment of an empirical formula to the 
exact mass of interest (e.g. Weiss et al. [101] used the composition tool provided in Xcalibur) 
and, (iii) a database search of plausible structures for the determined empirical formula (e.g. 
PubChem, ChemSpider) [93].  
The determination of the molecular ion from a given spectrum is one of the crucial 
steps during mass spectral evaluation. In most LC-MS studies, electrospray (ESI) and 
atmospheric pressure chemical ionisation (APCI) are used and both produce adducts such as 
[M+H]+ or [M+Na]+ or multiple others. Thus, the nature of the adduct has to be determined 
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before assigning the elemental composition using accurate mass measurements [103]. As soon 
as the elemental composition is known, database searches are performed and the resulting 
possible structures can be numerous. At this stage it is important to be able to rank the 
candidates for selection and exclusion from the list of candidates. This procedure usually 
involves HR-MSMS. However the search for unknowns in MSMS ion libraries is limited to 
the recorded spectra of analytical standards [84], which is not sufficient for a real unknown 
screening [90].  Hill et al. [98] showed that unknown chemical structures can be determined 
by matching their experimental fragmentation spectra with computational fragmentation 
spectra of compounds retrieved from chemical database and matching experimental MSn 
fragments with predicted fragments is a valuable tool to select candidates from database. 
 
MZmine is a software enabling data processing of LC-MS analysis. Its special features 
are: (i) input file manipulation, (ii) spectral filtering, (iii) peak detection, aiming to find the 
peaks in the measurement data, chromatographic alignment, which allow comparison in 
between LC-MS/MS runs by the search for corresponding peaks across different runs, (iv) 
visualisation of the peak shape of the extracted m/z as well as its area and height (after 
processing, data is exported as a delimited peak height and area matrix) and (v) data export to 
an excel sheet  in order to create csv files which are then used as “libraries” to compare and 
search other LC-MS/MS runs [104]. 
 
MOLGEN-MSMS [105] is a computer program that assigns the empirical formula to 
an unknown compound based on MS and MS2 experimental data. The program uses the 
measured exact mass of the unknown molecular ion to generate candidate molecular formulas. 
For each of these, the theoretical isotope pattern is compared to the measured intensities of the 
isotopic peaks in the MS to generate a match value. The MS2 fragments are then investigated 
to determine if a sub-formula of the candidate formula can be assigned to each peak, with a 
match value calculated based on the number of assigned fragments (within a given error 
range). The combined match value (based on the MS and MS2 data) can then be used to select 
the formula best fits the data. The exact mass error can also be taken into account.  
 
MetFrag [106] is a computer program designed to support the identification of 
metabolite using tandem mass spectra. However, it can also be used for the identification of 
other organic compounds such as environmental pollutants. This program is able to screen 
dozens to thousands of candidates retrieved from compound databases such as PubChem or 
ChemSpider. It performs an exact mass search in these databases using the m/z value of the 
unknown compound of interest. A list of candidates is provided along with their 
fragmentation based on the bond disconnection approach instead of using cleavage rules. 
These “theoretical” fragments are then compared with the experimental fragments of the 
unknown compounds. Based on the m/z and intensity of the fragments, bond dissociation 
energy and neutral loss comparison between “theoretical” and experimental fragments, the 
candidates are ranked. It is then easy to remove unlikely candidates with low scores from the 
list. For instance a candidate can be removed from this list if it cannot explain the most 
intense fragment. Thus, MetFrag is able to identify small molecules from tandem MS 
measurement among a large set of candidate structures.  
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2.7 Further classifiers to support identification 
 
Matching experimental with computational fragmentation spectra is a valid method for 
rapid discrimination of compounds having the same empirical formula. However, there are 
often several possible candidate structures for an individual peak and thus an empirical 
formula of a compound to be identified. Further classifiers are needed to exclude as many 
candidates as possible. Retention prediction and toxicity prediction can help in the selection 
of candidates. 
 
2.7.1 Retention prediction 
 
Retention indices are important tools to help reduce the number of possible structures 
derived from mass spectra [22]. However, retention indices are not available for all 
compounds and have to be predicted. Retention time predictions are done with quantitative 
structure retention relationships (QSRRs) that describe properties and retention behaviours of 
analytes [107]. A simple approach is the retention prediction from log Kow as explained above 
(Section 2.4). Since octadecylsilica stationary phases differ significantly from octanol with 
respect to possible analyte interactions, log Kow based predictions may be rather poor for 
compounds exhibiting polar interaction or hydrogen bonding. For more exact retention 
prediction for structure elucidation, linear solvation-energy relationships (LSERs) [79] may 
be used. They allow the prediction of retention properties of organic compounds in GC and 
LC. The equation is presented below (Equation 2-1) and contains different parameters 
describing the interactions between analyte and solvent.  Each of these interaction terms is 
calculated as the product of two complementary descriptors, one representing the sorption 
properties of the chromatographic column and the other describing the complementary 
property of the analyte [83]. The idea of Abraham equation is that the solute property has to 
be related to the partitioning process (e.g. log Kow, solubility) and retention [108]. 
 
Equation 2-1: solute property = aA + bB + sS + eE + vV + c 
 
The solute property describes the interactions between analytes and mobile phase and 
between analytes and stationary phase. The descriptor A, B, S, E and V characterise the 
potency of the compounds to interact with surrounding phases while parameters a, b, s, e and 
v characterise the phase. Descriptor A corresponds to the hydrogen bond acidity, expressing 
the ability of the compound to donate a proton in a hydrogen bond. Descriptor B corresponds 
to the hydrogen bond basicity, expressing the ability of a compound to accept a proton in a 
hydrogen bond. Descriptor S measures the solute dipolarity and polarisability. E describes the 
excess molar refraction, and McGowan volume V is calculated from the molecular 
composition. The coefficient a reflects the ability of the solvent to accept a proton in a 
hydrogen bond, coefficient b describes the ability of the solvent to donate a proton in a 
hydrogen bond, coefficient s describes polarisability and dipolarity of the phase, coefficient e 
represents the Van-der-Waals forces of the solvent, coefficient v is the cavity formation of the 
phase and coefficient c is the intercept of the equation [109-111].  
 
The solute property is the dependant variable of this equation and can represent 
different properties including the octanol-water partition coefficient (log Kow) or the 
chromatographic hydrophobicity index (CHI) [110].  The latter is directly connected to the 
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elution gradient of the LC system. CHI is defined as the percentage of solvent (organic 
modifier) needed to elute the analyte in a linear gradient. For instance, with a gradient from 0 
to 100 % of solvent, a CHI value of 80 means that the compound will elute when the gradient 
reaches 80% of solvent. The advantage of the CHI is that it is nearly independent from the 
gradient setup and column dimensions. The model does not need to be developed on each 
column and require only a “calibration” of the column used for the analyses. This calibration 
is usually done with standards that have known CHI value (see Chapter 5, Section 5-2 for the 
application).  
This prediction was found to be accurate enough to be an excellent tool to efficiently 
reduce the list of possible candidates [83] and could be included in EDA study as an 
additional classifier to MSn fragments. 
 
2.7.2 Mutagenicity prediction 
 
In EDA studies, only those chemicals that may cause the effect of concern are 
important. However, standards are not always available. Therefore, quantitative structure 
activity relationships (QSARs) [112] and structural alerts [63] are valuable tools to (i) select 
potentially active compounds from identified substances in a toxic fraction and (ii) to reduce 
and prioritise the number of candidates [113].  
Kazius et al. [63] showed that mutagenicity is often related to specific chemical 
substructures, which are presented in Table 2-3. These structural alerts may be used as a 
starting point of mutagenicity prediction. However, not all of the compounds sharing these 
substructures are mutagenic. For instance within the large group of aromatic amines, some are 
known to be mutagenic (e.g. 2-aminoanthracene (used as positive control in the Ames test), 2-
amino-3-methylimidazo-[4,5-f]quinolone [42], 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole 
[42]) while others are not (e.g. 1-amino,2-hydroxynaphthalene [69], aniline).  
 
Table 2- 3: Substructures involved in mutagenicity. Table adapted from [63]. 
Substructures Representation Substructures Representation 
Aromatic nitro 
aro
N
+ OO
-
Unsubstituted 
heteroatom-bonded 
heteroatom N,O
NH2,OH
 
Aromatic amine 
aro
NH2
Azo-type N = N 
Three membered 
heterocycle 
NH,O,S Aliphatic halide -Cl,Br,I 
nitroso N = O Polycyclic aromatic system aro
arom. ring
arom. ring
 
Quantitative structure activity relationships (QSARs) are used to predict physico-
chemical properties and effects of chemicals from the structure [114]. Aromatic amines and 
azaarenes are widespread substances used in industry (e.g. drugs, dyes, paper, leather, 
plastics, cosmetics, and food) including many mutagens. While diagnostic strains can be used 
to link mutagenic effects to this compound group, QSARs may be helpful to predict the 
individual mutagenic potency of candidate structures. This is particularly useful since the 
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mode of action of aromatic amines is well investigated and is related to the stability of 
nitrenium ions as the ultimate electrophilic metabolite that covalently binds and alters DNA 
[65-67,69] (see section 2.3.2).  
Nitrenium ions are di-coordinate nitrogen intermediates with a single pair and positive 
charge on the nitrogen [67]. Such intermediates are short-lived and recent studies have shown 
that increasing their life-time will increase their potential toward DNA binding [65,67,69], 
suggesting nitrenium stability is the key factor in mutagenicity. In general, nitrenium stability 
is strongly correlated with charge density at the exocyclic nitrogen (charge distribution over 
the molecule) and the following factors were found to have stabilising effects on the 
nitrenium ion: 
 (i) hyperconjugation and inductive effects [65,69,115], involving mainly methyl 
substituent in ortho- position of the amine group.   
(ii) mesomeric effects (resonance effects) [65,115], involving delocalisation of the 
cationic charge through the aromatic system. These effects increase with the increase aromatic 
rings due to greater delocalisation of the cationic charge. These effects can also be linked to 
hydrophobicity, since the increased number of rings leads to the increase of hydrophobicity. 
 It was noted by some authors [63,115], that bulk substituent in the positions adjacent 
to the amino group is unfavourable and leads to a decrease of potency. Borosky [65] also 
showed that the nitrenium ion stability decreases when the number of nitrogen atoms 
increases in the ring system. 
 
One calculation method to predict mutagenicity of aromatic amines, was developed by 
Ford et al. [116,117] and used a semiempirical method (AM1) to calculate the stability of the 
nitrenium. In this method, reaction energies are calculated relative to aniline, which is a non 
mutagenic aromatic amine. It was shown that the energy of formation of the nitrenium ion 
varies significantly between different amines compared to other reaction steps during 
aromatic amine activation. This suggests nitrenium ion formation is the rate limiting step. 
Using aniline as a reference compound for relative formation energy can be calculated for the 
reaction below.  
 
Ar-NH2 + PhN+H → Ar-N+H + PhNH2 
 
Ar-NH2 represents the parent amine, while Ar-N+H is the corresponding nitrenium ion. 
Similarly PhNH2 is aniline with PhN+H as the corresponding nitrenium.  
From this reaction, relative energies ΔΔE are calculated by the equation 2-2, where ΔE 
values correspond to the heat of formation (ΔHf) of the compounds: 
 
Equation 2-2: ΔΔE = ΔEAr-N+H + ΔEPhNH2 - ΔEAr-NH2 – ΔEPhN+H 
 
Since aniline has been found to be non-mutagenic in the Ames test, positive ΔΔE 
values are related to a low probability of being mutagenic. Negative ΔΔE values indicate high 
probabilities of Ames positive results.  
In the present thesis this method of mutagenicity prediction was used to decrease the 
list of candidates by removing candidates with a low probability of being mutagenic. 
 
 
The methods described above were implemented in the following chapters of this 
work, with the aim of proposing a limited list of candidates and/or identifying mutagens 
present in a water sample. 
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CHAPTER 3: DEVELOPMENT AND APPLICATION OF INTEGRATED 
TOOLS FOR SAMPLING AND ISOLATION OF PLANAR 
POLYCYCLIC MUTAGENS  
 
3.1 Introduction 
 
Planar aromatic compounds, including many polar compounds, have been identified as 
a key compound group in waste and surface waters responsible for mutagenicity [8]. These 
compounds include combustion and pyrolysis products [118] as well as many products and 
by-products of chemical industry such as dyes [119,120] and are often present as complex 
mixtures in waters [121]. Planar compounds including those with multiple fused aromatic 
rings can be sampled selectively using blue rayon (BR), a fibre (e.g. rayon, cotton) with a 
covalently-bound copper phthalocyanine trisulfonate pigment [16,40].  
The separation of this highly complex compound group is one of the major challenges 
for the isolation and identification of individual components and requires adequate 
fractionation procedures. Poly-aromatic compounds include different sub-groups, such as 
polycyclic aromatic hydrocarbons (PAHs) and more polar, water soluble derivatives 
[122,123], such as quinones, hydroxyl-, keto-, nitro-keto-, carboxylic- and nitro-PAHs and 
heterocyclic amines with one or more nitrogens in the ring system [123]. These different 
compound groups are characterised by different physico-chemical properties, which can be 
used to efficiently separate them. Their ability or non-ability to act as acids or bases is a key 
property that can be exploited for separation using ion exchange [73,80,122]. Another 
important property is lipophilicity as the tendency to partition from water into lipids, octanol 
or reversed-phase (RP) chromatographic stationary phases. Many EDA studies use reversed-
phase high pressure liquid chromatography (RP-HPLC) [72]. While lipophilicity is the main 
driving force in RP-HPLC, the availability of a broad variety of stationary-phases allows for 
the exploitation of additional and complementary interactions (see Chapter 2, Section 2.4) 
supporting a selective and efficient separation.  
The aim of this study was to use a passive sampling method and develop a 
fractionation method for planar aromatic and potentially mutagenic compounds with a broad 
range of polarity from surface waters. The development aimed at a multistep fractionation 
procedure with an acid/base partitioning step and orthogonal separation on different RP 
stationary phases. To optimise recovery, two different approaches were applied. Fractionation 
of artificial mixtures of standard compounds provided precise chemical analytical recoveries 
for initial method development steps. In addition, recovery studies on the basis of 
mutagenicity were performed. 
 
3.2 Materials and methods 
3.2.1 Chemicals 
 
HPLC grade methanol (MeOH), GC grade toluene, analytical reagent grade dimethyl 
sulfoxide (DMSO), acetic and methanoic acid were obtained from Merck (Darmstadt, 
Germany). The ammonium hydroxide solution (NH4OH) (25% in water) was obtained from 
Fluka and ammonium acetate from Sigma-Aldrich. Other analytical standards suppliers are 
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given in Table 3-1. The water used was bi-distilled in the laboratory. The blue rayon was 
purchased from Funakoshi Co. Ltd. (Tokyo, Japan). OASIS MCX, MAX and HLB solid 
phase extraction cartridges (1 g, 500 mg, and 200 mg respectively) were purchased from 
Waters (Milford, MA, USA). 
 
Table 3- 1: Name, structure and suppliers of the analytical standards used. 
Name Chemical structure Suppliers 
acridine 
N
Aldrich 
atrazine N
N
N
NHNH CH3
CH3
CH3
Cl
Promochem 
2-amino-3,8-dimethylimidazo[4,5-
f]quinoxaline (MeIQX) N
N
N
N
NH2
CH3
CH3
Toronto research 
Chemicals  
 
2-amino-3-methylimidazo[4,5-f]quinoline
(IQ) 
N
N
N
NH2
CH3 ABCR 
2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PHIP) 
N
N
N
NH2
CH3
ABCR 
2-amino-9H-pyrido[2,3-b]indole 
(AαC) N
H
N
NH2 MP biomedicals 
LCC 
benalaxyl 
O
N
CH3
O
OCH3
CH3
CH3
Ehrenstorfer 
benz[c]acridine N
Ges. für 
Teerverwertung 
 
benzanthrone 
O
Aldrich 
benzo[h]quinoline 
N
Aldrich 
benzophenone 
O
Fluka 
benzotriazole 
N
N
N
H
Fluka 
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Name Chemical structure Suppliers 
caffeine N
NN
N
O
O
CH3
CH3
CH3
Merck 
carbamazepine N
NH2
O
Sigma 
Aldrich 
carbazole 
N
H
Aldrich 
1-chloro-2,4-dinitrobenzene 
NO2
NO2
Cl
Sigma Aldrich 
1,4 chrysenquinone 
O
O
Chiron 
5,6 chrysenquinone 
O
O
Chiron 
4H-cyclopenta[def]phenanthren-4-one 
O
Chiron 
1,8 diaminopyrene 
NH2
NH2 Chiron 
   
3,3’dichlorobenzidine 
Cl
Cl
NH2 NH2 Riedel 
N,N’-diethyl-N,N’-diphenylurea N N
O
CH3CH3
Aldrich 
1,5-dihydroxyanthraquinone 
O
O
OH
OH
Aldrich 
1,3-dinitrobenzene 
NO2
NO2
Fluka 
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Name Chemical structure Suppliers 
1,8-dinitropyrene 
NO2
O2N Aldrich 
2,4-dinitrotoluene 
CH3
NO2
NO2
Sigma Aldrich 
9-fluorenone 
O
Aldrich 
1H-isoindole-1,3(2H)-dione NH
O
O
Riedel 
1-hydroxyanthraquinone 
O
OOH
Synthesised 
2-hydroxyanthraquinone 
OH
O
O
Tokyo Kasei 
3-hydroxybenzo(a)pyrene 
OH
Chiron 
1-hydroxypyrene 
OH
Chiron 
metazachlor N
O
Cl
NN
CH3
CH3
Fluka 
 
4-methyl-2-nitrophenol 
CH3
NO2
OH
Alfa Aesar 
1-methyl-9H-pyrido[3,4-b]indole 
(Harmane) 
N
H
N
CH3
Aldrich 
 
2-naphthalenamine, N-phenyl- 
NH
Aldrich 
1,4 naphthalene-dione 
O
O
Fluka 
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Name Chemical structure Suppliers 
2-naphthoic acid 
OOH
Alfa Aesar 
1-naphthol 
OH
Fluka 
3-nitrobenzanthrone 
NO2
O
Chiron 
nitrofen O NO2
Cl
Cl
 
ABCR 
2-nitro-9-fluorenone 
O
NO2
Aldrich 
1-nitropyrene 
NO2
Aldrich 
4-nitroquinoline 1-oxid 
N
+
NO2
O
-
Fluka 
2-nitrotoluene 
 
CH3
NO2
Riedel 
9,10-phenanthrenedione 
OO
Promochem 
trinitrotoluene 
CH3
NO2O2N
NO2
Sigma Aldrich 
 
3.2.2 Mutagenicity assay 
 
To assess recovery based on mutagenicity, the Ames fluctuation assay (Ames II test) 
was performed as described by Perez et al. [124] with slight variations. Samples were tested 
using the tester strain TA98 with and without metabolic activation by S9 on 24-well and 384-
well microplates, with three replicates per sample. Cultures of TA98 were grown overnight in 
oxoid nutrient broth Number 2 and ampicillin (50 μg ml-1) in an incubation shaker at 37°C. 
The growth of the bacterial suspension was controlled by measuring the bacterial density with 
a spectrophotometer and adjusted with minimal medium to a given value. After the samples 
were transferred to 24-well plates (10 μL per well), the culture was added (490 μL per well) 
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and the suspensions were pre-incubated (90 min at 37°C with shaking). The pre-incubated 
suspensions were diluted six-fold in indicator medium and distributed into 384-well plates (50 
μL per well, 48 wells per replicate). Because growth of reversed bacteria leads to acidification 
and change of the indicator color from purple to yellow, yellow wells were counted after 
incubation (48 h at 37°C). Positive controls included 2-nitrofluorene (20 ng/well) for TA98 
and 2-aminoanthracene (5 ng/well) for the TA98 with activation and were performed with 
four replicates and at least eight replicates for the negative controls (only DMSO). 
 
A sample was considered mutagenic when the effect was higher than the baseline 
(BL), which was calculated based on the mean value (MV), standard deviation (SD), and 
negative control (K-) as shown in Equation 3-1: 
 
Equation 3-1:   BL = MVK- + 2 SDK- 
 
3.2.3  Optimisation of the fractionation procedure 
3.2.3.1 Method development strategy 
 
The fractionation procedure was developed stepwise as follows:  
 
First, 47 planar aromatic standard compounds were selected covering a broad range of 
lipophilicity (log Kow = 0 to 6). Priority was given to compounds that had been detected 
previously at the sampling site and those environmental chemicals reported in the literature to 
adsorb to BR.  
Secondly, mixed-cation exchange (MCX) and mixed-anion exchange (MAX) solid 
phase extraction (SPE) sorbents were used to separate the compounds into three distinct 
fractions. The elution mixtures were optimised for polar planar compounds and the ability of 
these sorbents to separate the chemicals into acidic, basic and neutral fractions according to 
their behaviour in water was studied.  
Following the SPE step, two sequential separation steps using reversed-phase HPLC 
columns were introduced into the procedure. Six different stationary phases were tested to 
find complementary elution times (orthogonal elution) and resolution of the maximum 
number of individual peaks. This was done with analytical columns. 
Finally, the three-step fractionation method was tested with the selected preparative 
columns and validated based on the separation and recoveries of the standard compounds as 
well as the recovery of the mutagenicity of a BR extract using the Ames fluctuation assay test.  
 
3.2.3.2   Ion exchange cartridges 
 
The protocol used was based on Lavén’s procedure for pharmaceuticals [80], with 
adapted and optimised elution mixtures for polar planar compounds. The optimisation was 
based on attaining maximum standard recovery. 
Standards mixtures and the BR extract, both in methanol, were diluted 20 times with 
water and the pH was adjusted to approximately 2.5 with methanoic acid, protonating the 
basic compounds for maximum ionic interaction with the sulfonic acid groups of the sorbent. 
The MCX sorbent was washed with 20 mL of methanol/ammonium hydroxide (90:10%, v/v) 
followed by 10 mL of bi-distilled water. The diluted standard mixture or the BR extract were 
loaded on the MCX sorbent, which was then rinsed with 10 mL of bi-distilled water. The 
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acidic and neutral compounds were eluted first as a single fraction (A+N) with 20 mL of a 
methanol/toluene mixture (50:50%, v/v). Following this, the basic compounds (fraction B) 
were eluted with 24 mL of methanol/ammonium hydroxide (90:10%,v/v) and 12 mL of 
toluene/ ammonium hydroxide (90:10%,v/v). Both fractions were evaporated to dryness. The 
A+N fraction was then redissolved in methanol, diluted 20 times with water and the pH was 
adjusted to approximately 11 using ammonium hydroxide to deprotonate acidic compounds 
for ionic interaction with the quaternary amine groups of the MAX sorbent. The sorbent was 
washed with 20 mL of methanol/methanoic acid (90:10%, v/v) followed by 10 mL of bi-
distilled water. The diluted A+N fraction was loaded on the MAX sorbent, which was then 
rinsed with 10 mL of bi-distilled water. The neutral compounds (fraction N) were eluted with 
20 mL of a methanol/toluene mixture (50:50%, v/v) followed by the acidic compounds 
(fraction A) with 24 mL of methanol/methanoic acid (90:10%, v/v) and 12 mL of 
toluene/methanoic acid (90:10%, v/v). These two fractions were evaporated to dryness.  
  
3.2.3.3   Separation on analytical columns 
 
LC separation of standards on analytical columns was performed on an Agilent series 
1200 HPLC system consisting of a degasser, a high-pressure binary SL pump, an 
autosampler, a column oven and a diode array detector operated from 210 to 250 nm (Agilent 
Technologies, Santa Clara, CA, USA).  This system was controlled by the ChemStation 
software. Standard compounds were analysed with an ion trap-Orbitrap hybrid instrument 
(LTQ Orbitrap, Thermo Scientific, Bremen, Germany) equipped with an atmospheric pressure 
chemical ionization (APCI) source and controlled by the Xcalibur software. MS spectra in the 
mass range of m/z 60-400 were acquired in the Orbitrap with a resolving power of R = 60 
000. Tandem MS (MS2) experiments were conducted by collision-inducted dissociation (CID) 
in the ion trap and product ions were transferred to the Orbitrap for detection. All data were 
processed by Qual Browser (Thermo Fisher Scientific, San Jose, USA).  
The next two steps of the fractionation procedure relied on reversed-phase HPLC 
columns. In this set-up the two columns that allowed for the best separation of the whole set 
of standards were selected. The target compound groups were expected to display the 
following interactions with the chromatographic phases: (i) lipophilicity according to log Kow, 
(ii) shape selectivity, (iii) polar selectivity and (iv) aromatic selectivity (π-π interactions). 
Orthogonal elution of both stationary phases with low correlation between retention times on 
the different columns and the greatest number of eluted peaks possible was the goal. Six 
stainless steel analytical columns were tested, a polymeric C18 (Zorbax Eclipse PAH Plus 
rapid resolution, 150 x 3.0 mm, 1.8µm, Agilent, Santa Clara, CA,USA), a C18 (Lichrospher 
100 RP-18, 250 x 4.0 mm, 5µm, Merck, Darmstadt, Germany), a phenyl-hexyl (Zorbax 
Eclipse Plus rapid resolution, 150 x 3.0 mm, 1.8µm, Agilent), a pentafluorophenyl (Pursuit 5 
PFP, 250 x 4.0 mm, 5µm, Varian, Palo Alto, CA,USA), a pyrenyl (Cosmosil 5PYE Waters, 
150 x 4.6 mm, Nacalai Tesque, Kyoto, Japan) and a ß-cyclodextrin phase (ChiraDex, 250 x 
4.0 mm, 5µm, Agilent).  
Columns were tested with five different gradients each using a solution containing all 
47 standards at 1 mg/L each in methanol. The orthogonality of different chromatographic 
settings was determined by plotting retention times on one column versus another column.  
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3.2.3.4   Fractionation on preparative columns 
 
Separation of standards and samples on preparative LC columns was performed on a 
HPLC system consisting of a Rheodyne manual valve, a Varian ProStar 210 Binary Pump 
System with 25 mL stainless steel pump heads (Varian, Darmstadt, Germany), an UVD340U 
diode-array-detector (Dionex, Idstein, Germany) and a Foxy®2000 fraction collector 
(Teledyne Isco Inc., Lincoln, USA) controlled by the software Chromeleon® 6.7 (Dionex). 
The polymeric C18 (Zorbax Eclipse PAH, 250 x 9.4 mm, 5 µm, Agilent) and the 
phenyl hexyl (Zorbax Eclipse, 21 x 250 mm, 5µ m, Agilent) stationary phases were selected 
for the fractionation procedure (see Section 3.1.2 for details). These two columns were used 
for the validation of the methods with the standards and a BR sample. For fractionation, an 
up-scaling from analytical columns to the preparative system was done. In the case of the 
phenyl-hexyl column the equipment available required a reduction to half of the calculated 
preparative flow, resulting in a doubling of retention times. Up-scaling had no impact on 
elution orders and provided highly correlated retention times on the analytical and 
corresponding preparative system (r2: > 0.975 for both columns). Chromatographic details are 
given in Table 3-2. On this preparative fractionation set-up, fractions were collected every 
minute. Adjacent fractions were combined when they contributed to the same peak based on 
the UV absorption chromatogram. The fractions were diluted in water (neutral compounds) or 
in an ammonium acetate buffer, 50 mM, pH 4 (acidic compounds) and then extracted with 
solid phase extraction (SPE) OASIS HLB cartridges to remove water from the fractions. The 
cartridges were then eluted with 30 mL of methanol and the volume reduced to 2-3 mL with a 
rotary evaporator and gentle nitrogen stream. The recoveries of standards were determined by 
LC-MS/MS after the fraction were recombined.  
 
Table 3- 2: Gradient used on preparative columns. 
Stationary phase Flow 
(mL/min) 
Gradient Mobile phase 
Polymeric C18 3.3 
0-40 min 50-100%MeOH, 40-60 
min 100% MeOH, then 
equilibration of the phase 
MeOH/water for the neutral 
fraction 
MeOH/water in ammonium 
acetate buffer (50mM, pH 4) 
for the acidic fraction Phenyl-hexyl 8.0 
0-80 min 40-100%MeOH, 80-110 
min 100% MeOH, then 
equilibration of the phase 
 
3.2.4 Collection and preparation of organic extract from river water 
 
The sample was collected in May 2008 on the River Elbe at Prelouc, Czech Republic, 
downstream of dye factory discharges. Before use, BR was washed according to the protocol 
developed by Kummrow et al. [13]. The final extract of the BR washing procedure was tested 
for mutagenicity to exclude blank mutagenicity. Ten bags, each containing 10 g BR were 
deployed in the river for 24 hours as described by Sakamoto and Hayatsu [38]. The BR was 
removed and washed several times with bi-distilled water to remove the trapped particles 
from the BR. The BR was extracted with 160 mL of methanol/ammonium hydroxide (50:1; 
v/v) per 1 g of BR and agitating for 30 minutes [38]. The procedure was repeated once and the 
combined extracts were evaporated to dryness and redissolved in methanol. A sub-sample of 
the residue, corresponding to 5 g of BR equivalent, was taken and prepared for the bioassay 
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by evaporating it to dryness and redissolving it in dimethyl sulfoxide (DMSO). The remaining 
sample (95 g of BR equivalent) was retained for fractionation and analysis. 
3.2.5  Evaluation of the method 
 
The three-step fractionation method was evaluated based on the ability of each step (i) 
to recover reference standard mixtures and the mutagenicity in a BR sample and (ii) to 
separate the standard mixtures and the BR sample within clearly defined fractions. 
This evaluation was done as follow: 
 Firstly, reference standard mixtures (Table 3-1) at individual concentrations of 1 
mg/L were prepared in methanol and were used to calculate the recoveries of all single 
standards for each step.  
Secondly, the same reference standard mixtures were used to evaluate the ability of the 
ion exchange step to separate these different standards within the acidic, basic and neutral 
fraction, with limited overlapping between each fraction. Actual separation was compared to 
the pKa of each standard to determine if pKa could be used to predict fractionation. The 
capacity factor of each standard on the analytical and preparative columns for the two RP-
HPLC steps was tested to ensure separation was not affected by up-scaling. 
Thirdly, a BR sample was used to evaluate the recovery of the sample for each step. 
This was done by comparing the mutagenicity of the non-fractionated sample/fraction and the 
fractionated-recombined sample/fraction for each step. The strain TA 98 with and without S9 
was used and the comparison was based on the mutagenic concentration response curves, 
using eight concentrations of BR equivalent (further details below, Section 3.3.2). 
Finally, the separation of the different compounds contained in the sample/fraction 
was studied to ensure that mutagenicity was distributed on few isolated fractions with very 
limited overlapping within neighbouring fractions. This was done by measuring the 
mutagenicity of each fraction, prioritising the most mutagenic fractions for further 
fractionation and chemical analysis. 
 
3.3  Results and discussion 
3.3.1  Evaluation of the method based on standards  
3.3.1.1   Ion exchange recoveries and separation 
 
Mixed-cation- and anion-exchange SPE columns were used to separate the analytes 
into three fractions (acidic, basic and neutral fractions), based on their pKa. The recoveries for 
the different classes of chemicals range from 32% (quinones) to 92% (amides). In general, 
azaarenes, keto-PAHs, nitro-keto-PAHs, hydroxy-quinones, amides, amino-compounds and 
large nitro-PAHs had high recoveries (Table 3-3). Quinones (16 to 56 ± 3%) and the 1-2 ring 
structure nitro-compounds (0 to 44 ± 8%) exhibited the lowest recoveries. Recoveries in ion 
exchange fractionation were reproducible with standard deviations (STDV %) below 10 % 
(Table 3-3).  
The structures of the MCX and MAX sorbent are presented in Figure 3-1 and enable 
two sites and types of interactions between sorbents and analytes: (i) the first possibility of 
interactions is reversed-phase, driven by π-π interactions due to the presence of aromatic rings 
in the sorbent and in the analytes. Such interactions are apolar interactions. Bäuerlein et al. 
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[125] showed that with the increase of the number of aromatic bonds in the analyte, the π-π 
interactions are intensified, resulting in a higher sorption capacity. Reciprocally, the smaller 
the number of aromatic bond is the lower the interactions are between sorbent and analytes, 
and hence decreasing the possibilities for π-π interactions. Furthermore, the presence of polar 
moieties can disturb these apolar interactions, resulting in the decrease of retention capability 
of the sorbent for the more polar analyte [125]; (ii) the second possibility of interactions is of 
type strong ion exchange interaction ruled by Coulomb forces, which are electrostatic 
interactions between charged groups on a sorbent and charged molecules [125]. 
Thus, the low recoveries of the one aromatic ring nitro-compounds can be connected 
to incomplete retention on MCX and MAX sorbents due to their small aromatic structure and 
the presence of the polar nitro groups.  
4-nitroquinoline-1-oxide also shows a low elution efficiency from the MCX column, 
as the nitrogen of the amine oxide group bears a partial positive charge even at the high pH 
during elution and is thus retained on the sulphonic acid groups of the MCX. 
 
RCH3
CH3
CH3
CH3 CH3
CH3
N
O
R = SO3- (MCX)
R = N+(CH3)2C4H9 (MAX)
Reversed-phase 
interactions
Strong ion-exchange  
interactions
 
Figure 3- 1: Structure of the MCX and MAX sorbents 
 
All of the standards eluted according to their pKa. In general, compounds containing 
hydroxyl and/or carboxylic functional groups were recovered in the acidic fraction, those with 
a carbonyl and/or nitro functional group were in the neutral fraction and those with an amino 
functional group (including quaternary amines) were collected in the basic fraction (as shown 
in Table 3-3). The combined use of the MCX and MAX sorbents allowed separation with 
negligible overlap (< 5 %) except 9,10 phenanthrenedione with 14% present in the acidic 
fraction and 30 % in the neutral one. 
Acid-base separation at defined pH values assisted in optimising buffer selection during 
subsequent RP-HPLC separation to ensure the analytes remained uncharged to enable 
optimum separation and minimise peak-tailing. The probable presence or absence of certain 
functional groups indicated by the ion exchange SPE method also supported the identification 
and confirmation of unknowns in the fractions by reducing the number of possible molecular 
structure candidates (see e.g. [126,127]).  
  
Table 3- 3: Recoveries (average ± standard deviation of three replicates) of the standard compounds in the individual fractionation steps. *pKa values were 
calculated with the SPARC Online Calculator, na: pKa outside of the pH range (1-14), (1 to 47): standard number used for the chromatogram in Figure 3-2 
 pKa* Ion exchange step Polymeric C18 step Phenyl hexyl step 
Standards class  Acidic fraction  
Basic   
fraction  
Neutral 
fraction    
Azaarenes           
(3) acridine 4.9 x 50.24(2.5) x 68.8 (1.4) 66.2 (2.0) 
(6) 2-amino-3,8-dimethylimidazo[4,5-
f]quinoxaline 
4.1; 2.3; 3.1 x 71.6 (6.2) x 71.5 (3.1) 73.6 (4.9) 
(5) 2-amino-3-methylimidazo[4,5-f] 
quinoline 
5.7 x 83.8 (3.0) x 81.3 (1.8) 83.3 (3.9) 
(9) 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine 
5.4; 4.7 x 17.2 (0.2) x 72.9 (4.1) 58.4 (3.7) 
(8) 2-amino-9H-pyrido[2,3-b]indole 1.4; 4.9 x 68.8 (3.0) x 70.9 (2.5) 34.3 (0.9) 
(10) benz[c]acridine 4.3 x 84.4 (3.7) 2.5 (0.4) 71.0 (4.6) 73.1 (5.1) 
(4) benzo[h]quinoline 4.2 0.01 (0.0) 69.9 (5.0) 0.3 (0.2) 65.7 (1.1) 77.8 (4.4) 
(2) benzotriazole 8.5 97.0 (0.9) 1.2 (1.3) 0.3 (0.2) 81.6 (0.9) 111.3 (79.8) 
(1) carbazole na 0.1 (0.1) 0.5 (0.2) 91.2 (5.5) 84.2 (1.5) 82.0 (3.4) 
(7) 1-methyl-9H-pyrido[3,4-b]indole 5.6               x 94.3 (8.2) x 83.1 (1.0) 88.0 (9.9) 
Keto-PAHs           
(12) benzanthrone na 0.2 (0.2) 3.3 (0.9) 83.9 (1.7) 81.2 (5.3) 82.9 (5.8) 
(13)4H-cyclopenta[def]phenanthrene-
4-one 
na 0.2 (0.1) 0.5 (0.8) 93.2 (1.0) 77.7 (1.6) 89.9 (9.0) 
(11) 9-fluorenone na x x 72.1 (1.8) 70.2 (1.2) 102.0 (5.3) 
Ketone           
(14) benzophenone na 0.2 (0.1) x 53.4 (4.6) 70.9 (2.2) 77.5 (5.5) 
Nitro-keto-PAHs           
(15) 3-nitrobenzanthrone na x x 83.7 (9.1) 70.5 (2.9) 79.4 (2.2) 
(16) 2-nitro-9-fluorenone na 0.1 (0.1) x 95.2 (5.6) 71.6 (2.1) 73.2 (8.8) 
Quinones           
(20) 1,4-chrysenequinone na x x 15.7 (1.5) 18.0 (1.0) 6.3 (6.0) 
(21) 5,6-chrysenequinone na x x 29.1 (6.2) 38.5 (0.1) 16.3 (20.9) 
  
 pKa* Ion exchange step Polymeric C18 step Phenyl hexyl step 
Standards class  Acidic fraction  
Basic   
fraction  
Neutral 
fraction    
(19) 1H-isoindole-1,3(2H)-dione 9.9 55.9 (2.5) x x 58.7 (4.1) 75.6 (1.4) 
(17) 1,4-naphthalene-dione na 2.7 (4.7) x 32.6 (2.4) 41.7 (0.5) 50.3 (8.0) 
(18) 9,10-phenanthrenedione na 14.4 (9.1) x 30.5 (3.9) 39.5 (4.4) 34.3 (13.8) 
OH-quinones           
(22) 1,5-dihydroxyanthraquinone 9.2 76.5 (4.2) x x 72.0 (8.0) 76.1 (3.6) 
(24) 1-hydroxyanthraquinone  7.5 64.9 (2.6) x 2.3 (2.0) 80.94 (5.71) 88.5 (9.8) 
(23) 2-hydroxyanthraquinone  7.5 92.8 (4.1) 3.2 (3.2) x 87.4 (4.5) 84.9 (8.3) 
Amino-compounds           
(27) atrazine 1.11 x 75.2 (0.6) x 82.5 (3.7) 71.9 (6.2) 
(46) 3,3’dichlorobenzidine 2.64 x 70.8 (5.3) x 74.2 (3.9) 15.1 (1.1) 
(25) 1,8-diaminopyrene 4.0 x 50.8 (3.8) x 54.74 (5.41) 43.3 (5.6) 
(26) N-phenyl-2-naphthalenamine na 0.2 (0.2) 4.0 (1.7) 50.5 (2.0) 30.5 (2.7) 12.0 (10.2) 
Amides           
(30) benalaxyl na 0.2  (0.1) 0.7 (0.5) 92.3 (3.3) 81.2 (2.9) 87.4 (6.8) 
(28) carbamazepine na 0.3  (0.1) 3.3 (0.8) 90.7 (7.6) 86.8 (7.7) 86.1 (3.9) 
(31) N,N’-dimethyl-N,N’-diphenylurea na 0.3  (0.1) 0.6 (0.2) 90.54 (3.3) 81. 5 (1.6) 66.1 (6.5) 
(29) metazachlor na 0.2  (0.1) 1.6 (0.3) 93.9 (7.0) 79.9 (2.3) 76.8 (1.7) 
NO2-compounds           
(39) 1-chloro-2,4-dinitrobenzene - x x 0.3 (0.4) 63.0 (0.5) 65.1 (13.4) 
(37) 1,3-dinitrobenzene - x x 44.0 (7.7) 56.5 (3.8) 51.0 (17.2) 
(33) 1,8-dinitropyrene - x x 61.0 (4.6) 59.0 (8.2) 65.1 (10.2) 
(38) 2,4-dinitrotoluene - x x 13.0 (7.2) 58.0 (4.3) 62.1 (13.6) 
(34) 4-methyl-2-nitrophenol 7.4 x x 16.2 (3.7) 17.1 (3.0) 4.2 (0.7) 
(41) nitrofen - x x 77.6 (1.5) 75.1 (3.7) 70.1 (8.6) 
(35) 4-nitroquinoline 1-oxid - x x 24.7 (8.3) 65.2 (3.3) 71.9 (2.6) 
(32) 1-nitropyrene - x 2.2 (1.9) 78.5 (7.8) 70.0 (5.4) 78.7 (5.6) 
(36) 2-nitrotoluene - x x x 8.5 (0.0) 7.0 (12.1) 
  
 pKa* Ion exchange step Polymeric C18 step Phenyl hexyl step 
Standards class  Acidic fraction  
Basic   
fraction  
Neutral 
fraction    
(40) trinitrotoluene - x x x 53.0 (0.0) 51.7 (7.6) 
OH-PAHs           
(43) 3hydroxybenzo(a)pyrene 7.3 54.6 (10.0) x x 68.2 (12.8) 69.4 (9.4) 
(42) 1 hydroxypyrene 7.9 57.4 (2.8) x x 82.1 (3.9) 84.0 (2.0) 
(44) 1-naphthol 9.3 31.4 (9.1) x x 55.0 (11.3) 65.6 (5.3) 
COOH-PAHs           
(45) 2-naphthoic acid 4.1 75.5 (3.6) x x 52.3 (2.9) 67.6 (3.7) 
Purine-dione           
(47) caffeine na 0.6 (0.1) 5.0 (2.9) 90.8 (3.3) 84.5 (4.0) 61.9 (15.6) 
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3.3.1.2   Selection of the stationary phases for the preparative liquid chromatography  
 
Column combinations and gradients were optimised by investigating standard mixtures 
on six analytical columns and minimising the co-elution of analytes. The retention times on 
different columns were plotted against each other, with the resulting 2D-plot correlation 
coefficients ranging between 0.27 for Chiradex and C18 to 0.85 for pentafluorophenyl and 
C18 (Table 3-4). Thirty-eight out of 47 compounds could be separated on the phenyl-hexyl 
phase, while the other phases separated between 20 and 26 compounds. The polymeric C18 
phase eluted slightly more peaks than the monomeric C18 phase, probably due to shape 
selectivity particularly for isomers such as 1-hydroxyanthraquinone and 2-
hydroxyanthraquinone eluting at 32 and 27 min respectively and the two chrysenequinone 
isomers. The combination of polymeric C18 and the phenyl-hexyl stationary phase exhibited 
good orthogonality combined with a maximum number of separated peaks and was thus 
selected for the optimised fractionation procedure. 
 
Table 3- 4: Pearson correlation coefficients between the retention times on the two C18 columns, on the 
four polar columns and number of peaks obtained from the separation of 47 standards compounds. 
 Phenyl-hexyl Chiradex Pyrenyl Pentafluorophenyl Eluted peak 
Polymeric C18 0.3632 0.3214 0.4207 0.5897 23 
C18 0.5886 0.2664 0.6131 0.8486 20 
Eluted peak 38 26 22 24  
 
3.3.1.3   Separation with the combination of the polymeric C18 and phenyl hexyl columns 
 
The chromatograms of the standards were obtained by LC-APCI-MSMS (Figure 3-2a 
(polymeric C18 phase) and Figure 3-2b (phenyl-hexyl phase)).  
The polymeric C18 phase is expected to separate complex mixtures according to 
lipophilicity modified by the shape selectivity of this phase. Within one compound class, the 
retention times increase with the number of fused rings, for example 9-fluorenone (3 fused 
rings) eluted at 22.7 min, 4H-cyclopenta[def]phenanthrene-4-one (4 fused rings including one 
ring with 5 carbons) at 29.6 min and benzanthrone (4 fused rings) at 32.10 min. Shape 
selectivity allowed the separation of similar compounds and isomers based on the 
intramolecular steric hindrance and maximum length to breadth ratio [95]. This is showed by 
1-hydroxyanthraquinone, which is able to form intramolecular H-bonding between the 
hydroxy- and neighbouring carbonyl- group, resulting in a reduction of its ability to interact 
with the mobile phase of the system. Thus, this compound becomes more lipophilic than its 
isomer, 2-hydroxyanthraquinone, which is not able to create such intramolecular H-bonding 
and elutes at 31.6 minutes instead of 26.9 min for the latter. The capacity factors, k, used to 
evaluate the ability of this stationary phase to separate the standards are listed in Table 3-5. 
All standards within the same compound class could be separated, except 2-amino-3-
methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline 
(MeIQx) (azaarenes) and 4-methyl-2-nitrophenol and 1-chloro-2,4-dinitrobenzene (nitro-
compounds). 
The phenyl-hexyl phase is expected to have a high selectivity for aromatic compounds 
due to π-π interactions between aromatic analytes and the phenyl group in addition to 
lipophilic interactions [76]. The capacity factors, k, for the standards on analytical and 
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preparative phenyl-hexyl are listed in Table 3-5. Both sets of capacity factors are very similar. 
The chromatogram obtained with LC-MS/MS (Figure 3-2b) exhibits 23 completely isolated 
standards and the 24 remaining standards were divided among 15 peaks. For instance 
benzo(h)quinoline, 1-chloro-2,4-dinitrobenzene and naphthoic acid co-eluted at 32 + 0.1 min.  
The complementarity of the two columns is confirmed by the chromatograms 
presented in Figure 3-2a and 3-2b, which show that the standards that are not separated on the 
polymeric C18 column (e.g. IQ – MeIQx –caffeine) are separated perfectly on the phenyl-
hexyl column and vice versa (e.g. benzo(h)quinoline – 1-chloro-2,4-dinitrobenzene – 2-
naphthoic acid separate completely with the polymeric C18 column but co-elute on the 
phenyl-hexyl ). This complementarity in the separation and elution order is important as the 
aim of the EDA study is to provide an efficient method to isolate compounds in order to 
reduce the complexity of each fraction step by step for the analysis and identification of 
mutagenic compounds. 
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Figure 3- 2: LC-APCI-MS chromatograms of the standard mixtures on analytical columns a) polymeric C18, b) phenyl-hexyl column. See Table 3-3 for corresponding 
names of the 1 to 47 numbers. Encircled numbers were obtained with APCI negative mode, numbers without circles in positive mode. 
  
Table 3- 5: Capacity factors k and retention times of the 47 standard compounds on the preparative polymeric C18 and phenyl-hexyl columns. 
Standards class log Kow tR polymeric C18 column 
k polymeric 
C18 column 
tR phenyl-
hexyl column 
k phenyl hexyl 
column 
tR phenyl-hexyl column 
adapted flow for 
preparative
k phenyl hexyl column 
adapted flow for 
preparative
Azaarenes        
acridine 3.4 25.58 8.92 27.17 6.59 57.77 7.29
2-amino-3,8-
dimethylimidazo [4,5-f] 
quinoxaline 
1.4 4.94 0.79 7.17 1.00 15.25 1.19
2-amino-3-methylimidazo 
[4,5-f]quinoline
1.2 4.42 0.77 5.87 0.64 12.58 0.80
2-amino-1-methyl-6-
phenyl imidazo [4,5-b] 
pyridine
1.3 9.39 2.32 19.82 4.54 42.74 5.13
2-amino-9H-pyrido[2,3-b] 
indole
2.0 15.29 4.51 22.71 5.34 47.79 5.86
benz[c]acridine 4.6 38.24 12.49 41.46 10.58 85.29 11.24
benzo[h]quinoline 3.3 32.90 10.63 31.90 7.91 65.79 8.44
benzotriazole 1.3 5.84 0.92 8.95 1.50 18.73 1.69
carbazole 3.7 28.07 9.11 33.41 8.33 68.63 8.85
1-methyl-9H-pyrido[3,4-
b] indole
2.6 8.41 1.96 12.09 2.38 25.77 2.70
Keto-PAHs        
benzanthrone 4.8 32.10 10.52 39.15 9.94 80.43 10.54
4H-cyclopenta[def] 
phenanthrene-4-one 
3.9 29.55 9.45 38.24 9.68 78.68 10.29
9-fluorenone 3.6 22.69 6.81 32.88 8.18 67.69 8.71
Ketone        
benzophenone 3.2 19.44 5.52 32.55 8.09 67.07 8.62
Nitro-keto-PAHs        
3-nitrobenzanthrone 4.5 34.74 11.61 44.68 11.48 91.53 12.13
2-nitro-9-fluorenone 3.4 29.89 10.13 38.69 9.81 80 10.48
Quinones        
1,4-chrysenequinone 4.3 37.30 12.04 38.35 9.71 79.12 10.35
5,6-chrysenequinone 4.4 40.50 13.16 44.12 11.32 90.37 11.97
1H-isoindole-1,3(2H)-
dione 1.3 5.79 0.61 10.78 2.01 24.05 2.45
1,4-naphthalene-dione 1.7 10.06 2.52 23.88 5.67 49.87 6.15
  
Standards class log Kow tR polymeric C18 column 
k polymeric 
C18 column 
tR phenyl-
hexyl column 
k phenyl hexyl 
column 
tR phenyl-hexyl column 
adapted flow for 
preparative
k phenyl hexyl column 
adapted flow for 
preparative
9,10-phenanthrenedione 3.1 16.19 4.44 29.28 7.18 60.54 7.69
OH-quinones        
1,5-
dihydroxyanthraquinone 3.9 37.94 12.41 44.61 11.46 91.42 12.12
1-hydroxyanthraquinone 3.6 31.56 10.05 41.11 10.48 84.41 11.11
2-hydroxyanthraquinone 2.9 26.91 8.62 32.05 7.95 65.79 8.44
Amino-compounds        
atrazine 2.6 13.66 3.39 24.67 5.89 51.49 6.39
3,3’dichlorobenzidine 3.5 24.47 7.55 31.01 7.66 64.06 8.19
1,8 diaminopyrene 2.6 36.96 12.06 47.87 12.37 97.91 12.92
2-naphthalenamine, N-
phenyl-
4.2 33.49 11.21 40.87 10.42 83.82 11.03
Amides        
benalaxyl 3.2 24.47 7.31 38.75 9.82 79.62 10.42
carbamazepine 2.7 10.82 2.43 24.32 5.79 50.6 6.26
N,N’-dimethyl-N,N’-
diphenylurea 4.2 17.46 4.56 32.15 7.98 66.34 8.52
metazachlor 2.1 12.37 2.90 29.18 7.15 60.49 7.68
NO2-compounds        
1-chloro-2,4-
dinitrobenzene 2.3 13.54 3.62 32.07 7.96 66.01 7.36
1,3-dinitrobenzene 1.5 10.69 2.79 26.51 6.41 55.12 6.91
1,8-dinitropyrene 4.7 38.24 12.37 46.54 12.00 96.79 12.89
2,4-dinitrotoluene 2.2 14.05 4.30 31.47 7.79 65.18 8.35
4-methyl-2-nitrophenol 2.5 15.74 3.72 27.70 7.96 58.25 7.36
nitrofen 4.6 31.95 10.29 44.88 11.54 91.97 12.20
4-nitroquinoline 1-oxid 0.9 6.83 1.21 21.34 4.96 44.37 5.37
1-nitropyrene 5.1 45.56 13.13 44.57 11.45 91.27 12.09
2-nitrotoluene 2.4 14.49 4.12 31.47 7.79 65.18 8.35
trinitrotoluene 2.0 11.44 2.61 34.97 8.77 72 9.35
OH-PAHs        
3hydroxybenzo(a)pyrene 5.6 55.35 18.56 42.98 11.01 87.96 11.62
1 hydroxypyrene 4.5 38.79 13.38 38.06 9.63 78.14 10.21
1-naphthol 2.7 20.30 3.97 26.06 6.28 53.98 6.74
COOH-PAHs        
  
Standards class log Kow tR polymeric C18 column 
k polymeric 
C18 column 
tR phenyl-
hexyl column 
k phenyl hexyl 
column 
tR phenyl-hexyl column 
adapted flow for 
preparative
k phenyl hexyl column 
adapted flow for 
preparative
2-naphthoic acid 3.1 27.64 8.77 32.01 7.94 66.01 8.47
Purine-dione        
caffeine 0.0 4.34 0.42 9.68 1.70 20.04 1.88
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3.3.1.4   Recoveries of the liquid chromatography fractionations  
 
The recoveries and repeatability from triplicates listed in Table 3-3 ranked from 
8.5 ± 0% (2-nitrotoluene) to 87.4 ± 4.5% (2-hydroxyanthraquinone) for the polymeric 
C18 column and from 4.2 ± 1% (4-methyl-2-nitrophenol) to 102 ± 5% (9-fluorenone) 
for the phenyl hexyl column. On both columns, the azaarenes, keto-PAHs, ketone, nitro-
keto-PAHs, hydroxy-quinones, amino-compounds (except PNA), amides, hydroxy-
PAHs, carboxylic acid-PAH and caffeine had high recoveries (single standard recovery 
≥ 70%). Nitro-compounds (except 2,4-dinitrophenol and 2-nitrotoluene) recovered from 
57 to 75 %. The quinones had poor recoveries with values from 18 ± 1 to 59 ± 0.5% for 
the polymeric C18 column and values from 6 ± 14% to 59 ± 6% for the phenyl hexyl 
column. 
For both columns, the standard deviations were in most cases below 10%, except 
for some compounds with the lowest recoveries compounds. This shows the good 
reproducibility of the method.   
 
3.3.2 Fractionation of the BR sample 
 
The aim of the following section was to confirm that the three step fractionation 
procedure allows separation and recovery of mutagens from a complex environmental 
mixture (the BR extract). After each fractionation step, an aliquot of each fraction was 
taken and recombined (termed “recombined sample/fraction”). The mutagenicity of the 
raw sample/fraction was compared to the mutagenicity of the recombined 
sample/fraction with and without S9. Eight concentrations of BR equivalent/well were 
used for concentration response curves.  
In the first step, non logarithmic concentrations of BR were plotted versus the 
number of revertants obtained for each tested dose. The linear part of the curve was 
used to calculate the slope, which represents the number of revertants per well/g of BR, 
for the raw and recombined sample/fraction and are presented in Table 3-6 with the 
difference expressed in percentage.  
In the second step, the logarithmic concentrations were plotted versus the 
number of revertants using eight doses and a sigmoidal regression was applied. The 
resulting concentration-response curves are presented below (Figure 3-3, Figure 3-5, 
Figure 3-7, Figure 3-9, Figure 3-10, Figure 3-13 and Figure 3-14). 
The recovery comparisons were based on a quantitative comparison using the 
slope comparison between the raw and recombined sample/fractions (number of 
revertants per well/g of BR). The differences in percentage enabled the evaluation of 
each fractionation step in terms of mutagenicity recovery. 
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Table 3- 6: Calculated slopes of the raw and recombined sample/fractions for each fractionation 
step. 
Step and fraction 
Number of 
revertants per 
well/g of BR 
- S9 
Loss 
(%) 
Number of 
revertants per 
well/g of BR 
+ S9 
Loss 
(%) 
Ion Exchange raw fraction 2989.6 
-22 
980.2 
+13 Ion Exchange recombined fraction 2340.1 1107.1 
Polymeric C18 raw N fraction 883.1 
-16 
874.8 
-5 Polymeric C18 recombined N fraction 739.9 835.1 
Polymeric C18 raw A fraction 1624 
-14 
554.1 
+6 Polymeric C18 recombined A fraction 1402.2 589.6 
Phenyl-hexyl raw  N-2 fraction - 
- 
299.2 
-5 Phenyl-hexyl recombined N-2 fraction - 282.9 
Phenyl-hexyl raw  N-7 fraction 143.9 
+25 
- 
- Phenyl-hexyl recombined N-7 fraction 180.4 - 
Phenyl-hexyl raw  A-2 fraction 223.1 
+7 
108.2 
-6 Phenyl-hexyl recombined A-2 fraction 238.3 101.5 
Phenyl-hexyl raw  A-8 fraction 138.8 -14 - - Phenyl-hexyl recombined A-8 fraction 120 - 
 
3.3.2.1   Fractionation by ion exchange 
 
Three fractions were collected (acidic, basic and neutral) and tested using eight 
concentrations ranging from 0.3 mg to 80 mg of BR equivalent/well. The concentration 
response curves (Figure 3-3) show that the mutagenicity is preserved as the trends with 
and without S9 for both raw and recombined BR extract are similar, with slightly higher 
mutagenicity of the recombined extract without S9 with the highest concentration of BR 
(80 mg of BR equivalent/well). This was confirmed by the slopes presented in Table 3-
6, showing 2990 and 2340 revertants per well/g of BR without S9 for the raw and the 
recombined extracts, respectively, representing a loss of 22% of mutagenicity. In 
contrast, the recombined extract with S9 activation (1107 revertants per well/g of BR) 
was 13% more mutagenic than the raw sample (980 revertants per well/g of BR). 
The mutagenicity results of the three fractions showed that the acidic and neutral 
fractions were the most mutagenic (Figure 3-4). The mutagenicity of the acidic fraction 
was surprising as the effects were expected to be in the basic fraction, consistent with 
previous studies which generally identified basic mutagens when using the passive 
sampler BR. (e.g. 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-3,8-
dimethylimidazo[4,5-f]quinoxaline, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, 3-
amino-1-methyl-5H-pyrido[4,3-b]indole, phenylbenzotriazoles-type compounds, 3,3’-
dichlorobenzidine) [30,39,42,47,49,74,128]. The acidic and the basic fraction were 
further fractionated. 
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Figure 3- 3:  Recoveries of ion exchange separation, raw BR without S9 (  ), recombined BR 
without S9 ( ), raw BR with S9 ( ) and recombined BR with S9 ( ). 
 
 
Figure 3- 4: Mutagenicity of the ion exchange fractions 
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3.3.2.2   Fractionation by polymeric C18 
 
The neutral (N) and acidic (A) fractions were fractionated with the preparative 
polymeric C18 column, using a solvent mixture of methanol/bi-distilled water (N) and 
methanol/bi-distilled water in ammonium acetate (50mM, pH 4) buffer (A). In both 
cases eleven sub-fractions were collected as described above. The eight tested doses 
ranked from 0.6 to 160 mg of BR equivalent/well.  
In the case of the fraction N, the dose response curves (Figure 3-5) show that the 
recombined fraction N is slightly less mutagenic than the raw fraction N without S9 and 
there are no significant mutagenicity losses with S9. The comparison of the raw and 
recombined N fraction showed a loss of 16 % of the mutagenicity in the recombined 
fraction without S9 and a loss of 8 % with S9 (see Table 3-6 for details). 
 The mutagenicity results of the eleven sub-fractions (Figure 3-6) show that the 
first three fractions are mutagenic only with S9. The remaining fractions are mutagenic 
mainly without S9. The chemicals eluting in N-1 to N-3 fractions are more hydrophilic 
compounds (approximate log Kow = 0 to 3) than the chemicals eluting in the following 
fractions (N-4 to N-11), which contain compounds with increasing lipophilicity (higher 
log Kow, expected range 3 to 8.5). The sub-fractions exhibiting the greatest mutagenicity 
(N-2, 33 revertants with S9 and N-7, 41 revertants without S9, respectively) were 
selected for fractionation with the phenyl-hexyl column.  
 
 
Figure 3- 5: Recoveries of the neutral fraction, raw fraction N without S9 (  ), recombined 
fraction N without S9 ( ), raw fraction N with S9 ( ) and recombined fraction N with S9    
( ). 
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Figure 3- 6: Mutagenicity of neutral sub-fractions (polymeric C18 fractionation step) 
 
 In the case of fraction A, the dose response curves (Figure 3-7) show that the 
recombined fraction A is slightly less mutagenic than the raw fraction A without S9 and 
there are no significant mutagenicity losses with S9. The comparison of raw and 
recombined fractions showed a loss of 14 % of the mutagenicity in the recombined 
fraction without S9 and an increase in the mutagenicity of 6 % with S9 (see Table 3-6 
for details).   
After the fractionation step the mutagenicity was more widely distributed over 
sub-fractions, with high mutagenicity spread over eight of the eleven fractions (Figure 
3-8). As a result, the possibility of overlapping compounds in neighbouring fractions 
was investigated.  
The fractions were analysed by LC-MS/MS, along with a blank (non exposed 
piece of BR). The program MZmine [129] was used to extract exact m/z and retention 
times of ions from the mass spectrum and to create a mass list for each fraction and the 
blank. These lists were compared to the blank list and the common ions (mass tolerance 
of 0.003 u and retention time tolerance of 30 sec [95]) were removed. Then the lists of 
neighbouring fractions were compared. The maximum overlapping was found between 
fraction A-7 and A-8 with 13 % (26 ions in common over 200). The number of 
overlapping peaks for the other fractions was under 10%, which was considered to be a 
minimal overlap. Thus, the fact that mutagenicity was spread over 75% of the collected 
fractions suggests a broad range of mutagenic compounds rather than inefficiency of the 
polymeric C18 stationary phase to separate the compounds. The first fractions were 
mutagenic both with and without S9, while the following fractions were mutagenic only 
without S9 activation. Again the mutagenicity with S9 activation was  associated with 
compounds of low to medium hydrophobicity (lower log Kow, approximately 0-4). A-2 
and A-8 were selected for further fractionation as they exhibited a slightly higher 
mutagenicity than the other fractions. 
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Figure 3- 7: Recoveries of the acidic fraction A, raw fraction A without S9 (  ), recombined 
fraction A without S9 ( ), raw fraction A with S9 ( ) and recombined fraction A with S9    
( ). 
 
 
Figure 3- 8: Mutagenicity of acidic sub-fractions (polymeric C18 fractionation step). 
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3.3.2.3   Fractionation by phenyl-hexyl 
 
The neutral (N-2 and N-7) and acidic (A-2 and A-8) fractions were fractionated 
with the preparative phenyl-hexyl column using a solvent mixture of methanol/bi-
distilled water (N) and methanol/bi-distilled water in ammonium acetate (50mM, pH 4) 
buffer (A). Sub-fractions were collected as described above. The eight tested 
concentrations ranked from 0.8 to 200 mg of BR equivalent/well.  
  In the case of the neutral fractions, N-2 was tested only with S9 and N-7 only 
without S9. The concentration-response curves (Figure 3-9 for N-2 and Figure 3-10 for 
N-7) show that both recombined fractions remained as mutagenic as the corresponding 
raw fractions. The results in Table 3-6 show a loss of 5 % of the mutagenicity in the 
recombined N-2 fraction with S9 and an increase of 25% in the mutagenicity in the 
recombined N-7 fraction without S9  
For N-2 (Figure 3-11), three fractions showed mutagenicity, N-2-6, N-2-7 and 
N-2-8 with the last fraction showing the highest response (44.8, 46.6 and 85.2 revertants 
per well/g of BR, respectively). For N-7 (Figure 3-12), only the fraction N-7-12 
exhibited mutagenicity (73.6 revertants per well/g of BR). 
 
 
Figure 3- 9: Recoveries of fraction N-2, raw fraction N-2 with S9 ( ) and recombined fraction 
A-2 with S9 ( ). 
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Figure 3- 10: Recoveries of fraction N-7, raw fraction N-7 without S9 (  ) and recombined 
fraction N-7 without S9 ( ). 
 
 
Figure 3- 11: Mutagenicity of the N-2 sub-fractions (phenyl-hexyl fractionation step). 
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Figure 3- 12: Mutagenicity of the N-7 sub-fractions (phenyl-hexyl fractionation step). 
 
In the case of the acidic fractions, A-2 was tested with and without S9 and A-8 
only without S9. The concentration response curves (Figure 3-13 for A-2 and Figure 3-
14 for A-8) show that raw and recombined fractions of A-2 exhibited the same 
mutagenicity (with and without S9). The recombined fraction A-8 is slightly less 
mutagenic than the raw fraction A-8. The slopes (Table 3-6) represented an increase of 
7 % and a decrease of 6 % of the mutagenicity in the recombined A-2 fractions without 
and with S9, respectively. A loss of 14 % of the mutagenicity was observed in the 
recombined A-8 fraction without S9.  
For A-2 (Figure 3-15), two fractions showed mutagenicity, A-2-9 and A-2-10. 
Fraction A-2-9 was the most mutagenic. The slopes resulted in 184.2 and 102.2 
revertants per well/g of BR without S9, and 15.8 and 2.4 revertants per well/g of BR 
with S9 for fraction A-2-9 and A-2-10, respectively. For fraction A-8 (Figure 3-16), 
only fraction A-8-9 showed mutagenicity, exhibiting the use of this method to separate 
complex samples into only a few fractions containing mutagenic compounds.   
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Figure 3- 13: Recoveries of fraction A-2, raw fraction A-2 without S9 (  ), recombined fraction 
A-2 without S9 ( ), raw fraction A-2 with S9 ( ) and recombined fraction A-2 with S9 (
). 
 
 
Figure 3- 14: Recoveries of fraction A-8, raw fraction A-8 without S9 (  ) and recombined 
fraction A-8 without S9 ( ). 
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Figure 3- 15: Mutagenicity of the A-2 sub-fractions (phenyl-hexyl fractionation step). 
 
 
Figure 3- 16: Mutagenicity of the A-8 sub-fractions (phenyl-hexyl fractionation step). 
 
3.4 Conclusions 
 
The above results show that the three step fractionation method is efficient and 
reliable for recovering most of the mutagenicity of the BR extract and isolating the 
mutagens within a few fractions. Furthermore, information regarding the presence or 
absence of certain functional groups in the structure of the compounds involved are 
gained. This, could assist in the eventual identification of candidate structures. 
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CHAPTER 4: DEVELOPMENT OF A HPLC-ESI/APCI-ORBITRAP 
METHOD AND A PROCEDURE TO IDENTIFY PLANAR 
POLYCYCLIC MUTAGENS IN RIVER WATER 
 
4.1  Introduction 
 
In EDA studies, samples are progressively fractionated until the toxic fractions 
are suitable for chemical analysis [31,130]. However, the identification of unknowns 
remains one of the most challenging steps, complicated by the fact that these toxic 
fractions remain complex even after extensive fractionation [22]. As the amount and 
purity of the compounds present  are often not sufficient for nuclear magnetic resonance 
(NMR) or infrared (IR) spectroscopy, mass spectrometry remains the method of choice 
for identification [95]. In many cases fractions are analysed by gas chromatography 
coupled to mass spectrometry (GC-MS) methods, due to the availability, ease of use, 
reproducibility of the method and the extensive databases available (e.g. NIST) [83]). 
The major drawback of GC-MS is that many compounds need to be derivatised prior to 
analysis [84,131].  
Liquid chromatography-mass spectrometry (LC-MS) based methods are 
becoming increasingly popular for the structure elucidation of toxicants [132] as they 
are suitable for polar, thermally-unstable and higher molecular weight compounds. 
However, a major drawback of LC-MS/MS is the lack of spectral libraries for structure 
elucidation [133,134]. Thus, alternative approaches for structure elucidation are 
required and have to be integrated with computer tools, involving an identification 
strategy (see Chapter 2, Section 2.6).  
Furthermore, the success of identification relies as well on information gained 
during fractionation and biotests and the use of different strains of Salmonella could 
provide information regarding the presence of specific functional group. Indeed as 
explained in Chapter 2, Section 2.3.2, the YG strains such as YG 1024 and YG 1041, 
which are highly sensitive to nitroarene and/or aromatic amines can be used to confirm 
the presence or absence of amino- and nitro- functional groups. As the sampling site 
was located in an industrial area, where dyes and pharmaceuticals are produced, such 
amino- and nitro-compounds are expected to be present, thus the YG 1024 and YG 1041 
were used to help during the identification process.  
The aim of this chapter is to compare the use of ESI and APCI to “target” a 
range of potentially mutagenic planar compounds and to develop a strategy to identify 
mutagenic compounds in two fractions (N-2-8 and N-7-12, see Chapter 3, Section 
3.3.2). The first approach is target screening using a set of planar mutagens, comparing 
ESI and APCI to define ionisation and fragmentation rules connected to the presence of 
certain functional group, the second approach is a suspect-compound screening using 
exact mass filtering of compounds produced in the sampling site and the third approach 
is a non-target screening using fragmentation prediction and database search.  
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4.2 Material and methods 
4.2.1 Standards and samples 
 
The solvents and the 47 standards compounds used are given in Chapter 3 
(Section 3.2.1 and Table 3-1).  
The fractions N-2-8 and N-7-12 were collected according to the three step 
fractionation procedure described in Chapter 3. These two fractions were selected for 
further investigation because they showed the highest mutagenicity within the neutral 
sub-fractions (see Chapter 3, Section 3.2.3 Figure 3-10 for N-2-8 and Figure 3-11 for N-
7-12). 
 
4.2.2 LC-MS system 
 
The LC system used is described in Chapter 3 (Section 3.2.3.3). Standards and 
active fractions were separated on an analytical C18 reversed-phase column (LC-PAH, 
250 x 2.1 mm, 5 µm particle size, Supelco, CA, USA), designed specifically for the 
analysis of the priority PAHs listed in US EPA Method 610 [135]. This phase is able to 
separate complex mixtures of polyaromatic compounds including isomers due to shape 
selectivity. A gradient elution was used, with water and methanol for negative ionisation 
or an ammonium acetate buffer (10 mM, pH 4) in water and methanol for positive 
ionisation. The samples were eluted at a flow of 0.2 mL/min with the following 
conditions: 0-50 min, 50-95% of methanol; 50-65 min, 95% of methanol, then re-
equilibration of the phase. A volume of 5 µL was injected for the standards and 10 µL 
for the fractions.  
This LC system was coupled to an LTQ-Orbitrap hybrid instrument (Thermo 
Fisher Scientific, Bremen, Germany), described in Chapter 3 (Section 3.2.3.3).  The 
mass spectrometer was equipped with an atmospheric pressure chemical ionisation 
(APCI) source or an electrospray ionisation (ESI) source and controlled by the Xcalibur 
software. MS spectra in the mass range of m/z 140-1400 were acquired in the Orbitrap 
at a resolving power of 60 000 (full width at half maximum, referenced to m/z 400). 
Tandem MS (MS2) experiments were conducted using collision-inducted dissociation 
(CID). The MS2 products were transferred to the Orbitrap for detection, such that high 
resolution (HR) fragments were obtained. Further details regarding MSn experiments for 
the active fractions are given below (Section 4.2.4).  
Calibration of the Orbitrap was performed prior to sample analysis. The 
deviation of the calibration masses from theoretical values was within the range -1 to 3 
ppm. The deviation of the measured and exact mass for the 47 method development 
standards was always below 5 ppm. Thus, this value was used for candidate selection. 
 
4.2.3 Peak detection and data processing  
 
Full-scan HRMS chromatograms were processed using the free software 
MZmine [104,129], which performs a peak detection, calculates peak heights and areas 
and peak identification via a user-defined database search. The noise level was set to 1 × 
103, the minimum peak height to 1 × 105, mass resolution to 60 000, m/z tolerance to 
0.001 Da and minimum peak duration to 0.2 min.  
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The target identification list contained all the standard compounds used during 
method development, including the retention time and exact mass in positive and 
negative ionisation mode.  
The suspect screening compound list contained the chemicals known to be 
produced at the sampling site and contained many dyes as well as pharmaceuticals. The 
original list of compounds obtained was complemented using additional information 
found in ChemSpider (e.g. empirical formula, exact mass, structure). Potential 
transformation products of the dyes were added, including the products of azo- and C-N 
bond cleavage of the dyes as described by Rehorek and Plum [136,137]. The masses of 
all compounds and potential degradation products were added to the suspect-compounds 
list. 
 
MZmine uses csv files to compare target compounds with extracted masses, 
using two different approaches. The first, target identification, relies on matching both 
the exact mass and the retention time whereas the suspect-compounds screening 
identification relies only on matching the exact mass of compounds that could be 
present in the sample. The second strategy has a higher uncertainty, as only one 
parameter is used to identify a compound. A m/z tolerance of 0.003 Da and a retention 
time tolerance of 30 seconds were used for the blank search and the target search [95], 
while only the mass tolerance was applied for the suspect-compounds  screening.  
MOLGEN-MSMS was used to determine the empirical formula of extracted m/z 
and to assign fragmentation losses [105], using the elements C, H, N, O, S, Si, P, Br, Cl, 
F, I, K and Na. The error margin used was 5 ppm in the formula and fragment 
assignment, while both ionisation products ([M]+ and [M+H]+ for positive mode, [M]- 
or [M-H]- for negative mode) were considered.  
MetFrag [106] was used to identify candidate structures based on the MS2 
match. PubChem and ChemSpider searches were performed using the formula 
calculated with MOLGEN-MSMS, or using the exact mass where no clear matching 
formula was found. A search margin of 5 ppm was used for exact mass searches, while 
the Mzabs and Mzppm were set to 0.001 and 5, respectively. The fragmentation mode 
was set according to the MOLGEN-MSMS results and could include [M]+, [M+H]+, 
[M]- or [M-H]-.  
 
4.2.4 Identification procedure of active fractions  
 
The peaks to be investigated were selected from those detected by MZmine 
according to the following criteria:  
(i) absence in the blank [94] and in the non-mutagenic neighbouring fractions 
(ii) signal at least 100 times higher than noise (103) [94],  
(iii) mass ≥ 140 Da (BR adsorption limited to large planar molecules) and  
(iv) degree of unsaturation greater than 7 (planar compounds with at least 2 aromatic 
rings) 
The selected peaks were compared to the target list of standard compounds. The 
MS2 fragmentation patterns of all matches (exact mass and retention time) were 
investigated to support or reject the tentative identification.  
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The selected peaks were then searched against the suspect-compounds list. Any 
matches obtained for the exact mass were checked against the physical-chemical 
properties (pKa and log Kow) to determine whether this compound was likely to end up 
in the fraction, as the fractionation steps included pKa and log Kow based-separations.  
pKa values were predicted using the SPARC online calculator [138] and the log 
Kow values using Kowwin from EPISuite [78] and ChemSpider database (ACD values) 
[139]. The range of log Kow of the fraction of interest was calculated from the polymeric 
C18 column fractionation (second analytical step) by plotting the log Kow versus the 
retention time of the analytical standards presented in Table 3-1, Chapter 3. Fraction N-
2-8 was collected between 10 and 15 min and fraction N-7-12 between 38 and 46 min, 
resulting in calculated log Kow ranges of 1.5–3.1 and 3.9–5.1, respectively. For 
candidate selection, fragmentation pattern was investigated for substructural 
information. This procedure for the suspect-compounds is summarised in Figure 4-1 
 
m/z hit No m/z hit
Physico chemical 
properties fitting
Fit No fit
MSn comparison 
(observed & 
predicted)
Standard 
confirmation
Unknown 
identification
No fit
m/z selection
 
Figure 4- 1: Suspect-compounds screening identification procedure 
 
Finally, in the case of unsuccessful match with the target and suspect-compounds 
screening, unknown identification was undertaken. This included the following steps: 
 (1) Determination of the empirical formula. The MS full scan was run with a 
resolving power of 100 000 to obtain the most precise isotopic pattern for determination 
of the number of carbons (13C ratio), as well as the presence of sulphur, nitrogen, 
oxygen, chlorine and bromine (see e.g. [140,141]). Both Xcalibur and MOLGEN-
MSMS were used to calculate the empirical formulas. 
 (2) Structural information collection by exploiting the MS2 and MS3. Here, the 
fractions were run in   data-dependent   acquisition   mode including tandem MS 
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experiments using collision-inducted dissociation (CID) (MS2 and MS3) and the higher 
energy collision dissociation (HCD) cell (MS2). The MSn products were transferred to 
the Orbitrap for detection, such that high resolution fragments were obtained.  
 (3) Candidate selection. The calculated empirical formula was used to generate 
candidates using MetFrag searching ChemSpider. The log Kow, pKa and fragment loss 
information was used in selection.  
The unknown identification procedure is presented in Figure 4-2. All candidates 
provided by target, suspect-compounds screening or unknown identification need to be 
confirmed by standards when available and/or affordable [22]. 
 
Database candidates with same empirical formula
Candidate(s) matching     
the best with the   
predicted       
fragmentation            
pattern 
Candidates fitting pKa value 
allowing their presence in the 
neutral, basic or acidic 
fraction
Candidates possessing the functional groups 
allowing neutral losses observed in MSn
Candidates fitting log Kow range assigned to the 
fraction
m/z selection
 
Figure 4- 2: Strategy for the unknown identification 
 
4.2.5 Mutagenicity assay 
 
 Fractions N-2-8 showed mutagenic effects when tested with the TA98 strain 
without and with activation. Additional testing was also performed with two other 
strains, YG 1024 and YG 1041, both without and with activation. These experiments 
were performed in collaboration with Dr. G. Reifferscheid at the Federal Institute for 
Hydrology (Bundesanstalt für Gewässerkunde), Koblenz, Germany. The protocol was 
as described by Perez et al. [124]. The tested concentration of the fractions ranged from 
6.3 to 200 mg of BR equivalent/well. 4-Nitro-o-phenylenediamine (4.6 ng/well) and 2-
aminoanthracene (0.77 ng/well) were used as positive control without and with 
activation respectively. The samples were incubated at 37ºC for 72 h (YG 1041) or 48 h 
(TA98 and YG 1024). 
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4.3 Results and discussion 
4.3.1 Ionisation of standard compounds by ESI and APCI sources 
 
The ionisation source most suitable for a screening of compounds was selected 
based on the comparison of the ionisation modes APCI and ESI for standard 
compounds. Furthermore, the fragmentation pattern in positive and negative mode was 
studied to identify typical losses of each class of compounds to assist the detection of 
functional groups present in the molecular structure of unknown compounds. The 
detection limits, observed signals and fragmentation losses are presented in Table 4-1. 
Detection limits were determined by injecting 5 µL of standard solutions at different 
concentrations (from 1 ng/mL to 2 µg/mL). 
In APCI positive mode, [M+H]+ ions were observed for all standards except for 
1,8-diaminopyrene, 1,3-diaminopyrene and 3-hydroxybenzo(a)pyrene, which were 
observed as [M]+ ions. In APCI negative mode, [M-H]- ions were observed for the 
azaarenes, hydroxy- and carboxylic acid-PAHs, while [M]- ions were observed for the 
keto-, nitro-keto-PAHs, quinones, hydroxyl-quinones and nitro-compounds. The 
detection of azaarenes in APCI positive mode was achieved by adding an ammonium 
acetate/acetic acid buffer (10 mmol/L at pH 4).  
In ESI positive mode, [M+H]+ ions were observed for all compounds, except for 
3-hydroxybenzo(a)pyrene, for which both signals [M+H]+ and [M]+ were present.  
[M-H]- ions were observed for all the analytical standards in ESI negative mode. As 
mentioned above, chemicals ionisable in solution will be better detected in ESI [87]. 
This was confirmed for the azaarenes and amino-compounds, with detection limits up to 
five times lower in ESI compared with APCI. However, the hydroxy-quinones and 
hydroxy-PAHs, which are acidic in solution, were detected better with APCI. 
Furthermore, non polar compounds lacking a protonation site are difficult to ionise 
using ESI [142,143] and this was confirmed for the nitro-compounds, which do not have 
proton accepting or proton donating functional group and were not ionisable in ESI 
negative or positive mode.  
The MSn fragments of the standards were assigned using MOLGEN-MSMS to 
determine the typical losses associated with a compound group (e.g. nitro-, hydroxyl-, 
keto-PAHs) to identify similar substructures present in unknowns. The typical losses 
observed for APCI+ are: CHN (azaarenes), CO (keto-PAHs, quinones), NO (nitro-keto-
PAHs, nitro-PAHs), NH2 and NH3 (amino-PAHs) and H2O and CO (hydroxy-PAHs). 
Generally, compounds observed in APCI- did not generate many fragments and the 
molecular or protonated ion ([M]- or [M-H]-) was often the most abundant ion, 
confirming the observations of Lupton et al. [144] for polybrominated diphenyl ethers. 
Typical neutral losses for ESI+ were: CHN and/or CH2N (azaarenes), CO and CHO 
(keto-PAHs), CO (quinones), NH2 and NH3 (amino-PAHs) and OH and H2O (hydroxyl-
PAHs). 
As a larger range of compound groups (particularly nitro compounds) could be 
ionised in APCI, this technique was used to identify unknowns of interest in original 
sample screening. However, the information from ESI was used to confirm the presence 
or absence of certain functional groups in the molecular structure of the unknown 
compounds according to the criteria presented in Table 4-2.  
  
Table 4- 1: Ionisation of standard compounds in APCI and ESI, limits of detection (DL), and neutral losses observed during CID fragmentation. nd = 
non determined (no signal or > 1000 pg).  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
Azaarenes        
acridine -/-2.4 nd/50 nd/10 M+H 
no fragments 
no signal M+H 
CH2N 
no signal 
2-amino-3,8-
dimethylimidazo[4,5-f] 
quinoxaline 
 
-2.6/-2.0 nd/25 nd/5 M+H 
C3H4N2, CH2N2, C2H3N, 
CHN, H3N, CH3 
M-H 
CH3 
 
 
M+H 
C2H3N3, C3H4N2,    
CH2N2, C2H3N,  
CHN, H3N, H2N,    
CH3 
M-H 
no fragments 
2-amino-3-
methylimidazo[4,5-f] 
quinoline 
-3.4/-2.2 nd/25 nd/5 M+H 
C3H4N2, CH2N2, C2H3N, 
CHN, H3N, CH3 
M-H 
CH3 
 
 
M+H 
C2H3N3, C3H4N2,    
CH2N2, C2H3N,  
CHN, H3N, H2N,    
CH3 
M-H 
no fragments 
2-amino-1-methyl-6-
phenylimidazo[4,5-
b]pyridine 
-2.8/-1.6 nd/50 nd/5 M+H 
CHN, H3N, 
M-H 
C2H3N 
M+H 
CHN, H3N 
no signal 
2-amino-9H-pyrido[2,3-
b]indole 
 
-2.1/-1.9 nd/25 nd/5 M+H 
C3H4N2, C2H3N,      CHN, 
H3N, CH4,      CH3 
M-H 
no fragments 
M+H 
C3H4N2, C2H3N,      
CHN, H3N, CH4,   
CH3 
M-H 
no fragments 
benz(c)acridine -/-1.3 nd/25 nd/5 M+H 
C3H7N3, C3H5N3,  C3H4N3, 
C6H6,  C2H5N3, C3H4N3, 
C2H6N2, C2H5N2, CH4N2,      
CH2N2,  C2H3N, CHN, 
H3N,     CH3 
M-H 
CH3 
M+H 
C3H7N3, C6H6, 
C3H4N2, C2H6N2,    
CH4N2, CH2N2, 
C2H3N, CHN, H3N,    
CH3 
no signal 
benzo(h)quinoline -/-2.3 nd/50 nd/10 M+H 
CHN 
no signal M+H 
CH3N, CH2N, CHN 
no signal 
benzotriazole -0.9/-4.1 50/50 50/50 M+H 
N2 
M-H 
no fragments 
M+H 
CHN3, N2 
M-H 
no fragments 
carbazole -2.5/-2.4 50/50 nd/500 M+H 
no fragments 
M-H 
no fragments 
M+H 
no fragments  
no signal 
  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
1-methyl-9H-pyrido[3,4-
b]indole 
-2.8/-2.4 nd/25 nd/5 M+H 
C3H4N2, C2H6N2, C2H2N2, 
C3H3N,     CH4N2, CH2N2,    
C2H3N, CH3N, CHN, 
C2H2, H3N,    H2N, CH3 
M-H 
CH3 
M+H 
C3H4N2, C2H6N2, 
C2H2N2, CH2N2, 
C2H3N, CH3N, 
CHN, H3N, H2N,  
CH3 
M-H 
no fragments 
Keto-PAHs        
benzanthrone -3.5/-1.4 50/50 nd/10 M+H 
CHO, CO 
M- 
no fragments 
M+H 
CHO, CO 
no signal 
4Hcyclopenta [def] 
phenanthrene-4-one 
-3.4/-2.2 50/50 nd/250 M+H 
C3H2O, CHO, CO 
M- 
no fragments 
M+H 
CO 
no signal 
9-fluorenone -2.8/-1.5 50/50 nd/100 M+H 
CHO, CO 
M- 
no fragments 
M+H 
CHO, CO 
no signal 
Ketone        
benzophenone -/-1.9 nd/25 nd/25 M+H 
C7H6O, C6H6 
no signal M+H 
C7H6O, C6H6 
no signal 
Nitro-keto-PAHs        
2-nitro-9-fluorenone -3.46/-2.2 75/nd nd/nd M+H 
CNO2, NO2, NO,      OH 
M- 
NO 
no signal no signal 
3-nitrobenzanthrone -4.0/-0.7 50/25 nd/500 M+H 
C3H5O3, C2HNO3,   CNO2, 
C2O2, NO2,  NO, HO, N 
M- 
NO, CHO, CO 
(no M+H signal) 
CNO2, NO2,  NO,    
HO 
no signal 
Quinones        
1,4-chrysenequinone -3.9/-0.9 50/400 nd/1000 M+H 
No fragments 
M- 
no fragments 
(no M+H signal) 
C3H2O2, C2O2,  
CO2, C2H2O, CO,    
H2O 
no signal 
5,6-chrysenequinone -3.9/-1.1 50/500 nd/1000 M+H 
C2HO2, CO 
M- 
no fragments 
M+H 
C2HO2, CO 
no signal 
1-Hisoindole-
1,3(2H)dione 
-2.1/-3.2 50/nd 500/nd M+H 
H2O 
M-H 
no fragments 
(no M+H signal) 
H2O 
M-H 
no fragments 
naphthalene-1,4-dione -1.9/- 100/nd nd/nd M+H 
CO
M- 
no fragments
no signal no signal 
  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
phenanthrene-9,10-dione -3.4/-2.0 50/50 nd/nd M+H 
C4H2O2, C2HO2,  C2O2, 
CO 
M- 
no fragments 
no signal no signal 
OH-quinones        
1,5-
dihydroxyanthraquinone 
-3.75/- 50/nd nd/nd M+H 
C7H4O2, C3O4, C2O4, C3O3,  
C2H2O3, C2O3, C2O2, 
CH2O2, CO2, C2H2O, CO, 
H2O 
M- 
no fragments 
M+H 
C8H4O4, C7H4O2,    
C3O4, C3O3, C2O3, 
C2O2, CH2O2, CO2, 
C2H2O, CO, H2O 
no signal 
1-hydroxyanthraquinone -4.0/-1.9 50/50 nd/50 M+H 
C8H4O3, C7H4O2,    C3O3, 
C2H2O3, C2HO3, C2O3,  
C2O2, CH2O2, CO2, 
C2H2O, CO, H2O 
M- 
no fragments 
M+H 
C7H4O2, C3O3, 
C2HO3, C2O3, C2O2, 
CO2, C2H2O, CO, 
H2O 
M-H 
CO 
2-hydroxyanthraquinone -3.6/-1.6 50/75 nd/50 M+H 
C8H4O3, C7H4O2,    C3O3, 
C2H2O3, C2HO3, C2O3,          
C2O2, CH2O2, CO2,             
C2H2O, CO, H2O 
M- 
no fragments 
M+H 
C7H4O2, C3O3, 
C2O3, C2O2, C2H2O, 
CO 
M-H 
CO 
Amino-compounds        
27) atrazine -/-0.6 nd/25 nd/5 M+H 
C4H9N2Cl,                   
C6H12N2, C4H8N2,  
CH3N2Cl, C3H6N2,  C3H6, 
HCl, C2H4 
no signal M+H 
C6H13N2Cl, 
C7H11N3,           
C4H9N2Cl, C6H12N2, 
C4H8N2, CH3N2Cl, 
C5H10,  C3H6N2, 
C3H6,        HCl, 
C2H4 
no signal 
46) 3,3'-
dichlorobenzidine 
-/-0.7 nd/50 nd/500 M+ 
HCl2, Cl2, CHNCl, H3NCl, 
H2NCl, Cl, H2N 
no signal M+H 
H2Cl2, HCl2, HCl, 
Cl, H 
 
no signal 
  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
1,8-diaminopyrene -/-1.3 nd/25 nd/10 M+ 
CH3N2, HN2,  CH2N, 
CHN, H3N,  H2N, HN, H 
no signal M+H 
CH2N, CHN, H3N 
no signal 
N-phenylnaphthalen-2-
amine 
-/-0.9 nd/10 nd/5 M+H 
C10H8, C9H8, C7H7N, 
C7H5N, C6H6N, C6H6,           
C6H5, C2H4N, C2H3N, 
C2H5, CHN, H4N, H3N, 
CH4, CH3, H3,H2 
no signal M+H 
C10H8, C9H8, 
C7H7N, C7H5N, 
C6H6N, C6H6, C6H5, 
C2H4N, C2H3N, 
C2H5, CHN, H4N, 
H3N, CH4, CH3, 
H3,H2 
no signal 
Amides        
benalaxyl -/-0.6 nd/25 nd/5 M+H 
C10H10O3, C8H6O,  
C2H4O2, CH4O 
no signal no signal no signal 
28) carbamazepine -/-1.7 nd/50 nd/5 M+H 
CH3NO, CHNO, H3N 
no signal (no M+H signal) 
CH3NO, CH2NO,   
CHNO, H3N 
no signal 
N,N’-dimethyl-N,N’-
diphenylurea 
-/-1.4 nd/10 nd/5 M+H 
C8H9NO, C7H9N 
no signal M+HC9H12N2O, 
C9H10N2O,                  
C8H9NO, C8H12N, 
C7H9N 
no signal 
metazachlor -/-1.25 nd/50 nd/5 no signal no signal (no M+H signal) 
C5H5N2OCl,C3H4N2 
no signal 
NO2-compounds        
1-
chloro2,4dinitrobenzene 
-3.5/- 50/nd nd/nd no signal M- 
NO2, NO
no signal no signal 
1,3-dinitrobenzene -3.0/- 50/nd nd/nd no signal M- 
NO 
no signal no signal 
1,8-dinitropyrene -/-1.1 50/nd nd/nd M+H 
C2NO4, HN2O4,HN2O3, 
N2O3, CNO3, HNO3, N2O2, 
CNO2, HNO2, NO2, NO, 
HO 
M- 
NO2, NO 
no signal no signal 
  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
2,4-dinitrotoluene -3.3/- 50/nd nd/nd no signal M- 
CH2NO3, CNO2, 
H2NO2, CH3O2,      
HNO2, CH2O2, 
CHO2, NO, CHO, 
H2O, HO 
no signal no signal 
4-methyl-2-nitrophenol -2.0/- 50/nd nd/nd no signal M- 
no fragments 
no signal no signal 
nitrofen -3.9/- 50/nd nd/nd no signal M+ 
C6H2Cl2, C6H3Cl, 
Cl, NO 
no signal no signal 
4-nitroquinoline-1-oxide -3.2/-2.0 50/50 nd/75 M+H 
C3H2N2O3, C2HN2O3,            
C3H2NO3, C2HNO3, 
C2NO3, CHNO3, CNO3, 
CHNO2,   CNO2, HNO2,       
NO2, HNO, NO, HO 
M- 
CNO3, C2H2NO2, 
CNO2,   H2NO2, 
NO2, NO, HO 
M+H 
C3H2N2O3, 
C2HN2O3,             
C3H2NO3, C2HNO3, 
C2NO3, CHNO3, 
CNO3, CHNO2, 
CNO2, O3, HNO2, 
NO2, HNO, NO 
no signal 
1-nitropyrene -3.6/-1.3 25/25 nd/nd M+H 
HNO2, NO2, NO,      OH 
M- 
NO 
no signal no signal 
2-nitrotoluene -1.5/- 50/nd nd/nd no signal M- 
no fragments 
no signal no signal 
trinitrotoluene -4.0/- 125/nd nd/nd no signal M- 
C2H2NO4, CHNO4, 
N3O3, CH2NO3, 
CHNO3, H2NO3, 
CH3O3, CH2NO2, 
N2O2,   CHNO2, 
CNO2, H2NO2, 
HNO2, CH2O2, 
CHO2, CH2O, NO, 
CHO,  HO 
 
no signal no signal 
  
Name 
Mass 
error in 
ppm (-/+)
APCI 
DL 
pg (-/+)
ESI DL 
pg (-/+) 
Neutral losses  recorded 
in APCI positive mode 
Neutral losses 
recorded in APCI 
negative mode
Neutral losses 
recorded in ESI 
positive mode
Neutral losses 
recorded in ESI 
negative mode
OH-PAHs        
3-hydroxybenzo 
(a)pyrene 
-3.2/-2.1 50/100 nd/750 M+ 
CHO, CO, H2O, HO, O, H 
M-H 
no fragments 
M+ & M+H 
CHO, CO, HO, O 
M-H 
no fragments 
1-hydroxypyrene -3.7/-1.5 125/75 50/nd M+H 
C10H6O, CHO, CO, H2O, 
HO, H 
M-H 
no fragments 
no signal M-H (& M-) 
CO 
1-naphthol -2.1/-3.4 50/500 50/nd M+H 
CO, H2O 
M-H 
no fragments 
no signal M-H 
no fragments 
COOH-PAHs        
2-naphthoic acid -2.9/-2.5 100/- 50/- M+H 
H2O, CO, CO2 
M-H 
CO2 
M+H 
H2O, CO, CO2 
M-H 
CO, CO2 
Purine-dione        
caffeine -/-2.3 nd/25 nd/50 M+H 
C5H6N2O2, C3H3NO2,            
C2H3NO2, C2HNO2, 
CH3NO2, C2H3NO, CO2, 
CH4O, CH3, CH2 
no signal M+H 
C5H6N2O2, 
C4H4N2O2, 
C3H3NO2, 
C3H4N2O, C2H3NO, 
CO2, CH4O 
no signal 
 
Table 4- 2: Ionisation rules for the presence of functional group in ESI and APCI +/-.  
+: ionisable/detected, -: non ionisable/not detected, I+: ionisable and stronger signal  
associated to one ionisation source vs. the other source and nd: dependant of the compounds 
Chemical classes  ESI + ESI - APCI +  APCI - 
Azaarenes I+ - + + 
Keto-PAHs + - I+ I+ 
Nitro-keto-PAHs - - I+ nd 
Quinones - - + I+ 
Hydroxy-quinones + + + I+ 
Amino compounds I+ - + - 
Amides I+ - + - 
Nitro compounds - - nd I+ 
Hydroxy-PAHs + + + I+ 
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4.3.2 Target and suspect compounds screening in fractions N-2-8 and N-7-12 
 
The mutagenic fractions N-2-8 and N-7-12 were run using the APCI source, 
along with the non-mutagenic neighbouring fractions to eliminate possible 
overlapping non-mutagenic peaks. No hits were recorded using the target screening 
described above (Section 4.2.4)  
The suspect-compounds screening was run on both mutagenic fractions, with 
one hit in the N-7-12 fraction. A peak with m/z of 341.1247 Da and a retention time 
of 47.0 minutes was extracted using MZmine and identified by mass in the suspect-
compounds screening list as Pigment Yellow 1, shown Figure 4-3.  
CH3
O
N N
CH3
N
+
O
-
OO
NH
 
Figure 4- 3: Structure of Pigment Yellow 1 [2512-29-0] 
 
The predicted pKa of 10.7 (SPARC) indicates that this compound could be 
present in the neutral and acidic fractions, while the log Kow (EPISuiteTM) was 3.9, 
within the defined range of 2.9 – 6.1 (including the error margin). The MS2 fragments 
of the suspected Pigment Yellow 1 are shown in Figure 4-4 a. Pigment Yellow 1 was 
purchased from Tokyo Chemical Inc. Europe for confirmation and analysed as for the 
sample, using APCI in positive mode. The standard had a mass of 341.1258 Da at 
46.9 minutes with matching MS2 fragments (see Figure 4-4 b for the proposed 
substructures). Thus, the Pigment Yellow 1 was identified as present in fraction N-7-
12.  
Testing of this chemical with the Ames fluctuation assay (with and without 
S9), however, revealed no mutagenic effects despite the presence of azo and nitro 
groups [63]. Thus, this compound cannot be considered responsible for the 
mutagenicity in this fraction. It is suspected that the lack of mutagenic activity could 
result from the lack of access to the functional groups, such that the azo group cannot 
be metabolised with the bulky substituents (only a metabolised product is mutagenic), 
while the nitro group may be sterically hindered. 
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Figure 4- 4: Mass spectrum (MS2) of Pigment Yellow 1 a) Suspected Pigment Yellow in the 
sample b) Pigment Yellow standard.  
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4.3.3 Unknown identification in fraction N-2-8  
 
The fraction N-2-8 was analysed by APCI positive mode (APCI +) at a 
resolution power of 100 000 in order to have the most accurate masses of the 
chemicals to determine their empirical formula. Using MZmine software, 159 m/z 
ions were detected (m/z ≥ 140 Da and intensity ≥ 105). After comparison with a blank 
and non mutagenic neighbouring fractions, 17 peaks (m/z ions) of interest were left 
and are presented in Table 4-3. The full scan chromatogram with the extracted peaks 
is presented in Figure 4-5. We can see that the compounds of interest for identification 
are eluting between 13 and 25 minutes. This is consistent with the fractionation 
procedure described in chapter 3, which included a polymeric C18 reversed-phase 
column. The fraction N-2-8 was collected between 10 and 15 minutes on this column. 
For the LC-MS/MS analysis, another polymeric C18 reversed-phase column was 
used, so it is expected that the unknowns contained in the fraction N-2-8 are still 
eluting together. In the second part of the chromatogram, only peaks belonging to the 
blank and non mutagenic neighbouring fraction where found. The blank consisted of 
10 g of clean and non exposed blue rayon, which was extracted and fractionated as 
described in Chapter 3 for the blue rayon sample. Thus, our interest focused on the 
first part of the chromatogram.  
 
Table 4- 3: peaks of interest contained in the fraction N-2-8 
Peak identity m/z Retention time (min) 
Peak_3 259.0528 16.2 
Peak_19 168.0801 24.2 
Peak_35 225.0540 20.5 
Peak_36 293.1084 20.0 
Peak_40 233.0963 18.5 
Peak_50 204.1012 13.2 
Peak_60 377.1598 20.2 
Peak_99 273.1226 19.4 
Peak_109 250.0855 16.5 
Peak_138 330.1438 17.2 
Peak_143 302.0804 14.5 
Peak_208 323.0694 25.3 
Peak_212 276.1020 13.5 
Peak_213 241.1329 20.4 
Peak_228 326.0802 17.0 
Peak_233 360.1545 18.4 
Peak_242 185.1066 16.6 
  
 
Figure 4- 5: Full scan chromatogram with the peaks of interest
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4.3.3.1  Determination of the empirical formula 
 
 The high resolution isotopic pattern of the selected m/z was used to determine 
the elements composing the formula. The atoms considered were C, H, N, O, S, Si, P, 
Br, Cl, F, I, K and Na. The isotopic composition of these atoms (except for  phosphorus, 
fluorine and iodine which are monoisotopic elements) are presented in Table 4-4. 
Sodium is also monoisotopic but as it is able to form adduct, the formed adduct 
[M+Na]+ was also considered. When the elemental composition is determined, the 
relative intensity of the isotope peak is used to calculate the number of each element 
contained in the empirical formula. This procedure was done automatically by 
MOLGEN-MSMS [105] and formulas were proposed.  
In case of several fitting formulas, selection of the “best” empirical formula was 
made with the following criteria: (i) number of carbons close to the calculated number, 
(ii) the degree of unsaturation at least 7 and (iii) a mass error (difference between the 
theoretical mass and the mass detected by the Orbitrap) of less than 5 ppm. As seen in 
Table 4-1, we observed negative error on the masses detected by the machine with all 
the standards. Thus, the experimental masses were always lower than the theoretical 
masses. Furthermore these error were within 5 ppm. Thus, negative errors are 
considered more likely than positive errors. Furthermore, ion such as diisooctyl 
phthalate and dimethylphthalate are common background ions and can be used to 
estimate the mass error. The contaminant ion diisooctyl phthalate (391.2843 Da) was 
found with -3.57 ppm error and the dimethylphthalate (195.0657 Da) with -3.4 ppm 
error. To eliminate fitting formulas to the isotopic pattern an error of about -3.4 ppm 
was considered. 
 
Table 4- 4: Isotopic composition  
Atom or adduct [Misotop- Mmost abundant isotop]
(Da) 
Relative abundancy (%) 
13C 1.0034 1.02 
2H 1.0063 0.01 
15N 0.9970 0.37 
17O 1.0042 0.04 
18O 2.0042 0.20 
33S 0.9994 0.75 
34S 1.9958 4.21 
36S 3.9950 0.02 
29Si 0.9996 4.35 
30Si 1.9968 3.26 
81Br 1.9980 98 
37Cl 1.9970 32 
40K 1.0003 0.01 
41K 1.9981 6.45 
CNa instead of CH 21.9819 100 
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Table 4- 5: Proposed empirical formulas for peak 3 
Formula Degree of unsaturation Mass error (ppm) 
1) C3H15ON7P2S 1 -0.21 
2) C5H14O4N4S2 1 -0.47 
3) C7H11ON6PS 6 0.99 
4) C6H17O3N2P3 1 1.24 
5) C11H9ON5S 10 2.19 
6) C5H6O5N8 7 -2.28 
7) C6H13O10N 1 -2.31 
8) C10H15O3NP2 5 2.44 
9) C7H19N2PS3 0 2.80 
10) C4H10O9N4 2 2.88 
11) C13H10O2N2S 10 -2.99 
12) CH10O5N9P 2 -3.48 
13) C14H11O3P 10 3.64 
14) C11H17NS3 4 4.00 
15) C9H14O2N3PS 5 -4.19 
16) C3H13O3N7S2 1 4.71 
17) CH13N10P2S 2 4.98 
 
 
Peak 19: The mass spectrum is presented in Figure 4-7. Only the 13C isotope 
peak was detected with a relative abundance of 12 (+1.0034). Thus, the formula is 
expected to possess about 12 carbon atoms . Only two formulas were proposed, (i) 
C4H14O2N3S with no degree of unsaturation and an error of -0.08, and (ii) C12H9N with 
9 degrees of unsaturation and an error of -3.78 ppm. The first formula does not fit the 
number of estimated carbon, the isotopic pattern and the mass error. Thus, the C12H9N is 
the formula we will use for the identification procedure. This formula is also the 
formula of one of the standards used in Section 4.3.1 of this chapter, carbazole which 
have a mass of 168.0808 Da and a retention time of 28.1 min. The detected peak is an 
isomer of carbazole.  
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Table 4- 6: Determination of empirical formulas for remaining peaks 
Peak 
 
Isotope 
peak 
Estimated 
number 
of carbons 
Proposed 
Formulas fitting 
the best the 
isotopic pattern 
Degree of 
unsaturation
Mass 
error 
(ppm) 
Formula 
selected 
35 13C 14 C14H8O3 C12H7O2N3 
11 
11 
-2.76 
3.21 C14H8O3 
36 13C 20 C21H12N2 C19H17OP 
16 
11 
2.51 
-3.13 C19H17OP 
40 13C 20 
C17H12O 
C15H11N3 
C14H13FO2 
12 
12 
8 
-2.32 
3.44 
-3.42 
C17H12O 
50 13C 13 C10H12ON4 C12H13NO2 
7 
7 
3.12 
-3.46 C12H13NO2 
60 13C 23 
C20H24O7 
C19H19N7O2 
C20H30NP3 
C21H20N4O3 
C24H26P2 
9 
14 
8 
14 
13 
-0.51 
0.52 
2.94 
-3.04 
3.76 
C21H20N4O3 
99 13C 16 C15H16N2O3 C13H15N5O2 
9 
9 
-2.82 
2.17 C15H16N2O3 
109 13C 16 C14H10N4O C16H11NO2 
12 
12 
2.34 
-3.02 C16H11NO2 
138 13C 18 C17H19NO4 10 -3.04 C17H19NO4 
143 13C 21 C17H10N4O2 C19H11NO3
15 
15 
2.03 
-2.42 C19H11NO3 
208 13C 20 C20H9N3O2 C22H10O3
18 
18 
-1.74 
-2.42 
C20H9N3O2 
C22H10O3 
212 13C 18 C16H12N4O C18H13NO2 
13 
13 
2.20 
-2.67 C18H13NO2 
213 13C 16 C15H16N2O 9 -3.07 C15H16N2O 
228 13C 22 
C19H10N4O2 
C21H11NO3 
C18H14O6 
17 
17 
12 
0.78 
-3.34 
4.90 
C21H11NO3 
233 13C 18 C17H16N10 C18H21N3O5
15 
10 
-2.70 
-2.71 
C17H16N10 
C18H21N3O5 
242 13C 11 C12H12N2 8 -3.86 C12H12N2 
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4.3.3.2  From the empirical formula to the candidate(s) 
    
In this section, candidates are selected from the databases ChemSpider and 
Pubchem. This selection was based on the match of each candidate to the log Kow range 
defined for the fraction N-2-8 (0.5 – 4.2 including the error range) and pKa values. The 
candidates were selected from the databases using MetFrag, which performs an 
empirical formula search (or exact mass search) in these databases. A list of candidates 
is provided, ranked according to their fragmentation according to the bond 
disconnection approach (instead of using cleavage rules). These “theoretical” fragments 
are then compared with the experimental fragments of the unknown compounds. The 
candidates are ranked based on the m/z and intensity of the fragments, bond dissociation 
energy and neutral loss comparison between “theoretical” and experimental fragments 
[106]. Unlikely candidates are easily removed from the list, as they have a score close or 
equal to 0. The closer to 1 the score is, the better, especially if many of the fragments 
are predicted. Thus, the selection is based on the score and the number of predicted 
fragments.  
 
 Peak 3: This peak of formula C13H10O2N2S (m/z 259.0528 Da), eluting at 16.2 
min was detected in APCI + and ESI +. The APCI + MS2 spectrum of the unknown is 
presented in Figure 4-8a (CID fragmentation) and Figure 4-8b (HCD fragmentation). 
Nine fragments in total were found (encircled in Figures 4-8a and 4-8b, including the 
parent ion).  The neutral losses identified by MOLGEN-MSMS were: CH4N2, C2H4N2O 
and C2H4N2O2. Using the ChemSpider database, 293 chemicals having C13H10N2O2S as 
an empirical formula and within the determined log Kow range were found. This number 
of candidates was decreased to four using MetFrag. These top match candidates are 
presented in Table 4-7 with their structure, pKa, log Kow, MetFrag score and number of 
predicted fragment. For the remaining 289 compounds, only one or two fragments were 
predicted and they had a very low score (< 0.263). The corresponding predicted MS2 
spectrum of the top match candidates are presented in Figures 4-9 to 4-12.  
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Table 4- 7: Top match candidates for Peak 3. na: pKa out of range 0-14 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 2-amino-5-(1,3-benzodioxol-5-
yl)-4-methylthiophene-3-carbonitrile 
(ChemSpider ID 291445) 
S O
O
NH2
N
CH3
 
1 5 1.8/1.4 na 
(2) 2-amino-4-(2,3-dihydro-1,4-
benzodioxin-6-yl)thiophene-3-
carbonitrile (ChemSpider ID 
4204525) 
 
S
O
O
NH2
N
 
0.939 4 1.8/1.4 na 
(3) methyl 3-amino-5-(4-
cyanophenyl)thiophene-2-carboxylate 
(Chemspider ID 10167241) 
S
O
O
NH2
N
CH3
 
0.81 4 3.2/2.0 na 
(4) 2-amino-5-(2H-chromen-3-
ylmethylidene) -1,3-thiazol-4(5H)-
one (ChemSpider ID 3386684) 
S
OON
NH2
 
0.778 3 1.9/1.7 3.9 NArH+ ↔ NAr 
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Candidate 1 is better ranked than the other candidates due to the greater number 
of predicted fragments but also due to the “ease” of fragmentation. Indeed this candidate 
lost functional groups bounded to the structure skeleton. In all four cases the most 
intense fragment (m/z 216) was always assigned (loss of CH4N2). For candidates 1, 2 
and 3 this loss corresponded to the loss of two functional groups (NH3 and HCN). The 
amino group loss was commonly observed with the standards (e.g. 2-amino-3-
methylimidazo[4,5-f]quinoline, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline,  2-
amino-9H-pyrido[2,3-b]indole), supporting more these three candidates than candidate 
4. Furthermore, for candidates 1, 2 and 3 the pKa values allow them to elute completely 
in the neutral fraction, as opposed to candidate 4, which would be mainly positively 
charged at pH 2 and thus would mostly elute in the basic fraction. The unknown was not 
detected in the basic fraction, thus the compound 4 (2-amino-5-(2H-chromen-3-
ylmethylidene)-1,3-thiazol-4(5H)-one) can be removed from the list of candidates. 
Furthermore the unknown compound was also observed in ESI + mode (higher intensity 
in ESI than APCI), supporting the amino substituent present in the structure of the three 
remaining candidates (1, 2 and 3) (see Table 4-2). No information regarding the use of 
these chemicals were found on Google and ChemSpider, and only candidate 2 is 
available as standard. 
 
Peak 19: This peak of formula C12H9N (m/z 168.0801 Da), eluting at 24.1 min 
was detected in APCI + only. Its MS2 spectrum obtained by APCI + revealed only one 
fragment, corresponding to the loss of a hydrogen atom (Figure 4-13), similar to 
carbazole (m/z 168.0808, empirical formula C12H9N and retention time of 28.1 min). 
The search performed with ChemSpider provided 103 hits, with only 58 fitting the log 
Kow range (0.5 – 4.2 including the error range). As only the parent ion was present in the 
MS2 spectrum, MetFrag could not be used to reduce the number of candidates. 
However, the fragmentation behaviour of the standards presented in Table 4-1 was used 
instead.  Indeed the 58 hits presented two types of structure, one for which fragment(s) 
were likely and one for which fragment(s) were less likely. Some examples of these 
structures are presented in Table 4-8. As seen in Table 4-1, substitutents on aromatic 
rings are easily lost during fragmentation (e.g. methyl group: 2-amino-3-
methylimidazo[4,5-f]quinoline or 1-methyl-9H-pyrido[3,4-b]indole, amino group: N-
phenylnaphthalen-2-amine or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 1,8-
diaminopyrene). Furthermore, this unknown was only observed in APCI + and not in 
ESI mode, excluding the presence of an amino group.  Using these expected 
fragmentation and ionisation behaviour the number of hits was decreased to 32 
compounds.  
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similar to carbazole, even if the carbazole can exchange four hydrogens while the 
unknown exchanges only three hydrogens [146]. Thus, the type of structure expected is 
similar to carbazole, structure 1, which also explains the loss of a hydrogen atom. Seven 
compounds in the ChemSpider database are still possible. The number of exchangeable 
hydrogen atoms bound to nitrogen is two.  However, in addition, the two hydrogen 
atoms in the peri position may be partly exchanged [147]. The retention time of the 
carbazole was 28.1 min while the unknown’s was 24.2. According to Bataneih et al. 
[95], the decrease of the number of peri- or bay-region hydrogen leads to a decrease in 
the retention time of the chemical. Thus, our unknown compound should possess one 
peri- or one bay-region hydrogen instead of two peri-hydrogens. Only four candidates 
remain with these properties and are presented in Table 4-9 (structure, pKa, log Kow).  
Only the 1h-benz[g]indole was available as standard (Sigma Aldrich) and was 
purchased for confirmation. This compound showed the same loss of hydrogen, as the 
unknown compound (Figure 4-14), but had a different retention time (22.6 min,instead 
of 24.2 min). Within the remaining candidates, 3H-benz[e]indole is used in the synthesis 
of pharmaceuticals, and some pharmaceutical industries are present in the sampling 
area, while the 1H-azuleno[1,2-b]pyrrole could be involved in the synthesis of 
squarilium compounds or liquid crystal and no information was available for the 1H-
benz[f]indole.  The remaining candidates are not available as standards and would need 
to be synthesised for confirmation. However, as 1h-benz[g]indole and carbazole are not 
mutagenic, the mutagenicity observed in this fraction N-2-8 is not likely to be connected 
to this unknown compound.  
 
Table 4- 9: Top Candidates for Peak 19. na: pKa out of range 0-14 
Structure log Kow 
ACD/EPI SUITE 
pKa information 
(1) 3H-benz[e]indole (ChemSpider ID 
9519149) 
N
H  
3.4/3.2 na 
Mainly used in the 
synthesis of anti-tumour 
pharmaceuticals (8 
patents) [139]  
(2) 1H-benz[g]indole  (ChemSpider 
ID 89061),  
N
H
 
3.4/3.2 na 
Used in the synthesis of 
different 
pharmaceuticals (4 
patents) [139] 
Incorrect retention time 
(3) 1H-benz[f]indole  (Chemspider ID 
10496645) 
N
H
3.7/3.2 na No information available 
(4) 1H-azuleno[1,2-b]pyrrole 
(ChemSpider ID 14524926) 
N
H
 
3.7/3.2 na 
Use in the synthesis of 
squarilium compounds 
(1 patent) [139] 
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could be undertaken, in order to determine the empirical formula. At this stage we 
cannot propose another candidate having this formula. Structure generation, as 
developed for GC-MS identification could be considered [150], but in this case the MS2 
provides little information about the structure.  
 
 An exact mass search was also attempted using the neutral exact mass of 
232.0884 Da, 290 hits were found. The first three chemicals proposed had a formula of 
C9H16N2O3S, explaining 3 or 4 fragments with scores from 0.977 to 1. However the 
degree of unsaturation was too low (5 unsaturations). Nine chemicals had a formula of 
C14H13FO2, explaining 4 fragments (scores 0.876 to 0.966) and another 27 structures 
explained 3 fragments and still had a high score (0.862 - 0.864). The third best formula 
found was C11H16NOFCl with three explained fragments and score of 0.864. However, 
the degree of unsaturation was also too low (4 unsaturations), while we set up the 
minimum of unsaturation to 7 to have large planar molecules, as they are known to 
better adsorbed on the blue rayon. The nine chemicals (highest score, four fragments 
predicted) resulting from this mass search were checked for log Kow and pKa and one 
candidate was removed. The eight remaining candidates are presented in Table 4-14. All 
these candidates have a hydroxyl group, which is well detected in ESI + and ESI -. 
However, the unknown was only detected in APCI +, which does not support the 
presence of this group. Thus, the possibility that the unknown is one of these candidates 
is unlikely, and even with the mass search we cannot provide a candidate for this peak. 
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Table 4- 14: Candidates for Peak 40 from the mass search, na: pKa out of range 0-14,   nd: log 
Kow not predicted 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 5-fluoro-2-(2-methoxybenzyl) 
phenol  (ChemSpider ID 14273794) 
F OH
O
CH3
 
0.966 4 3.8/3.8 9.8 OH ↔ O- 
(2) 4-fluoro-2-(3-methoxybenzyl) 
phenol (ChemSpider ID 11343506)  
CH3
O
OH
F  
0.966 4 3.6/3.8 9.8 OH ↔ O- 
(3) 4-fluoro-2-(4-methoxybenzyl) 
phenol  (Chemspider ID 11445011) 
CH3
O
OH
F
 
0.966 4 3.4/3.8 9.9 OH ↔ O- 
(4) 2-[1-(3-fluorophenyl)-1-
hydroxyethyl]phenol  (ChemSpider 
ID 15185584) 
F
OH
CH3
OH
 
0.883 4 2.4/2.9 10.8         OHAr ↔ OAr- 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(5) 4-[(4-fluorophenyl) methoxy]-3-
methyl-phenol  (ChemSpider ID 
25530933) 
O
F
OH CH3 
0.883 4 3.2/nd 10.1 OH ↔ O- 
(6) 2-[(4-fluorophenyl) methoxy]-5-
methyl-phenol  (ChemSpider ID 
25531216) 
O
OH F
CH3
 
0.883 4 3.1/nd 9.7 OH ↔ O- 
(7) 2-[(2-fluorophenyl)methoxy]-5-
methyl-phenol  (ChemSpider ID 
25531498) 
O
F
OH
CH3
 
0.883 4 3.1/nd 9.7 OH ↔ O- 
(8) 1-[5-(4-fluorobenzyl)furan-3-
yl]prop-2-en-1-ol  (ChemSpider ID 
14669156) 
CH2
O
F
OH
 
0.876 4 3.0/3.7 na 
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Table 4- 15: Candidates for Peak 50, na: pKa out of range 0-14, nd: log Kow not predicted 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 1-benzyl-4-methyl pyrrolidine-2,3-
dione  (ChemSpider ID 219476) 
O
O
N
CH3
 
0.945 1 1.0/0.2 na 
(2) 1-ethyl-5,7-dimethyl-1H-indole-2,3-
dione  (ChemSpider ID 20523428)  
N
O
O
CH3 CH3
CH3
 
0.945 1 2.0/1.9 na 
(3) 5,6-diethyl-1H-indole-2,3-dione 
(Chemspider ID 13494962) 
CH3
CH3
N
H
O
O
 
0.945 1 2.5/2.5 10.9 NH ↔ N- 
(4) 7-methyl-1-propyl-1H-indole-2,3-
dione  (ChemSpider ID 2407695) 
O
O
N
CH3
CH3
 
0.945 1 2.1/1.8 na 
(5) 1-(2-phenylethyl) pyrrolidine-2,3-
dione (ChemSpider ID 24798308) 
N
O
O
 
0.945 1 1.8/nd na 
(6) 5-isopropyl-1-methyl-indoline-2,3-
dione (ChemSpider ID 24021760)
N
O
O
CH3
CH3
CH3
 
0.945 1 1.9/nd na 
(7) 4,5,6,7-tetramethyl-1H-indole-2,3-
dione (ChemSpider ID 19461480) 
CH3
CH3 O
O
N
H
CH3
CH3
 
0.945 1 2.4/2.6 11.4 NH ↔ N- 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(8) 5-tert-butyl-1H-indole-2,3-dione 
(ChemSpider ID 517156) 
O
O
N
H
CH3
CH3
CH3
 
0.945 1 2.2/2.4 10.6 NH ↔ N- 
(9) 1-isopropyl-5-methyl-1H-indole-
2,3-dione (ChemSpider ID 1606080) 
O
O
N
CH3
CH3
CH3
 
0.945 1 1.0/1.7 na 
(10) 5-butyl-1H-indole-2,3-dione 
(ChemSpider ID 2339601) 
O
O
N
H
CH3
 
0.945 1 2.6/2.5 10.6 NH ↔ N- 
(11) 1-(2-methylpropyl)-1H-indole-2,3-
dione (ChemSpider ID 1783307) 
O
O
N CH3
CH3
 
0.945 1 2.0/1.7 na 
(12) 4,4-dimethyl-1-phenyl-pyrrolidine-
2,3-dione (ChemSpider ID 9238673) 
O
O
N
CH3
CH3
 
0.945 1 1.6/0.4 na 
(13) 5-(1-methylpropyl)-1H-indole-2,3-
dione  (ChemSpider ID 16812332)
N
H
O
O CH3
CH3
 
0.945 1 2.4/1.6 10.6 NH ↔ N- 
(14) 7-(2-methylpropyl)-1H-indole-2,3-
dione  (ChemSpider ID 513041)
O
O
N
HCH3
CH3
 
0.945 1 2.4/2.4 10.6 NH ↔ N- 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(15) 1-butyl-1H-indole-2,3-dione 
(ChemSpider ID 1283920)
N
O
O
CH3
 
0.945 1 2.2/1.8 na 
(16) 5-methyl-1-propyl-1H-indole-2,3-
dione  (ChemSpider ID 2378726)
O
O
N
CH3
CH3
 
0.945 1 2.1/1.8 na 
(17) 7-methyl-1-(1-methylethyl)-1H-
indole-2,3-dione  (ChemSpider ID 
3347751) 
O
O
N
CH3
CH3CH3
 
0.945 1 1.9/1.7 na 
(18) 1-ethyl-4,6-dimethyl-indoline-2,3-
dione  (ChemSpider ID 24209284)
N
O
O
CH3
CH3
CH3  
0.945 1 2.1/nd na 
(19) 7-amino-4-propyl-2H-chromen-2-
one  (ChemSpider ID 2012579)
OO NH2
CH3  
0.89 1 2.2/2.1 2.2 NH3+ ↔ NH2 
 
All of these candidates may explain the fragment 148. However, based on the 
study of standards (Table 4-1), some candidates could be removed from this list. Indeed 
for structures 1, 5 and 12 the loss of the benzyl group is expected, as seen for the 2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, N,N’-diethyl-N,N’-diphenylurea, 
benzophenone and the N-phenyl-2-naphthalenamine.  
 Candidate 9 (1-isopropyl-5-methyl-1H-indole-2,3-dione) was available as 
standard and was purchased for confirmation. Its retention time was 13.0 min instead of 
13.2 min for the unknown and its  MS2 fragmentation pattern (Figure 4-22) and was 
different to the unknown fragmentation pattern (Figure 4-21). The only fragment 
observed was at 162.0544 Da corresponding to the loss of C3H6 (tert-butyl group bound 
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Table 4- 16: Top match candidates for Peak 50 
Name of Candidate Information 
(3) 5,6-diethyl-1H-indole-2,3-dione Use in the synthesis of imino-indeno[1,2-c]quinoline 
derivatives (anti-cancer therapy) (2 patents) [139] 
 
(7) 4,5,6,7-tetramethyl-1H-indole-2,3-dione No information available 
(8) 5-tert-butyl-1H-indole-2,3-dione Use in the preparation of six membered heterocycle 
derivatives which are used as selective inhibitor of 
serine protease enzyme (1 patent) [139] 
 
(10) 5-butyl-1H-indole-2,3-dione No information available
(13) 5-(1-methylpropyl)-1H-indole-2,3-dione   No information available
(14) 7-(2-methylpropyl)-1H-indole-2,3-dione   No information available
(19) 7-amino-4-propyl-2H-chromen-2-one   No information available
 
Peak 60: This peak of formula C21H20N4O3 (m/z 377.1598), eluting at 20.2 min 
was detected in APCI +/- and ESI +. The MS2 fragments were obtained with APCI + 
(Figure 4-24) and these two fragments corresponded to the two halves of the molecule 
(254.0930 corresponding to C14H12N3O2 and 124.0756 to C7H10NO). Thus, the molecule 
fragmented easily in two fragments as observed for two standards, benzophenone and 
1,3-dimethyl-1,3-diphenylurea, for which the cleavage appeared at the carbonyl group. 
MS3 fragmentation of the most intense ion, 254.0930 Da was performed. The fragments 
obtained from this peak are presented in Table 4-17, as well as their corresponding 
losses. In total six fragments were used to search the ChemSpider database with 
MetFrag. There were more than 1600 hits, but only seven of them showed a very high 
score (≥ 0.856) and could explain four or five fragments of the six observed fragments. 
After verification of the log Kow and pKa values, three were excluded as their pKa values 
would have led to elution the basic fraction. These four candidates are presented in 
Table 4-18 and the predicted fragments in Figure 4-25 (Structure 1) and Figure 4-26 
(Structures 2, 3 and 4).   
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Table 4- 18: Candidates for Peak 60 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 2-ethoxy-N-(3-
[(phenylcarbamoyl) amino] 
phenyl)pyridine-3-carboxamide 
(ChemSpider ID 16999411) 
CH3
O
N 
a
O
NH 
b
NH 
c
O
NH 
d
 
1 4 3.9/3.5 
0.5 
NaH+ ↔ Na 
 
11.8 
NbH ↔ Nb- 
 
13.5 
NcH ↔ Nc- 
 
14.0 
NdH ↔ Nd- 
 
(2) N-(2-aminophenyl)-4-([2-
(pyridin-3-yloxy)propanoyl] 
amino)benzamide (ChemSpider ID 
11536340)  
CH3
ONH 
c
ONH 
b
O
N 
d
NH2 
a
 
0.945 5 2.0/1.9 
2.8 
NaH3+ ↔ NaH2 
 
13.2 
NbH ↔ Nb- 
 
11.3 
NcH ↔ Nc- 
 
3.8 
NdH ↔ Nd- 
 
(3) N-(2-aminophenyl)-4-([(pyridin-
2-ylmethoxy)acetyl]amino) 
benzamide (Chemspider ID 
11536336) 
NH 
b
O
c
 HN
O
NH2 
a
O
N 
d
 
0.945 5 2.5/2.5 
2.8 
NaH3+ ↔ NaH2 
 
13.2 
NbH ↔ Nb- 
 
11.4 
NcH ↔ Nc- 
 
3.3 
NdH ↔ Nd- 
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Table 4- 19: Candidates for Peak 99  
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 2-methoxy-N'-[1-(5-methylfuran-
2-yl) ethylidene]benzo hydrazide   
(ChemSpider ID757961)
O
O
O NH b
a
 N CH3
CH3
CH3
 
1 1 2.3/3.4 
3.8 
NaH+ ↔ Na 
 
11.7 
NbH ↔ Nb- 
 
1.8 
NbH2+ ↔ NbH 
 
(2) benzamide, N-(4-amino-2-
methoxyphenyl)-4-methoxy- 
(ChemSpider ID 833606) 
O
O
O
b
 HN
NH2 
a
CH3
CH3
 
0.987 1 0.9/1.4 
3.4 
NaH3+ ↔ NaH2 
 
13.6 
NbH ↔ Nb- 
 
0.07 
NbH2+ ↔ NbH 
 
(3) acetamide, N-(4-amino-2-
methoxyphenyl)-2-phenoxy- 
(ChemSpider ID 833624) 
O
O
O
b
 HN
NH2 
a
CH3
 
0.987 1 1.6/1.4 
3.4 
NaH3+ ↔ NaH2 
 
13.6 
NbH ↔ Nb- 
 
0.07 
NbH2+ ↔ NbH 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(4) 1,3-Bis(4-methoxyphenyl)urea 
(Chemspider ID 120696) 
O
O
O
NH
NH
CH3
CH3  
(plus 5 of OCH3 rearrangement 
isomers) 
0.987 1 2.8/3.1 
13.6 
NH ↔ N- 
 
 
(5) 3-amino-4-methoxy-N-(2-
methoxyphenyl) benzamide      
(Chemspider ID 8811261) 
O
O
O NH 
b
a
 H2N
CH3
CH3
 
(plus two isomers ID 16805321 and 
13317570) 
0.987 1 2.1/1.4 
2.7 
NaH3+ ↔ NaH2 
 
13.6 
NbH ↔ Nb- 
 
0.07 
NbH2+ ↔ NbH 
 
(6) bis(3-amino-4-methoxyphenyl) 
methanone     (ChemSpider ID 
660964) 
O
O
a
 H2N
CH3
NH2 
a
O
CH3
 
0.987 1 2.5/1.5 
2.7 
NaH3+ ↔ NaH2 
 
(7) 6-amino-3-(piperidin-1-
ylcarbonyl) -2H-chromen-2-one 
(Chemspider ID 26898) 
O
OO
N
NH2
 
0.873 2 0.4/0.7 
3.6 
NH3+ ↔ NH2 
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   While only candidate 7 has two fragments predicted with MetFrag, the other six 
candidates could generate a loss of a methyl group from the fragment at 124 Da. The 
presence of this unknown in ESI + is supporting all the candidates presented above 
(most of them possessing an amino function group). We observed similar fragmentation 
pattern with the 1,3-diethyl-1,3-diphenylurea and benzophenone which enable the 
observation of two fragments (snap bond on one side of the carbonyl group). The fact 
that the fragment 124 is the most intense could indicate a symmetrical compound such 
as candidates 4 and 6. Furthermore urea derivatives already have been found at the 
sampling site. Information regarding the use of these candidates was checked and only 
candidate 4 had a specific use (one patent [139]). The urea derivative is needed in the 
production of urea, which is an important compound in the preparation of various 
products (particularly agricultural chemical for the treatment of soils). We know about 
the pharmaceutical and dyes industries at the site, but nothing about the production of 
agricultural chemicals. Nevertheless, a direct use of the chemical in field can be 
possible. It is here again difficult to choose one candidate over another one, but urea 
derivatives are not known to be mutagenic, and the standard we used for the study (1,3-
diethyl-1,3-diphenylurea) was not mutagenic either. 
 
Peak 109: This peak of formula C16H11NO2 (m/z 250.0855), eluting at 16.5 min 
was detected in APCI +/- and ESI +. The APCI + MS2 spectrum of the unknown is 
presented in Figure 4-30a (CID fragmentation) and Figure 4-30b (HCD fragmentation). 
Only two fragments were observed, corresponding to the loss of NH3 and CH3NO. The 
signal resulting from a loss of NH3 was the most intense and the molecule probably 
contains an amino group (see Section 4.3.1, Table 4-1). The NH3 loss was associated 
with  high intensity peaks in the standards 2-amino-3-methylimidazo[4,5-f]quinoline, 2-
amino-3,8-dimethylimidazo[4,5-f]4quinoxaline, 2-amino-1-methyl-6-phenylimidazo4,5-
b]pyridine, 2-amino-9H-pyrido[2,3-b] indole, 3,3’dichlorobenzidine and 1,8-
diaminopyrene. The second loss, CH3NO (NH3 +CO), indicates the possible presence of 
a carbonyl group, although the corresponding [M+H-CO] signal was not detected. 
Using ChemSpider, 346 chemicals with  the formula C16H11NO2 were proposed. 
MetFrag identified five chemicals with an amino group in their structure, explaining one 
or two of the fragments. Furthermore, these five candidates showed a high score with 
MetFrag. No further decrease of the number of candidates was possible as they all 
matched the log Kow and pKa values. These candidates are presented in Table 4-20 and 
the predicted MS2 in Figure 4-31 (Structures 1 and 2) and Figure 4-32 (Structure 3, 4 
and 5). This peak was also present in the acidic fraction A-2-8, showing low 
mutagenicity.  
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Table 4- 20: Candidates for Peak 109, na: pKa out of range 0-14 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 2-[amino(phenyl)methylidene]-
1H-indene-1,3(2H)-dione 
(ChemSpider ID 4373802) 
O
O
NH2
 
1 1 2.5/2.0 na  
(2) 3-amino-2-benzoyl-1H-inden-1-
one  (ChemSpider ID 10520884)  
O
NH2
O
 
1 1 1.0/1.7 
 
12.8 
NH2 ↔ NH- 
 
 
 
(3) 1-oxo-3-phenyl-1H-indene-2-
carboxamide (Chemspider ID 
216520) 
O
O
NH2
 
0.879 2 2.4/2.2 
na 
 
 
(4) 9-ethynyl-9H-fluoren-1-yl 
carbamate  (Chemspider ID 
2315078) 
O
O
NH2
H
 
0.879 2 2.9/2.9 
 
12.2 
NH2 ↔ NH- 
 
 
(5) 2-aminoanthracene-9,10-
dicarbaldehyde (Chemspider ID 
15224742) 
O
NH2
O
 
0.879 2 2.2/2.9 
2.1 
NH3+ ↔ NH2 
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expected to elute in the acidic fraction. Only candidate 4 would be present in the acidic 
fraction in some extent. From Structure 4, more fragments would be expected, as the 
loss of an ethyne group. Indeed we saw for some of the standards (Table 4-1) that 
functional groups on a PAH skeleton were the first to be fragmented (e.g. CH3 in 2-
amino-3-methylimidazo[4,5-f] quinoline). However, in the present selection of 
standards (Table 4-1), none of them have in their structure an ethyne group on a PAH 
skeleton, so we cannot assure that this functional group will be lost during 
fragmentation. At this stage and based on the database, 2-[amino(phenyl)methylidene]-
1H-indene-1,3(2H)-dione and 9-ethynyl-9H-fluoren-1-yl carbamate  are the best 
candidates we can propose, but no information regarding their use was found. 
 
Peak 138: This peak of formula C17H19N3O4 (m/z 330.1438), eluting at 17.2 min 
was detected in APCI +/- and ESI +. The APCI + MS2 spectrum of the unknown was 
obtained from CID fragmentation, and two fragments were observed (211.1081 and 
165.0657). MS3 (CID) of the 211 Da fragment was performed, and two fragments were 
obtained (196.0844 and 183.0762 Da). All are presented in Table 4-21 with the 
corresponding loss assigned by MOLGEN-MSMS.   Using ChemSpider, 2257 
chemicals with the formula C17H19N3O4 were proposed.  Metfrag identified ten 
chemicals with a score greater than 0.853 and explaining at least two fragments, with 
three other chemicals with a score between 0.722 and 0.792 explaining three fragments. 
These ten candidates fitted the log Kow range and pKa values. They are presented in 
Table 4-22 with the predicted MS2 in Figure 4-33 to Figure 4-38.  
 
Table 4- 21: Fragments for Peak 138 
m/z Assigned formula Neutral loss 
330.1452 C17H20N3O4 Parent ion 
211.1076 C10H15N2O3 C7H5NO 
196.0844 C9H12 N2O3 CH3O (from 211) 
183.0762 C8H11 N2O3 C2H4 (from 211) 
165.0657 C8H9 N2O2 
C9H11NO2 (from 330) 
H2O (from 183) 
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Table 4- 22: Candidates for Peak 138, na: pKa out of range 0-14, nd: log Kow not predicted 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1)  1-methyl-2-oxo-2-(phenylamino) 
ethyl 6-oxo-1-propyl-1,6-
dihydropyridazine-3-carboxylate  
(ChemSpider ID 16867074) 
CH3 N
N
O
OO
CH3
O
NH 
a
 
1 3 1.5/1.9 11.1 NaH ↔ Na- 
(2) ethyl 5-[(2-benzoylhydrazinyl) 
carbonyl]-2,4-dimethyl-1H-pyrrole-3-
carboxylate  (ChemSpider ID 
832693)  
O
O
O
O
NH 
c
b
 HN
NH a
CH3
CH3
CH3
 
0.923 2 2.9/2.5 
9.0 
NaH ↔ Na- 
 
9.1 
NbH ↔ Nb- 
 
9.1 
NcH ↔ Nc- 
(3) ethyl 5-[(4-carbamoylphenyl) 
carbamoyl]-2,4-dimethyl-1H-pyrrole-
3-carboxylate  (Chemspider ID 
7177168) 
O
O
O
O
c
 HN
b
 HN
a
 H2N
CH3
CH3
CH3
 
0.923 2 1.9/2.4 
0.7 
NaH3+ ↔ NaH2 
 
13.1 
NbH ↔ Nb- 
 
13.5 
NcH ↔ Nc- 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(4) ethyl 3-[(2-aminophenyl) 
carbonyl]-1-(cyclopropyl carbonyl)-
4,5-dihydro-1H-pyrazole-5-
carboxylate (ChemSpider ID   
9338397 ) 
O
O
O
O
N
b N
a H2N
CH3
 
0.892 4 0.2/2.4 
0.8 
NaH3+ ↔ NaH2 
 
0.7 
NbH+ ↔ Nb 
(5) 4-([(5-ethoxy-2-methyl-4-
oxopyridin-1(4H)-yl)acetyl] 
amino)benzamide (ChemSpider ID 
20907755 ) 
N
b HN
O
O
O
O
NH2 a
CH3
CH3
 
0.859 2 1.0/2.0 
0.5 
NaH3+ ↔ NaH2 
 
10.1 
NbH ↔ Nb- 
 
(6) ethyl 4-[(4-carbamoylphenyl) 
carbamoyl]-3,5-dimethyl-1H-pyrrole-
2-carboxylate  (ChemSpider ID 
7724394) 
O
O
O
O
NH 
c
b HN
a H2N
CH3 CH3
CH3
 
0.859 2 0.8/1.8 
0.8 
NaH3+ ↔ NaH2 
 
13.3 
NbH ↔ Nb- 
 
12.9 
NcH ↔ Nc- 
Chapter 4 
116 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(7) N-[3-(4-carbamoylanilino)-3-oxo-
propyl]-N-ethyl-furan-3-carboxamide  
(ChemSpider ID 22444805)  
CH3
N
Ob HN
O NH2 
a
O
O  
0.859 2 0.9/na 
0.6 
NaH3+ ↔ NaH2 
 
12.3 
NbH ↔ Nb- 
 
(8) 2-[(4-methoxy 
phenyl)carbamoylamino]ethyl N-
phenyl carbamate  (ChemSpider ID 
24782508) 
a
 HN
O
O
NH 
b
NHO
O
CH3  
0.853 2 2.6/na 
10.5 
NaH ↔ Na- 
 
12.8 
NbH ↔ Nb- 
 
(9) N-(3-(2-[(2,5-dimethylfuran-3-yl) 
carbonyl]hydrazinyl)-3-oxopropyl) 
benzamide (ChemSpider ID 
11702249) 
CH3
O
a
 HN
NH 
b
O
NH 
c
O
CH3
O
 
0.792 3 0.1/1.6 
9.5 
NaH ↔ Na- 
 
9.3 
NbH ↔ Nb- 
 
13.9 
NcH ↔ Nc- 
  
Fi
 
 
 
(10) ethyl 5
hydroxyphe
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2,4-dimethy
carboxylate 
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a N
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O
CH3
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 34: Predicted MS2 spectrum of candidates 2, 3, 5 and 6 for Peak 138 
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N-[3-(4-carbamoylanilino)-3-oxo-propyl]-N-ethyl-furan-3-carboxamide
(structure 7)    
2-[(4-methoxy phenyl)carbamoylamino]ethyl N-phenyl carbamate
(structure 8)
330.1452
[C17H20N3O4]+
211.1083
[C10H15N2O3]+
165.0664
[C8H9N2O2]+
 
Figure 4- 35: Predicted MS2 spectrum of candidates 7 and 8 for Peak 138 
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Regarding the MS2 prediction, the most three intense fragments are explained. 
The fragment 246 could also be possible by the loss of the carbonyl group present in the 
5 rings of the molecule skeleton, by breakage of two C-C bonds. We saw that keto-
PAHs can release such fragments (e.g. 9-fluorenone, benzanthrone, 4H-cyclopenta-
[def]phenanthren-4-one).  Thus, we would be able to explain four of the six fragments. 
The two fragments which cannot be explained with the presented structure are very low 
in intensity and this structure enabled to explain the most intense fragments, which is a 
good indicator.  However, a loss of a phenyl group could be expected from parent ion or 
the fragment 284, as seen for the benzophenone (phenyl group bounded to a carbonyl 
group Table 4-1).  Furthermore, the presence of signal in ESI +/- support this candidate. 
This candidate remain the best choice found in database. The search for information on 
ChemSpider or Google was not successful.  
 
Peak 208: This peak of formula C22H10O3 (m/z 323.0694), eluting at 25.3 min 
was detected in APCI + and ESI +. The APCI + MS2 spectrum of the unknown showed 
one fragment at 295.0763, corresponding to the loss of a carbonyl group.   Using 
ChemSpider, five chemicals with the formula C22H10O3 were proposed, but none of 
them matched the  log Kow range (> 4.5).  
 
The second formula to search for a structure was C20H9N3O2. Using 
ChemSpider, two hits were found but only one chemical fitted the log Kow range. Most 
of this compound should elute in the basic fraction, due to the pKa values. However, a 
small part is still expected in the neutral fraction (Table 4-25). The loss of the carbonyl 
group is also possible and the prediction MS2 is presented in Figure 4-40. 
 
Table 4- 25: Candidate for Peak 208 
Structure MetFrag Score 
Predicted 
fragments 
log Kow   
ACD/EPI 
SUITE 
pKa 
6H-indolo[6,7-a]pyrrolo[3,4-
c]carbazole-6,8(7H)-dione  
(ChemSpider ID 10705285) 
N
 a
O
N 
bO
N 
c
 
1 1 2.9/4.5 
1.7 
NaH+ ↔ Na 
 
0.3 
NbH+ ↔ Nb 
 
2.5 
NcH+ ↔ Nc 
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Table 4- 26: Candidates for Peak 208 from the mass search 
Structure MetFrag Score 
Predicted 
fragments 
log Kow   
ACD/EPI 
SUITE
pKa 
(1) 4-[(2-amino-4-oxo-1,3-
thiazol-5(4H)-ylidene) 
methyl]-2,6-dimethoxyphenyl 
acetate   (ChemSpider ID 
3421619) 
S
O
O O
O
O
b
 N
a
 H2N
CH3 CH3
CH3
 
 
C14H14NO5S 
0.903 1 1.0/0.7 
9.1 
NaH3+ ↔ NaH2 
 
3.5 
NbH+ ↔ Nb 
 
 
 
(2) 5-(1-[(4-amino-6-
cyanopyrimidin-2-yl)sulfanyl] 
ethyl)furo[2,3-c]pyridine-3-
carbonitrile (ChemSpider ID 
13748586) 
CH3
a
 N
O
N
S
NN
N
NH2
 
C15H10N6OS 
0.814 1 0.4/1.5 
3.1 
NaH+ ↔ Na 
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Table 4- 28: Candidate for Peak 213 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1)  (6Z)-6-(1-[2-(2-
methylphenyl)hydrazino] 
ethylidene)cyclohexa-2,4-dien-1-one      
(ChemSpider ID 5201826) 
O
NH
NH a
CH3
CH3  
+ 2 isomers  
1 2 3.0/2.8 13.0 NaH ↔ Na- 
(2) 4-(1-[2-(4-
methylphenyl)hydrazinyl]ethylidene)c
yclohexa-2,5-dien-1-one  
(ChemSpider ID 7349810)  
 
O
NH a
NHCH3 CH3
 
+ 1 isomer 
1 2 2.9/2.5 
12.2 
NaH ↔ Na- 
 
 
(3) N-(5-amino-2-methylphenyl)-2-
methylbenzamide  (Chemspider ID 
963260) 
O
NH
NH2 
a
CH3
CH3
 
 
+ 10 isomers 
0.96 2 2.4/2.3 
4.0 
NaH3+ ↔ NaH2 
 
(4) 3-amino-4-methyl-N-(4-
methylphenyl) benzamide   
(ChemSpider ID 15117243    ) 
CH3
NH
O
NH2 
a
CH3  
+ 13 isomers 
0.96 2 2.6/2.9 
3.1 
NaH3+ ↔ NaH2 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(5) N-(5-Amino-2-methylphenyl)-2-
phenylacetamide  (ChemSpider ID 
6863132) 
O
NH
NH2
 a
CH3  
+ 2 isomers 
0.96 2 1.3/1.9 
4.2 
NaH3+ ↔ NaH2 
 
(6) 3-amino-N,4-dimethyl-N-
phenylbenzamide  (ChemSpider ID 
11856278)  
N
O
NH2 
a
CH3
CH3
 
+ 4 isomers 
0.96 2 2.2/2.2 
2.6 
NaH3+ ↔ NaH2 
 
(7) 1-[2-amino-5-
(benzylamino)phenyl]ethanone           
(ChemSpider ID 9086908) 
O
NH
 ba
 H2N
CH3
 
+ 1 isomer 
0.96 2 2.5/2.1 
2.7 
NaH3+ ↔ NaH2 
 
4.3 
NbH2+ ↔ NbH 
 
(8) bis(4-amino-3-
methylphenyl)methanone 
(ChemSpider ID 11255017) 
CH3
NH2
O
CH3
NH2
 
+ 6 isomers 
0.96 2 2.3/2.4 
3.9 
NH3+ ↔ NH2 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(9) 4-amino-N-benzyl-3-
methylbenzamide (ChemSpider ID 
16491734) 
CH3
a
 NH2
O
NH
 
+ 5 isomers 
0.956 2 2.5/2.5 
2.7 
NaH3+ ↔ NaH2 
 
(10) N-(4-aminophenyl)-N,4-
dimethyl-benzamide  (ChemSpider ID 
16491734) 
N
O
NH2
CH3
CH3
 
+ 3 isomers 
0.879 2 2.7/2.5 
4.2 
NaH3+ ↔ NaH2 
 
 
 Based on the structure of the candidates presented in Table 4-28, we could 
removed candidates 6 and 10. Indeed the standards used (Table 4-1) showed that any 
alkyl group bound to a nitrogen atom was released during fragmentation. It was also 
seen with the purchased standard for Peak 50 (1-isopropyl-5-methyl-1H-indole-2,3-
dione) which lost its tert-butyl group linked to the nitrogen. Candidates 6 and 10 have a 
methyl group on a nitrogen atom, but no loss of CH3 was observed and hence, these 
nine candidates are not likely. Furthermore we saw with the benzophenone and the 1,3-
diethyl-1,3-diphenylurea, that there is always a bond split on one side or the other from 
the carbonyl group, and in the case of our unknown compound two fragments are 
obtained containing each an atom of nitrogen. However, for candidates 3 and 5 the two 
nitrogen atoms are located on the same side of the carbonyl group, thus fragment with 
CxHyN2 is expected, but not seen. These 14 candidates were also removed from the list. 
And 34 candidates are still remaining on the list, but we cannot further decrease the 
number of possible candidates. 
 
Peak 228: This peak of formula C21H11NO3 (m/z 326.0802), eluting at 17.0 min 
was detected in APCI +/- and ESI +. The APCI + MS2 and MS3 spectra of the unknown 
showed six fragments in total, which are presented in Table 4-29 with their assigned 
loss. Using ChemSpider, eight chemicals with the formula C21H11NO3 were proposed 
and Metfrag identified only one with a score of 1, 2-phenylanthra[2,3-d][1,3]oxazole-
5,10-dione, explaining only two of six fragments, not including the most intense 
fragments. Furthermore its log Kow did not fit the range (5.2 and 4.8 predicted by ACD 
and EPISuite respectively). All the other candidates had a score of 0. We cannot provide 
any candidate for this unknown, because it does not exist on the database or because the 
empirical formula is incorrect due to adducts (Na and K were not present) or coeluting 
compounds.  
 
Chapter 4 
134 
Table 4- 29: Fragments for Peak 228 
m/z Assigned formula Neutral loss 
326.0619 C21H12NO3  
298.0868 C20H12NO2 CO 
282.0919 C20H12NO CO2 
241.0501 No assignement No assignement 
223.0394 C14H7O3 C7H5N 
195.0436 C13H7O2 
C8H5NO (from parent ion) 
CO (from 223) 
139.0537 C11H7 C10H5NO3 
 
The second method we tried with this unknown was the exact mass search 
(neutral mass of 325.0732 Da), MetFrag found 240 molecules fitting the MS2 pattern. 
The only formula that showed a high score (≥ 0.897) and had at least seven degrees of 
unsaturation was C13H15N3O5S (10 degrees of unsaturation), explained only one 
fragment. In total two chemicals were found, but after matching the log Kow and pKa 
values none of them would have eluted in the neutral fraction, but in the acidic fraction 
instead. Adduct study to clarify the empirical formula and structure generation should 
be proceeded for further identification. 
 
Peak 233: This peak of formula C18H21N3O5 (m/z 360.1545), eluting at 18.4 min 
was detected in APCI + and ESI +. The APCI + MS2 and MS3 spectra of the unknown 
showed six fragments in total, which are presented in Table 4-30 with their assigned 
loss. Using ChemSpider, 1520 chemicals with the formula C21H11NO3 were proposed 
and Metfrag identified ten of them with a high score (> 0.833), explaining at least three 
fragments of the six observed. After matching the log Kow range and pKa values, three 
candidates were removed and another two were also removed due to their unplanar 
structure. The five remaining compounds are presented in Table 4-31 and the predicted 
MS2 in Figure 4-46 (candidate 1), Figure 4-47 (candidate 2) and Figure 4-48 (candidates 
3, 4 and 5).  
 
Table 4- 30: Fragments for Peak 233 
m/z Assigned formula Neutral loss 
360.1557 C18H22N3O5  
211.1080 C10H15N2O3 C8H7NO2 
196.0838 C9H12N2O3 CH3 (from 211) 
183.0760 C8H11N2O3 C2H4 (from 211) 
164.0655 C8H9N2O2 C2H6O (from 211) 
124.0755 C7H10NO C11H12N2O2  
109.0521 C6H7NO C12H15N2O2 
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Table 4- 31: Candidates for Peak 233, nd: log Kow not predicted 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1) 2-[(4-methoxyphenyl)amino]-1-
methyl-2-oxoethyl 6-oxo-1-propyl-
1,6-dihydro pyridazine-3-carboxylate  
(ChemSpider ID 16896706) 
CH3
N
N 
O
O O
CH3 O
NH 
a
O
CH3
 
1 4 1.5/2.0 
 
11.3 
NaH ↔ Na - 
 
 
(2) ethyl 3-(2-amino-5-methoxy 
benzoyl)-1-(cyclopropylcarbonyl)-
4,5-dihydro-1H-pyrazole-5-
carboxylate (ChemSpider ID 
9385631)  
O
O
O
O
O
NN
H2N 
a
CH3
CH3  
0.906 5 0.3/2.5 
 
1.2 
NaH3+↔ NaH2 
 
0.9 
NbH+↔ Nb 
 
 
(3) N-(2,4-dimethoxy-5-([(2-
methoxyphenyl) carbamoyl]amino) 
phenyl)acetamide  (Chemspider ID 
4991426) 
O
O
O
O
O
b
 HN
NH a
c
 HN
CH3
CH3
CH3
CH3
 
0.833 3 2.3/1.8 
11.9 
NaH↔ Na- 
 
12.8 
NbH↔ Nb- 
 
13.5 
NcH↔ Nc- 
b
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(4) N-(2,5-dimethoxy phenyl)-2-[(3-
methoxy phenyl)carbamoylamino] 
acetamide   (Chemspider ID 
21985955) 
CH3
O
NH aO
NH 
b
Oc HN
O
CH3
O
CH3
 
0.833 3 2.5/nd 
 
13.5 
NaH↔ Na- 
 
13.4 
NbH↔ Nb- 
 
10.9 
NcH↔ Nc-- 
 
 
(5) N-(2,4-dimethoxy phenyl)-2-[(3-
methoxy phenyl) carbamoylamino] 
acetamide (Chemspider ID 
15224742) 
CH3
O
NH aO
NH 
b
Oc HN
O
CH3
O
CH3
 
0.833 3 2.1/nd 
13.5 
NaH↔ Na- 
 
13.5 
NbH↔ Nb- 
 
11.4 
NcH↔ Nc-- 
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Peak 242: This peak of formula C12H12N2 (m/z 185.1066), eluting at 16.6 min 
was detected in APCI +, only. MS2 fragments were obtained with CID (Figure 4-49a) 
and HCD (Figure 4-49b). The losses corresponding to the fragments were assigned 
using MOLGEN-MSMS and were: CH3, CH4, CHN, N2, C2H4, C2H2N and C2H3N. 
Using ChemSpider, 500 chemicals with the formula C12H12N2  were proposed and 
Metfrag identified 81 candidates with a high score (≥ 0.802 including 15 with a score ≥ 
0.916 with six assigned fragments) and explaining five or six of the seven observed 
fragments. Amongst these candidates thirteen of them had an amino functional group 
and were removed from the list as amino-compounds are better ionised in ESI + and 
should have a greater signal than in APCI +. This unknown was not detected in ESI +, 
supporting the absence of amino group. After matching the log Kow and pKa values, 37 
candidates remained, with 15 within the score range of 0.916 to 1. These 15 candidates 
are presented in Table 4-32. In this case we cannot further decrease the number of 
candidates based on physical-chemical properties of the candidates, and/or MS2 
prediction.  
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Table 4- 32: Candidates for Peak 242, na: pKa out of range 0-14, nd: log Kow not predicted 
Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(1)  4-(cyanomethyl)-2-propyl 
benzonitrile  (ChemSpider ID 
15554727) 
CH3N
N
 
1 6 2.4/2.6 na 
(2) 2-(4-ethylphenyl) butanedinitrile  
(ChemSpider ID 25620509)  
N
N
CH3
 
1 6 1.6/nd na 
(3) 4-(cyanomethyl)-3-propyl 
benzonitrile  (Chemspider ID 
15555002) 
CH3
N
N
1 6 2.4/2.6 na 
(4) 3-(cyanomethyl)-2-
propylbenzonitrile  (ChemSpider ID 
15555691 ) 
CH3N
N
 
1 6 2.4/2.6 na 
(5) 3-(cyanomethyl)-4-
propylbenzonitrile  (ChemSpider ID 
15555015) 
CH3
N
N
 
1 6 2.4/2.6 na 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(6) (2,3-dimethyl-1H-indol-1-
yl)acetonitrile  (ChemSpider ID 
15425225)  
CH3
N
N
CH3
 
0.953 6 2.7/2.7 na 
(7) 3-(2-methyl-1H-indol-1-yl) 
propanenitrile  (ChemSpider ID 
15350264) 
CH3
N
N
 
0.945 6 2.5/2.7 na 
(8) 2,2'-(4,5-dimethyl benzene-1,2-
diyl) diacetonitrile  (ChemSpider ID 
269821) 
N
N
CH3
CH3  
0.941 6 1.8/2.2 na 
(9) 3-(3-methylphenyl) 
pentanedinitrile  (ChemSpider ID 
15160596) 
CH3
N
N  
0.941 6 1.4/2.0 na 
(10) 3-(2-methylindolizin-3-yl) 
propanenitrile  (ChemSpider ID 
1735125) 
N
N
CH3
 
0.941 6 2.5/3.2 na 
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Structure MetFrag Score 
Predicted 
fragments 
log Kow 
ACD/EPI SUITE 
pKa 
(11) 3-(4-methylphenyl) 
pentanedinitrile  (ChemSpider ID 
14306461)  
CH3
N
N
 
0.941 6 1.4/2.0 na 
(12) 3-(3-methyl-1H-indol-2-yl) 
propanenitrile  (ChemSpider ID 
2820995) 
N
H
N
CH3  
0.941 6 2.1/2.7 na 
(13) 3-(2-methylphenyl) 
pentanedinitrile  (ChemSpider ID 
15160320)  
CH3
N
N
 
0.941 6 1.4/2.0 na 
(14) 3-(3-methyl-1H-indol-1-yl) 
propanenitrile  (ChemSpider ID 
2075988) 
N
NCH3   
0.941 6 1.4/2.0 na 
(15) 3-(2-methylbenzyl) pyridazine  
(ChemSpider ID 15426110)  
CH3
N 
b
N 
a
 
0.916 7 1.7/nd 
2.8 
NaH+ ↔ Na 
 
2.8 
NbH+ ↔ Nb 
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4.3.4 Limitation of the method and new challenges 
 
We saw that for some peaks (40, 143, 208 and 228) it was impossible to propose 
either candidates at all or good candidates and this can be explained with two main 
reasons: 
 
(i) Wrong empirical formula assigned. The determination of the elemental 
composition requires a clean mass spectrum with no interfering noise or co-eluting 
compounds.  This is the case for Peak 40 and Peak 208 with two or three co-eluting 
compound with similar mass. Co-elution could be solved by using a different solvent 
gradient during the separation phase or another reversed-phase column. Another reason 
for unclear formula is that LC-MS using ESI and APCI can produce adducts, including 
[M+H]+ , [M+Na]+ and others [103,148]. While [M+H]+ adducts are not a problem, 
because already integrated in programs (e.g. MOLGEN-MSMS, MetFrag) or in 
databases (e.g. ChemSpider), and [M+Na]+ or [M+K]+ can be easily detectable due to 
their isotopic pattern on mass difference, (Table 4-4), the presence of other adducts or 
combination of different adducts can be a more difficult to determine. However, the 
nature of the adduct has to be determined before accurate mass data acquisition can be 
used for assigning elemental composition. One possible solution is to increase the 
concentration of a specific ion in the liquid phase to force the generation of the 
corresponding adduct [133].   
For the peaks, where no candidates were proposed an exact mass search was 
used, but was not very successful. This method presents also the disadvantage to 
propose several empirical formulas in the range above 185 Da when elements C, H, N, 
S, O and P were included in the search, even with the most accurate spectrometer [103]. 
The candidates can be numerous and with the wrong elemental composition assignment. 
Thus, applying isotopic abundance pattern is the best way of determining the elemental 
composition and also removes most of the wrongly assigned molecular formulas. 
 
(ii) The unknown compound is absent from the databases. At this stage, database 
searching, especially combined with predicted properties, is very useful to assist in the 
selection of the structure.  However, the results depend greatly on the compounds 
present in the database. The results for Peak 208 show this, as there are no satisfactory 
candidates fitting the log Kow, pKa and ionisation information. An alternative approach 
would be the use of structure generation software which delivers all chemically possible 
candidates for a given molecular formula. A recent study has shown that the 
combination of mass spectral substructure information and calculated properties is 
effective in reducing the number of possible candidates using structure generation 
techniques for GC-EI-MS [30]. Although this could be applied to peaks with no or no 
good candidates (e.g. Peak 143 or Peak 208), there is generally insufficient information 
from fragmentation patterns to limit the number of candidates sufficiently to apply 
structure generation here. For instance, the losses of H2O, CO, CH2O2 (H2O + CO), 
C2O2 (2 CO), C2H2O3 (H2O + 2 CO) and C2H3O3 were identified for Peak 143, which 
results in the generation of more than 10 000 000 possible structures. As aromatic 
structures fragment much less no information on ring structure is available, resulting in 
millions of possible structures. This is shown by Peak 208, with only one fragment 
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corresponding to a loss of carbonyl ([M+H-CO]+), resulting in even fewer restrictions to 
candidate numbers. Again here more than 10 000 000 structures were generated.  
 
In a lot of cases a single candidate is not possible, but the number of possible 
candidates remains below 10 candidates, which is acceptable. Peak 213 and Peak 242 
are two examples where the number of candidates is higher (34 for Peak 213 and 15 for 
Peak 242), including stereoisomers and many structurally highly similar compounds. 
MetFrag improves the identification in enabling the selection of candidates, but then it 
is not possible to distinguish stereoisomers from MS data alone [106] and standards or 
additional spectroscopic techniques, preferably NMR, to confirm the structure of the 
unknown are strongly needed. Sample preparation is crucial for NMR analysis, as a 
sufficient amount and high purity are essential and this would involve further 
fractionation steps to reach single compound isolation, which can be a problem for 
sample amount. Furthermore if standards are available and can be used to elucidate the 
structure, the high number of candidates can be a limitation, especially when synthesis 
is required for the standard. However, standards remain important in the study of the 
fragmentation behaviour and fragmentation rules can be implemented in the selection of 
candidates using standard information. This was the case for Peak 50, where we 
proposed 19 candidates, with some of them having a very similar structure. The 
purchased standard enabled us to remove 11 candidates from the list due to the 
fragmentation pattern. 
 
4.3.5 Strains to diagnostic mutagenicity to support structure elucidation of 
unknown mutagens 
 
Mutagenicity in specific diagnostic strains may be used to identify substructures 
likely contributing to mutagenicity. The sample was taken from an industrial area, 
where dyes, pharmaceuticals and explosives are produced. These types of chemicals 
often present in their structure amino- and nitro-groups and thus their presence at the 
sampling site is strongly expected. As seen in Chapter 2, Section 2.3.2, different strains 
of Salmonella exist and can be extremely sensitive to the presence of particular 
functional groups. The YG 1024 and YG 1041 are very sensitive to the nitroarenes 
and/or aromatic amines. Thus, in addition to strain TA 98, these two YG-type strains 
were used in this study to provide additional information during the identification 
process. Mutagenicity comparisons were performed as described in Chapter 3, Section 
3.3.2, based on slopes expressing the number of revertants per well/g of BR.  
The results are presented in Figure 4-50 without S9 and Figure 4-51 with S9. 
Without S9 activation, the TA98 and YG1024 strains did not show any mutagenicity, 
while only the YG1041 strain showed some slight mutagenicity in fraction N2-8. 
However, the number of revertants remained low, even at the highest concentration, 
which is contradictory to the high sensitivity of this strain for nitroarenes. Indeed the 
presence of such compounds should show a very high number of revertants in 
comparison to the TA98, which is not the case here. Thus, the presence of nitroarenes in 
the fraction N-2-8 can be excluded. This was also confirmed by the results of 
mutagenicity with S9, where the YG1041 exhibited a slightly higher mutagenicity than 
the YG1024.  With the YG 1041, 624.5 revertants per well/g of BR were induced and 
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521.8 revertants per well/g of BR with the YG 1024. This represented a difference of 
mutagenicity of 16%. However, both YG-type strains showed much greater mutagenic 
effects after S9 activation than the TA98, for which 120.5 revertants per well/g of Br 
were induced. The mutagenic effects with S9 activation were 5.2 times and 4.4 times 
higher in YG 1041 and YG 1024 respectively than in TA 98. Thereby aromatic amines 
are expected to contribute to mutagenicity of fraction N-2-8. This is in accordance with 
the list of candidates presented above (Section 4.3.3), where most of the proposed 
candidates are aromatic amines. 
 
 
Figure 4- 50: Mutagenicity of fraction N-2-8 using three strains without S9 activation, TA98  
(  ), YG1024 ( ) and YG1041 ( ). 
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Figure 4- 51: Mutagenicity of fraction N-2-8 using three strains with S9 activation,   TA98 (  
), YG1024 ( ) and YG1041 ( ).  
 
 
4.4 Conclusions 
 
  The identification of unknown compounds is of fundamental importance for the 
success of EDA studies. The success of the developed strategy is highly dependent on 
the availability of compounds databases and the compounds which are present. 
However, the availability of exact mass, enabling the determination of the empirical 
formula of the unknown compound combined with the fragmentation pattern allowed 
for the identification of candidates. The majority of this process combining different 
computer programs (MOLGEN-MSMS, MetFrag, Mzmine) remains manual and is time 
consuming. Thus, there is still a great need for automated database search development 
and improvement for the identification of polar unknown compounds, such as NIST for 
GC-MS. The identification is fundamental, but the confirmation is also an important 
step in EDA. In the case where the lack of commercially available or affordable 
standards present problems, a weight-of-evidence confirmation may be performed 
initially by matching the Ames test results with mutagenicity prediction results for the 
candidates, and/or by matching the retention behaviour of the unknown with predicted 
retention behaviour of candidates, in an effort to prioritize synthesis of standards for 
confirmation.  
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CHAPTER 5: USE OF RETENTION AND MUTAGENICITY 
PREDICTION TOOLS TO DECREASE THE NUMBER OF 
CANDIDATES FOR CONFIRMATION 
 
5.1  Introduction 
 
 In non-target screening and effect-directed analysis, confirmation of tentatively 
identified structures is typically achieved by the use of analytical standards if 
commercially available [22]. However, a lack of available standards for many 
components of environmental samples hampers confirmation, and chemical synthesis of 
the required standards may cause great expenses. Therefore, it is important to be able to 
prioritise the chemicals to be confirmed and to have a limited number of them and hence 
other evidences can be helpful in the selection of the candidate(s). These evidences can 
include retention prediction such as quantitative structure-retention relationships 
(QSSRs) [151] or linear solvation energy relationships (LSERs) [109] and toxicity 
prediction of candidates (quantitative structure-activity relationships (QSARs))  [114]. 
In the previous chapter, 92 candidates were proposed as possible components of 
the mutagenic fraction N-2-8, represented by 17 peaks of compounds with unknown 
structure. About half of the candidates are aromatic amines compounds. This class of 
chemicals is known to be widely used (e.g. dyes, pharmaceuticals), has been found in 
the environment [152] and is known to include potent mutagens [8]. The presence of 
aromatic amines was confirmed by the higher mutagenic effects in the YG 1041 and YG 
1024 than in the TA 98. Based on these analytical and biological results, it was 
hypothesised that aromatic amines cause or at least significantly contribute to the 
measured mutagenicity in the fraction N-2-8.  
Two complementary approaches were applied to reduce the number of candidate 
structures for every peak including: (i) retention prediction in reversed phase liquid 
chromatography calculating the Chromatographic Hydrophobicity Index (CHI) using 
Linear Solvation Energy Relationships (LSERs) as described in Ulrich et al. [110] and 
(ii) mutagenicity prediction of aromatic amines on the basis of the stability of 
corresponding nitrenium ions as the ultimate electrophiles attacking the DNA as 
described in Bentzien et al. [69]. 
 
5.2  Materiel and methods 
5.2.1 LC-MS/MS system 
 
The LC system used is described in Chapter 3 (Section 3.2.3.3). Active fraction 
N-2-8 and calibration standards (Table 5-1) used for the determination of the 
Chromatographic Hydrophobicity Index (CHI) were separated on an analytical C18 
reversed-phase column (Kinetex™ C18, 150 x 3.0 mm, 2.6 µm particle size, 
Phenomenex, Aschaffenburg, Germany). A linear gradient of ammonium acetate buffer 
(10 mmol/L, pH 7.3)  and 0.1% formic acid in methanol was used with a flow of 0.2 
mL/min with the following conditions: 0-3.2 min, 10% of methanol; 3.2-17.8 min, 10-
95% of methanol; 17.8-37.8 min, 95% of methanol, then re-equilibration of the phase. 
The column was placed in an oven at 22°C [153]. This LC system was coupled to a 
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LTQ-Orbitrap hybrid instrument (Thermo Fisher Scientific, Bremen, Germany), 
described in Chapter 3 (Section 3.2.3.3). 
 
5.2.2 LSER method 
 
Linear Solvation Energy Relationship (LSER) applied to reduce the list of 
candidates for fraction N-2-8 was taken from Ulrich et al. [110].    
In a first step, calibration standards (Table 5-1) with known CHI values were 
measured three times with the defined gradient system and column described above 
(Section 5.2.1). The mean value was used and plotted versus their CHI value (found in 
literature), providing a linear regression equation, which enabled to calculate the CHI of 
the unknowns from their measured retention times.  
In a second step, the phase parameters (descriptors a, b, s, e and v seen in 
Chapter 2, Section 2.7.1) were determined by measuring the solute property for a wide 
range of substances on different gradient systems with different pH and stationary 
phases. A multi-parameter linear regression was performed using Statistica 8.0 
(StatSoft, Hamburg, Germany). The resulting equation was used to calculate the CHI of 
the candidates provided in Chapter 4.  
In a third step, the solute descriptors A, B0, S, E and V for all candidate structures 
were predicted using ACD/ADME Suite 5.0.7 Absolv (ACD/Labs, Toronto, Canada).  
In a fourth step, CHI values of unknowns were compared to the CHI values of 
the candidates. Thus, it was possible to exclude candidates if the CHI value of the 
unknown did not fit the CHI range of the candidate. The comparison was based on a 
95% prediction interval. Structures with predicted CHI values outside this interval were 
excluded. The candidate structures in this study were rather complex with the possibility 
of intramolecular interactions and hence may present a greater risk of deviation from 
prediction than most of the compounds used to develop the Absolv model. This was 
considered by not excluding compounds if outside of the prediction interval by less than 
+ 0.2. 
 
  
 Chapter 5 
151 
Table 5- 1: Calibration standards  
Standard name Retention time (min) CHI (literature) 
Acetophenone 21.4 67.68 
Propiophenone 23.5 76.31 
Butyrophenone 25.0 82.31 
Valerophenone 26.1 87.33 
Paracetamol 11.3 40.29 
1-naphthol 24.1 78.92 
Diethyl phthalate 24.5 78.96 
Anisole  23.4 77.49 
2-naphthol 23.7 76.09 
Pyrene 28.9 100.24 
Ethylbenzene 26.5 90.29 
Propylbenzene 27.5 94.16 
2-nitrophenol 21.3 71.08 
Acetanilide 17.7 57.87 
Naphthalene 26.3 89.39 
Anthracene 28.1 96.55 
3-nitrobenzoic acid 21.0 79.75 
Caffeine 17.1 49.70 
Benzene 23.0 78.21 
Chlorbenzene 25.3 85.05 
Toluene 25.3 85.76 
Ibuprofen 26.9 90.85 
Vanillin 18.0 56.22 
 
5.2.3 Mutagenicity prediction 
 
The mutagenicity prediction method applied to reduce the list of candidates for 
fraction N-2-8 was based on the nitrenium theory as described by Bentzien et al. [69] 
(Chapter 2, Section 2.7.2). In this study, 257 amines were used (183 mutagenic and 74 
non mutagenic) to validate the method. The selected aromatic amines fitted the 
following criteria: (i) no formal charge, (ii) molecular weight lower than 500 Da, (iii) no 
more than one stereocentre in the molecule, (iv) less than 10 rotable bonds and (v) only 
one aromatic amine functionality. The method follows the suggestion of Ford et al. 
[117], applying reaction energies calculated relative to aniline according to Equation 2-2 
in Chapter 2, Section 2.7.2. 
While Ford et al. [116,117] used a ΔΔE of 0 kcal/mol as a cut off criteria 
discriminating non-mutagenic compounds from possible mutagens, Bentzien et al. [69] 
included a “margin error” of ± 5 kcal/mol in the prediction of ΔΔE values. The authors 
could show that using this margin error the number of false positives and false negatives 
were greatly improved. 
Thus, criteria for probable mutagenicity of candidate structures were applied 
according to Bentzien et al [69] and are as follow: (i) ΔΔE < -5 kcal/mol compounds 
considered as positive Ames compounds, (ii) ΔΔE within the range [-5 + 5] kcal/mol 
compounds are called non-predicted and (iii) ΔΔE > +5 kcal/mol compounds considered 
as negative Ames compounds. This approach is applicable to mono- and poly-cyclic 
aromatic amines. 
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The calculations were done using MOPAC (Molecular Orbital PACkage), which 
is a semi-empirical quantum chemistry program, allowing the calculation of the heat of 
formation of the different compounds present in the reaction presented in Chapter 2, 
section 2.7.2.  
 
5.3  Results and Discussion 
5.3.1 Application of the LSER method to fraction N-2-8 
 
In the first step, the column was calibrated using the standard references in Table 
5-1. The resulting equation is presented below and enabled the calculation of the CHI of 
the unknowns from their retention time (Rt), (Table 5-2). 
 
Equation 5-1:  CHI = 3.55 Rt – 4.86    with r2 = 0.9543 
 
 All the CHI values of the unknowns in this study were between 78 and 88, 
except for the unknown 242 with a CHI of 49. Thus, most of the unknowns required at 
least 78% of methanol to be eluted. 
 
In the second step, the phase descriptors were determined by multiple regression 
using the Abraham equation seen in Chapter 2 (Section 2.7.1) and the resulting equation 
is presented below. The predicted analyte descriptors for the candidates (A, B0, S, E and 
V) are presented in Table 5.2 as well as the calculated CHI, their range of prediction 
(including the error ± 0.2).  
 
Equation 5-2: CHIcalculated = -6.75(± 0.88)A - 34.05(± 1.13)B0 - 9.47(± 0.98)S + 
1.71(± 0.58)E + 35.20(± 0.91)V + 62.80(± 0.87) 
 
 From Table 5-2, we can see if the measured CHI of the unknown is within the 
calculated CHI range of the corresponding candidates and predicted retention range of 
22 out of all 92 candidates was in agreement with measured retention of the unknowns 
in fraction N-2-8.  
  
Table 5- 2: Descriptor values, CHI and CHI range for the candidates in fraction N-2-8, CHI of the unknowns. +: candidate retained on the list,  
-: candidate eliminated from the list  
 Candidates parameters Unknowns parameters  
Name (ChemSpider ID) A B0 S E V CHIcalc CHI Range 
Retention 
time (min) CHIunknown Prediction 
Unknown Peak 3        23.4 78.23  
2-amino-5-(1,3-benzodioxol-5-yl)-4-methylthiophene-
3-carbonitrile (291445) 
0.23 1.04 2.18 2.15 1.79 71.99 65.62 – 78.36   + 
2-amino-4-(2,3-dihydro-1,4-benzodioxin-6-yl) 
thiophene-3-carbonitrile (4204525) 
0.23 1.09 2.65 2.16 1.79 65.85 59.36 – 72.34   - 
methyl 3-amino-5-(4-cyanophenyl)thiophene-2-
carboxylate (10167241) 
0.18 0.93 2.09 1.93 1.85 78.86 72.52 – 84.80   + 
Unknown Peak 19        26.0 87.57  
3H-benz[e]indole (9519149) 0.31 0.36 1.43 1.94 1.32 84.51 78.20 – 90.82   + 
1H-benz[f]indole  (10496645) 0.31 0.36 1.43 1.94 1.32 84.51 78.20 – 90.82   + 
1H-azuleno[1,2-b]pyrrole (14524926) 0.13 0.87 1.01 1.62 1.32 71.79 65.32 – 77.84   - 
Unknown Peak 35        25.8 86.58  
2-oxo-2H-benzo[g]chromene-3-carbaldehyde 
(9416609)   
0 0.85 1.98 1.96 1.59 74.32 67.95 – 80.68   - 
Unknown Peak 50        23.9 80.01  
5,6-diethyl-1H-indole-2,3-dione (13494962) 0.36 0.91 1.42 1.62 1.58 72.22 65.92 – 78.54   - 
4,5,6,7-tetramethyl-1H-indole-2,3-dione (19461480) 0.36 0.9 1.5 1.47 1.58 73.78 67.47 – 81.10   + 
5-tert-butyl-1H-indole-2,3-dione (517156) 0.36 0.95 1.62 1.38 1.58 70.79 64.48 – 77.10   - 
5-butyl-1H-indole-2,3-dione (2339601) 0.36 0.91 1.69 1.39 1.58 71.51 65.20 – 77.81   - 
5-(1-methylpropyl)-1H-indole-2,3-dione (16812332)   0.36 0.94 1.67 1.40 1.58 70.69 64.38 – 77.00   - 
7-(2-methylpropyl)-1H-indole-2,3-dione (513041)    0.36 0.94 1.67 1.40 1.58 70.69 64.38 – 77.00   - 
7-amino-4-propyl-2H-chromen-2-one  (2012579) 0.23 0.80 1.49 1.29 1.58 77.85 71.56 – 84.15   + 
Unknown Peak 60        24.5 82.03  
2-ethoxy-N-(3-[(phenylcarbamoyl) amino]phenyl) 
pyridine-3-carboxamide (16999411) 
1.00 1.92 3.35 2.59 2.84 63.45 56.76 – 70.14   - 
N-(2-aminophenyl)-4-([2-(pyridin-3-yloxy)propanoyl] 
amino)benzamide (11536340) 
1.06 2.26 3.69 2.80 2.84 48.60 41.75 – 55.46   - 
N-(2-aminophenyl)-4-([(pyridin-2-ylmethoxy)acetyl] 
amino)benzamide (11536336) 
1.06 2.23 3.71 2.79 2.84 49.42 42.56 – 56.28   - 
N-(2-aminophenyl)-4-([(pyridin-3-ylmethoxy)acetyl] 
amino)benzamide (8197974) 
1.06 2.23 3.71 2.79 2.84 49.42 42.56 – 56.28   - 
  
 Candidates parameters Unknowns parameters  
Name (ChemSpider ID) A B0 S E V CHIcalc CHI Range 
Retention 
time (min) CHIunknown Prediction 
Unknown Peak 99        24.2 81.07  
2-methoxy-N'-[1-(5-methylfuran-2-yl) ethylidene] 
benzohydrazide (757961)   
0.26 1.17 1.77 1.50 2.08 80.19 73.81 – 86.56   + 
benzamide, N-(4-amino-2-methoxyphenyl)-4-
methoxy- (833606) 
0.65 1.45 2.44 1.91 2.08 62.37 55.94 – 68.81   - 
acetamide, N-(4-amino-2-methoxyphenyl)-2-phenoxy- 
(833624) 
0.65 1.46 2.50 1.88 2.08 61.41 54.97 – 67.86   - 
1,3-bis(4-methoxyphenyl)urea (120696) 0.59 1.25 2.19 1.73 2.08 71.65 65.27 – 78.02   - 
1,3-bis(2-methoxyphenyl)urea (260536) 0.62 1.19 2.03 1.78 2.08 75.09 68.73 – 81.45   + 
1-(2-methoxyphenyl)-3-(4-methoxyphenyl)urea 
(260538) 
0.60 1.22 2.11 1.75 2.08 73.40 67.03 – 79.56   - 
1-(3-methoxyphenyl)-3-(4-methoxyphenyl)urea 
(761644) 
0.59 1.2 2.15 1.71 2.08 73.70 67.53 – 80.06   - 
1,3-bis(3-methoxyphenyl)urea (641853) 0.59 1.15 2.10 1.68 2.08 75.82 69.46 – 82.18   + 
1-(2-methoxyphenyl)-3-(3-methoxyphenyl)urea 
(260537) 
0.6 1.17 2.07 1.73 2.08 75.44 69.08 – 81.80   + 
3-amino-4-methoxy-N-(2-methoxyphenyl)benzamide 
(8811261) 
0.66 1.48 2.37 1.95 2.08 62.02 55.58 – 68.45   - 
3-amino-4-methoxy-N-(3-methoxyphenyl)benzamide 
(16805321) 
0.65 1.46 2.40 1.90 2.08 62.40 55.96 – 68.83   - 
3-amino-4-methoxy-N-(4-methoxyphenyl)benzamide 
(13317570) 
0.65 1.51 2.45 1.93 2.08 60.23 53.82 – 66.72   - 
bis(3-amino-4-methoxyphenyl) methanone (660964)     0.48 1.56 2.47 2.15 2.08 59.90 53.42 – 66.38   - 
6-amino-3-(piperidin-1-ylcarbonyl)-2H-chromen-2-
one (26898) 
0.23 1.44 2.52 1.85 2.01 62.38 55.88 – 68.87   - 
Unknown Peak 109        23.7 79.12  
2-[amino(phenyl)methylidene]-1H-indene-1,3(2H)-
dione (8197974) 
0.21 1.31 2.32 2.18 1.87 64.24 57.79 – 70.69   - 
9-ethynyl-9H-fluoren-1-yl carbamate (2315078)   0.53 0.80 1.98 2.29 1.87 82.86 76.52 – 89.19   + 
Unknown Peak 138        23.9 80.08  
1-methyl-2-oxo-2-(phenylamino)ethyl 6-oxo-1-propyl-
1,6-dihydropyridazine-3-carboxylate (16867074) 
0.41 1.86 2.78 1.82 2.48 60.64 54.02 – 67.26   - 
ethyl 3-[(2-aminophenyl)carbonyl]-1-(cyclopropyl 0.18 1.83 2.64 2.12 2.41 62.74 56.11 – 69.37   - 
  
 Candidates parameters Unknowns parameters  
Name (ChemSpider ID) A B0 S E V CHIcalc CHI Range 
Retention 
time (min) CHIunknown Prediction 
carbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylate 
(9338397) 
ethyl 5-(((2Z)-2-[(2-hydroxyphenyl) methylidene] 
hydrazine)carbonyl)-2,4-dimethyl-1H-pyrrole-3-
carboxylate (18392286)   
1.06 1.63 2.43 1.96 2.48 67.64 61.12 – 74.06   - 
Unknown Peak 143        23.3 77.73  
3-(2-hydroxybenzoyl)-5H-indeno[1,2-b]pyridin-5-one 
(10514029) 
0.13 1.1 2.68 2.87 2.15 79.79 73.34 – 86.25   + 
Unknown Peak 212        22.9 76.46  
3-amino-2,5-diphenylcyclohexa-2,5-diene-1,4-dione 
(PubChem ID 12251096) 
0.21 1.40 1.40 2.24 2.11 78.40 71.72 – 85.07   + 
Unknown Peak 213        24.4 81.71  
(6Z)-6-[1-[2-(2-methylphenyl)hydrazino]ethylidene] 
cyclohexa-2,4-dien-1-one (5201826) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
(6Z)-6-[1-[2-(3-methylphenyl)hydrazino]ethylidene] 
cyclohexa-2,4-dien-1-one (5247178) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
6-[1-[2-(4-methylphenyl)hydrazino]ethylidene] 
cyclohexa-2,4-dien-1-one (5253314) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
4-[1-[2-(4-methylphenyl)hydrazinyl]ethylidene] 
cyclohexa-2,5-dien-1-one (7349810) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
4-[1-[2-(3-methylphenyl)hydrazinyl]ethylidene] 
cyclohexa-2,5-dien-1-one (7350957) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
4-[1-[2-(2-methylphenyl)hydrazino]ethylidene] 
cyclohexa-2,5-dien-1-one (7305321) 
0.26 1.37 1.81 1.79 1.96 69.36 62.92 – 75.80   - 
3-amino-4-methyl-N-(4-methylphenyl)benzamide 
(15117243) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
4-amino-3-methyl-N-(2-methylphenyl)benzamide 
(14815425) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
3-amino-4-methyl-N-(3-methylphenyl)benzamide 
(16801713) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
4-amino-3-methyl-N-(3-methylphenyl)benzamide 
(16808230) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
3-amino-4-methyl-N-(2-methylphenyl)benzamide 0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
  
 Candidates parameters Unknowns parameters  
Name (ChemSpider ID) A B0 S E V CHIcalc CHI Range 
Retention 
time (min) CHIunknown Prediction 
(16817934) 
3-amino-2-methyl-N-(2-methylphenyl)benzamide 
(16817998) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
3-amino-2-methyl-N-(3-methylphenyl)benzamide 
(16802496) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
3-amino-2-methyl-N-(4-methylphenyl)benzamide 
(16810443) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
4-amino-3-methyl-N-(4-methylphenyl)benzamide 
(16810500) 
0.64 1.12 2.16 1.82 1.96 72.04 65.69 – 78.40   - 
2-amino-3-methyl-N-(2-methylphenyl)benzamide 
(16814789)  
0.59 1.06 1.95 1.85 1.96 76.47 70.13 – 82.80   + 
2-amino-3-methyl-N-(3-methylphenyl)benzamide 
(16810019) 
0.59 1.06 1.95 1.85 1.96 76.47 70.13 – 82.80   + 
2-amino-3-methyl-N-(4-methylphenyl)benzamide 
(16801544) 
0.59 1.06 1.95 1.85 1.96 76.47 70.13 – 82.80   + 
2-amino-6-methyl-N-(2-methylphenyl)benzamide 
(16824275) 
0.59 1.06 1.95 1.85 1.96 76.47 70.13 – 82.80   + 
2-amino-6-methyl-N-(3-methylphenyl)benzamide 
(16805125) 
0.59 1.06 1.95 1.85 1.96 76.47 70.13 – 82.80   + 
1-[2-amino-5-(benzylamino)phenyl]ethanone 
(9086908) 
0.31 1.09 2.02 1.93 1.96 76.81 70.47 – 83.15   + 
1-[4-amino-3-(benzylamino)phenyl]ethanone 
(19441053) 
0.37 1.12 2.15 1.91 1.96 74.12 67.77 – 80.47   - 
bis(4-amino-3-methylphenyl)methanone (11255017) 0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
3,3'-diamino-4,4'-dimethylbenzophenone (508004) 0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
(4-amino-2-methylphenyl)(4-amino-3-methylphenyl) 
methanone (15990795) 
0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
bis(4-amino-2-methylphenyl)methanone (15990812) 0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
(3-amino-5-methylphenyl)(4-amino-3-methylphenyl) 
methanone (15990839) 
0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
bis(3-amino-5-methylphenyl)methanone (15990847) 0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
(3-amino-5-methylphenyl)(4-amino-2-methylphenyl) 
methanone (15990856) 
0.45 1.20 2.25 2.02 1.96 70.09 63.72 – 76.46   - 
  
 Candidates parameters Unknowns parameters  
Name (ChemSpider ID) A B0 S E V CHIcalc CHI Range 
Retention 
time (min) CHIunknown Prediction 
4-amino-N-benzyl-3-methylbenzamide (16491734) 0.48 1.11 2.30 1.79 1.96 72.09 65.71 – 78.46   - 
3-amino-N-benzyl-2-methylbenzamide (16815979) 0.48 1.11 2.30 1.79 1.96 72.09 65.71 – 78.46   - 
3-amino-N-benzyl-4-methylbenzamide (16822378) 0.48 1.11 2.30 1.79 1.96 72.09 65.71 – 78.46   - 
2-amino-N-benzyl-3-methylbenzamide (16821380) 0.43 1.05 2.10 1.82 1.96 76.41 70.08 – 82.75   + 
2-amino-N-benzyl-6-methylbenzamide (16818487) 0.43 1.05 2.10 1.82 1.96 76.41 70.08 – 82.75   + 
2-amino-N-benzyl-5-methylbenzamide (497152) 0.43 1.05 2.10 1.82 1.96 76.41 70.08 – 82.75   + 
Unknown Peak 233        24.1 80.72  
ethyl 3-(2-amino-5-methoxybenzoyl)-1-(cyclopropyl-
carbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylate 
(9385631) 
0.18 2.03 2.77 2.19 2.61 61.65 55.12 – 68.58   - 
N-(2,4-dimethoxy-5-([(2-methoxy phenyl) carbamoyl] 
amino)phenyl)acetamide (4991426) 
1.04 1.81 2.85 2.17 2.68 65.05 58.46 – 71.64   - 
N-(2,5-dimethoxy phenyl)-2-[(3-methoxy phenyl) 
carbamoylamino] acetamide (21985955)   
0.94 1.96 2.97 2.06 2.68 59.29 52.66 – 65.52   - 
N-(2,4-dimethoxy phenyl)-2-[(3-methoxy phenyl) 
carbamoylamino]acetamide (15224742) 
0.41 2.07 2.90 1.88 2.68 59.48 52.76 – 66.19   - 
Unknown Peak 242        15.2 49.08  
4-(cyanomethyl)-2-propylbenzonitrile (15554727)   0 0.44 1.62 0.96 1.59 90.05 83.67 – 96.43   - 
2-(4-ethylphenyl) butanedinitrile (25620509)   0 0.56 1.70 1.1 1.59 85.44 79.08 – 91.80   - 
4-(cyanomethyl)-3-propylbenzonitrile (15555002)   0 0.44 1.62 0.96 1.59 90.05 83.67 – 96.43   - 
3-(cyanomethyl)-2-propylbenzonitrile (15555691)  0 0.44 1.62 0.96 1.59 90.05 83.67 – 96.43   - 
3-(cyanomethyl)-4-propylbenzonitrile (15555015)   0 0.44 1.62 0.96 1.59 90.05 83.67 – 96.43   - 
(2,3-dimethyl-1H-indol-1-yl)acetonitrile (15425225)  0 0.49 1.46 1.46 1.52 88.41 82.11 – 94.70   - 
3-(2-methyl-1H-indol-1-yl) propanenitrile (15350264)  0 0.50 1.52 1.44 1.52 87.46 81.17 – 93.76   - 
2,2'-(4,5-dimethyl benzene-1,2-diyl) diacetonitrile 
(269821)   
0 0.45 1.57 1.02 1.59 90.28 83.93 – 96.64   - 
3-(3-methylphenyl) pentanedinitrile (15160596)   0 0.49 1.67 0.97 1.59 87.89 81.51 – 94.27   - 
3-(2-methylindolizin-3-yl) propanenitrile (1735125)  0 0.55 1.38 1.29 1.52 86.83 80.53 – 93.12   - 
3-(4-methylphenyl) pentanedinitrile (14306461)  0 0.49 1.67 0.97 1.59 87.89 81.51 – 94.27   - 
3-(3-methyl-1H-indol-2-yl) propanenitrile  (15160320) 0.31 0.47 1.55 1.45 1.52 86.12 79.83 – 92.42   - 
3-(2-methylphenyl) pentanedinitrile  (2075988) 0 0.49 1.67 0.97 1.59 87.89 81.51 – 94.27   - 
3-(3-methyl-1H-indol-1-yl) propanenitrile (15426110)  0 0.50 1.52 1.44 1.52 87.46 81.17 – 93.76   - 
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Applying the LSER model, predicted retention of 22 out of 92 candidates was in 
agreement with measured retention of the unknowns in fraction N-2-8. Thus, the most 
likely candidates remain for peaks 3, 19, 50, 99, 109, 143, 212 and 213. Unfortunately 
no candidate remains for peaks 35, 60, 138, 233 and 242.  Since this approach was 
based on database search and databases are always limited, it may be hypothesised that 
the compounds behind these peaks may be absent from the database. 
  
5.3.2  Application of the nitrenium stability to the selected candidates for fraction 
N-2-8 
 
Using MOPAC program, the ΔHf for the aniline (ΔEPhNH2) was 20.41 kcal/mol 
and ΔHf for the corresponding nitrenium ion of the aniline (ΔEPhN+H) was 126.27 
kcal/mol. The calculated values of ΔHf for the candidates having an amino group in 
their structure, the ΔHf of the corresponding nitrenium as well as the resulting values of 
ΔΔE and the prediction are presented in Table 5-3.  
 
Table 5- 3: Mutagenicity prediction results for the selected candidates for fraction N-2-8, with np: 
non predicted and *: should be listed as np 
Candidate name 
Amine 
ΔHf  
(ΔEAr-NH2) 
(kcal/mol) 
Nitrenium 
ΔHf  
(ΔEAr-N+H) 
(kcal/mol) 
ΔΔE 
(kcal/mol) 
Mutagenicity 
prediction 
Peak 3 
2-amino-5-(1,3-benzodioxol-5-yl)-4-
methylthiophene-3-carbonitrile 
398.75 72.26 - 432.34 Ames + 
2-amino-4-(2,3-dihydro-1,4-benzodioxin-6-yl) 
thiophene-3-carbonitrile 
12.67 69.51 - 49.01 Ames + 
methyl 3-amino-5-(4-cyanophenyl)thiophene-2-
carboxylate 
- 3.87 102.46 0.48 np 
Peak 50 
7-amino-4-propyl-2H-chromen-2-one - 52.73 58.60 5.48 Ames - 
Peak 60 
N-(2-aminophenyl)-4-([2-(pyridin-3-
yloxy)propanoyl] amino)benzamide 
- 21.97 78.04 - 5.84 Ames + 
N-(2-aminophenyl)-4-([(pyridin-2-
ylmethoxy)acetyl] amino)benzamide 
- 20.37 73.07 - 12.42 Ames + 
N-(2-aminophenyl)-4-([(pyridin-3-
ylmethoxy)acetyl] amino)benzamide 
- 15.71 78.43 - 11.71 Ames + 
Peak 99 
benzamide, N-(4-amino-2-methoxyphenyl)-4-
methoxy- 
-58.02 91.88 44.05 Ames - 
acetamide, N-(4-amino-2-methoxyphenyl)-2-
phenoxy- -57.78 201.41 153.34 Ames - 
3-amino-4-methoxy-N-(2-
methoxyphenyl)benzamide -53.86 90.53 38.54 Ames - 
3-amino-4-methoxy-N-(3-
methoxyphenyl)benzamide -57.62 35.83 -12.40 Ames + 
3-amino-4-methoxy-N-(4-
methoxyphenyl)benzamide -57.31 93.22 44.68 Ames - 
bis(3-amino-4-methoxyphenyl) methanone -57.19 199.21 150.54 Ames - 
6-amino-3-(piperidin-1-ylcarbonyl) -2H-
chromen-2-one 
- 71.16 33.20 - 1.49 np 
Peak 138 
ethyl 3-[(2-aminophenyl)carbonyl]-1-
(cyclopropyl carbonyl)-4,5-dihydro-1H-
pyrazole-5-carboxylate 
 
 
0 61.36 - 44.50 Ames + 
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Candidate name 
Amine 
ΔHf  
(ΔEAr-NH2) 
(kcal/mol) 
Nitrenium 
ΔHf  
(ΔEAr-N+H) 
(kcal/mol) 
ΔΔE 
(kcal/mol) 
Mutagenicity 
prediction 
Peak 212 
3-amino-2,5-diphenylcyclohexa-2,5-diene-1,4-
dione 24.30 134.72 4.57 np 
Peak 213 
3-amino-4-methyl-N-(4-
methylphenyl)benzamide 2.67 107.53 - 0.99 np 
4-amino-3-methyl-N-(2-
methylphenyl)benzamide 2.40 110.75 2.49 np 
3-amino-4-methyl-N-(3-
methylphenyl)benzamide 2.49 108.46 0.11 np 
4-amino-3-methyl-N-(3-
methylphenyl)benzamide 1.81 110.14 2.47 np 
3-amino-4-methyl-N-(2-
methylphenyl)benzamide 3.27 108.94 - 0.19 np 
3-amino-2-methyl-N-(2-
methylphenyl)benzamide 4.87 110.57 - 0.16 np 
3-amino-2-methyl-N-(3-
methylphenyl)benzamide 4.36 110.10 - 0.12 np 
3-amino-2-methyl-N-(4-
methylphenyl)benzamide 4.37 110.06 - 0.16 np 
4-amino-3-methyl-N-(4-
methylphenyl)benzamide 1.72 110.04 2.46 np 
2-amino-3-methyl-N-(2-
methylphenyl)benzamide 2.44 111.22 2.92 np 
2-amino-3-methyl-N-(3-
methylphenyl)benzamide 0.03 108.47 2.58 np 
2-amino-3-methyl-N-(4-
methylphenyl)benzamide 0.03 108.48 2.59 np 
2-amino-6-methyl-N-(2-
methylphenyl)benzamide 3.11 111.52 2.56 np 
2-amino-6-methyl-N-(3-
methylphenyl)benzamide 2.59 111.17 2.72 np 
1-[2-amino-5-(benzylamino)phenyl]ethanone 11.47 99.21 - 18.12 Ames + 
1-[4-amino-3-(benzylamino)phenyl]ethanone 12.61 97.10 - 21.36 Ames + 
bis(4-amino-3-methylphenyl)methanone 2.52 212.08 103.69 Ames - 
3,3'-diamino-4,4'-dimethylbenzophenone 0.53 217.64 111.26 Ames -* 
(4-amino-2-methylphenyl)(4-amino-3-
methylphenyl) methanone 
1.94 219.89 112.10 Ames -* 
bis(4-amino-2-methylphenyl)methanone 3.35 222.40 113.19 Ames -* 
(3-amino-5-methylphenyl)(4-amino-3-
methylphenyl) methanone 
1.51 215.87 108.50 Ames -* 
bis(3-amino-5-methylphenyl)methanone 2.59 215.17 106.73 Ames -* 
(3-amino-5-methylphenyl)(4-amino-2-
methylphenyl) methanone 
2.88 218.42 109.68 Ames -* 
4-amino-N-benzyl-3-methylbenzamide 1.55 111.04 3.64 np 
3-amino-N-benzyl-2-methylbenzamide 6.18 111.44 - 0.60 np 
3-amino-N-benzyl-4-methylbenzamide 4.57 109.73 -0.70 np 
2-amino-N-benzyl-3-methylbenzamide 1.82 110.48 2.80 np 
2-amino-N-benzyl-6-methylbenzamide 19.87 128.90 3.17 np 
2-amino-N-benzyl-5-methylbenzamide 3.56 110.29 0.88 np 
Peak 233
ethyl 3-(2-amino-5-methoxybenzoyl)-1-
(cyclopropyl carbonyl)-4,5-dihydro-1H-
pyrazole-5-carboxylate 
- 84.80 19.81 - 1.25 np 
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The mutagenicity prediction method identified nine amino-candidates as 
mutagens and thirteen as non-mutagens. However, six of the latter have two amino-
groups in their structure and do not fulfil the criteria defined by Bentzien et al. [69] to 
develop his prediction (only one amino functionality). Thus, these six candidates are 
listed as non-predicted. Twenty four amino-candidates cannot be determined as 
mutagens or non mutagens, because their ΔΔE value are within the [-5  +5] kCal/mol 
range.  
 
5.3.3 Combining retention and mutagenicity prediction 
 
 The results combining prediction from LSER and mutagenicity are presented in 
Table 2-4. Two candidates, 1-[2-amino-5-(benzylamino)phenyl]ethanone (Peak 213) 
and 2-amino-5-(1,3-benzodioxol-5-yl)-4-methylthiophene-3-carbonitrile (Peak 3) were 
positively identified by both methods, meaning that they could be strongly expected to 
be present in the fraction N-2-8 and involved in the mutagenic effects. Furthermore ten 
other compounds can be considered as very good candidates. They are all possible 
candidates (aromatic amine structure) with the LSER approach and they also could be 
responsible for the high mutagenicity response with the YG-types strains. Another nine 
candidates (positive with LSER) could not have their mutagenicity potential evaluated 
by the model we described above, as they do not possess an amino group in their 
structure. However, such compounds cannot be excluded from the list of candidates 
because they may still contribute to the mutagenicity of the fraction, via other 
mechanisms of reaction than the nitrenium ion. For instance, the unknown 
corresponding to Peak 109 was also found in fraction A-2-8 which showed low 
mutagenicity, none of the proposed candidates are aromatic amines, but we cannot 
exclude them of being involved in the low mutagenicity for fraction A-2-8.  
7-amino-4-propyl-2H-chromen-2-one, which is a candidate for Peak 50, was 
predicted to be non mutagenic, but its elution properties matched the elution properties 
of the unknown and was kept in the list of candidates for the confirmation step. This 
choice was justified by the fact that some compounds are not directly mutagenic but 
become mutagenic when reacting with another compound present in the mixture. This 
type of chemicals is called co-mutagens. Totsuka et al. [154] and Nishigaki et al. [155] 
showed that norharman (non-mutagenic) and aniline (non-mutagenic) when present in 
the same mixture formed the aminophenylnorharman compound, which is mutagenic 
with TA 98 and YG1024. This chemical was formed by the cytochrome P450 present in 
the S9 mix, followed by further activations to form the corresponding nitrenium. 
Fraction N-2-8 showed high mutagenicity only by activation, so some kind of synergy 
with the matrix of the blue rayon or other compounds present in this fraction could also 
be possible. 
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Table 5- 4: Candidates of interest for the confirmation step of the blue rayon EDA study, with np: 
non predicted, na: non applicable and #: candidate available as standard 
Candidate name 
Retention 
time 
prediction 
Mutagenicity 
prediction 
Peak 3  
2-amino-5-(1,3-benzodioxol-5-yl)-4-methylthiophene-3-carbonitrile + + 
methyl 3-amino-5-(4-cyanophenyl)thiophene-2-carboxylate + np 
Peak 19  
3H-benz[e]indole + na 
1H-benz[f]indole   + na 
Peak 50  
4,5,6,7-tetramethyl-1H-indole-2,3-dione + na 
7-amino-4-propyl-2H-chromen-2-one #   + - 
Peak 99  
2-methoxy-N'-[1-(5-methylfuran-2-yl)ethylidene]benzohydrazide    + na 
1,3-Bis(2-methoxyphenyl)urea # + na 
1,3-Bis(3-methoxyphenyl)urea # + na 
1-(2-methoxyphenyl)-3-(3-methoxyphenyl)urea # + na 
Peak 109  
9-ethynyl-9H-fluoren-1-yl carbamate   + na 
Peak 143  
3-(2-hydroxybenzoyl)-5H-indeno[1,2-b]pyridin-5-one + na 
Peak 212  
3-amino-2,5-diphenylcyclohexa-2,5-diene-1,4-dione + np 
Peak 213  
2-amino-3-methyl-N-(2-methylphenyl)benzamide # + np 
2-amino-3-methyl-N-(3-methylphenyl)benzamide # + np 
2-amino-3-methyl-N-(4-methylphenyl)benzamide # + np 
2-amino-6-methyl-N-(2-methylphenyl)benzamide # + np 
2-amino-6-methyl-N-(3-methylphenyl)benzamide # + np 
1-[2-amino-5-(benzylamino)phenyl]ethanone + + 
2-amino-N-benzyl-3-methylbenzamide # + np 
2-amino-N-benzyl-6-methylbenzamide # + np 
2-amino-N-benzyl-5-methylbenzamide + np 
 
5.4 Conclusions 
  
The combination of the LSER and mutagenicity prediction enabled us to 
severely decrease the number of candidates for the confirmation step.  Two compounds 
were positively predicted by both methods, but they are not commercially available as 
standards and would require to be synthesised. In addition ten other candidate 
compounds are commercially available. Thus, the confirmation involving standards 
could easily start with these available standards. The combination of these two 
approaches enabled us to prioritise compounds for the confirmation step of the EDA 
study.  
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CHAPTER 6: SUMMARY AND FUTURE WORK 
 
The methods developed throughout this thesis work provide a good basis for 
EDA studies of planar mutagens in water samples. The passive sampler used, blue rayon 
(BR), is specific to this class of compounds and thus lowers the complexity of the water 
extract due to its high selectivity. The Ames Fluctuation Test is a reliable test enabling 
the detection of mutagenicity in sample and has the advantage of the availability of 
multiple strains of Salmonella with different sensitivity to different classes of 
compounds. 
 
The aim of this was to end up with the chemical and biological measures of the 
candidates provided for fraction N-2-8. Despite our extensive efforts so far, we were 
unable to clarify the mutagenicity. We saw that this fraction showed mutagenicity only 
with S9 activation, and it would be worthwhile to assess the mixture toxicity of the 
identified compounds in the fraction N-2-8 by measuring the mutagenicity. Further, it 
may be possible that due to some kind of synergism or matrix/mixture effects, 
mutagenicity is measurable only in the fraction, while pure single compounds will not 
show any mutagenicity. 
 
The three-step fractionation method presented in this work showed that losses in 
the sample were limited to 20% and that the compounds were efficiently separated 
within the fractions/subfractions, with overlapping less than 10%. Beside these 
efficiencies in separating and recovering the sample, the method also provides 
information regarding physico-chemical properties of the eluted substances. Most of the 
previously published fractionation procedures used with BR extracts rely mainly on 
chromatography, such that only information on partitioning coefficient between 
octanol/water (log Kow) is available. The method described in this thesis work gives 
information about the acid/base properties of the compounds in addition to the log Kow. 
Thus, this method provides two criteria to help in the identification of unknown 
compounds. In general this fractionation method can be applied to any other samples 
collected with BR, as it is specific for planar compounds. 
As seen in [83] and Chapter 4 of this work, a given fraction can still be quite 
complex, even after extensive fractionation. The inclusion of a fourth step may improve 
this fractionation procedure. There are numerous stationary phases that provide other 
types of interactions in addition of the lipophilicity, thus changing the elution of 
analytes. The 2D-plot used to select the two RP-HPLC columns (polymeric C18 and 
phenyl-hexyl) was effective in selecting the best complementarity between these two 
phases and could be also used for the selection of a third column. While addition of a 
third column could improve the existing procedure, a fourth step was not possible in this 
study due to the small amount of sample remaining. This is the main disadvantage of 
subsequent fractionation. However, an additional fractionation step could result in 
single component isolation and hence NMR analysis would be accessible for structure 
elucidation, should sufficient sample be available. Such structural information would be 
of great help in the identification of compounds as this procedure often relies on 
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database searches and the confirmation remains very difficult due to the lack of 
standards.  
Another enhancement to the fractionation procedure could be implementation as 
an automatic setup such as the multi-step normal-phase fractionation method developed 
by Lubcke-von Varel et al. [77]. This would decrease the amount of solid phase 
extraction required to concentrate the sample and could help in limiting the risk of 
losses and contamination when handling the sample/fractions. 
 
High resolution mass spectrometry coupled to LC is a powerful combination for 
screening and identification purposes.  Three different types of identification procedures 
were used in this thesis work: 
(i) The target screening. Due to the limited number of standards used here (47), 
this strategy did not yield any identification. Expansion of the target library can improve 
this strategy as shown by Hogenboom and al. [91]. The authors used a self-created 
database containing about 3000 water pollutants, enabling the identification of many 
pollutants in sewage effluents, surface waters and groundwater. 
(ii) The suspect-compounds screening. This yielded the identification of pigment 
yellow 1 in fraction N-7-12. This strategy, if relying on a larger library including the 
suspect compounds as well as their transformation products, is a promising strategy for 
identification of compounds in water samples as showed in Kern et al. [94], using a 
large library containing more than 1700 suspect compounds.  
Awareness of the role of transformation products in water contamination is 
growing rapidly. Thus, there is a huge need for studies investigating the fate of 
contaminants in the environment in order to predict their transformation, and a need of 
software/program development such as the University of Minnesota Pathway Prediction 
System, able to predict products of microbial metabolism. Further development 
involving primarily products of abiotic reactions (e.g. hydrolysis, photolysis) could also 
be a great improvement in the creation of suspect compounds libraries. In general, the 
more compounds are present in databases, the greater the chances for identification. 
(iii) The non-target screening. This was by far the most challenging and time 
consuming strategy applied to this work. This strategy relies on the empirical formula 
determination, followed by database searches using the formula and the match of 
predicted and experimental MSn fragmentation pattern. In general, this identification 
procedure requires as much information as possible and satisfying the highest number of 
criteria to select the candidates. In many cases MSn fragmentation and retention 
(expressed by the log Kow) are most commonly used criteria in the identification of 
chemicals by LC-MS/MS. In the present work two other selection criteria were 
introduced and proved to be helpful in the selection of the candidates. The first one was 
the pKa of candidates to determine if the candidate could be present in the fraction of 
interest (acidic, neutral or basic fraction). The second classifier introduced was the 
ionisation behaviour of analytes.  The analytical study of reference standards enabled 
the identification of typical losses for the different classes of compounds (Chapter 4, 
Section 4.3.1) and to derive ionisation rules (see Chapter 4, Table 4-2) for the different 
classes of compounds.  Such rules were applied during the identification process and 
were found to be useful to decrease the number of candidate for the peaks of interest, as 
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seen for instance for Peak 40 in Chapter 4, Section 4.3.3.2. The acid/base properties 
(pKa) for the selection of candidates is specific to the procedure described in this work 
as it involved a fractionation step for the separation of chemicals according to their pKa 
value(s). In contrast, the behaviour of the different classes of compounds during LC-
MS/MS analysis is more a universal classifier that could be used in any identification 
procedure.  
Applying this strategy, benzyl(diphenyl) phosphine oxide was identified and 
confirmed and a list of 92 candidates was provided for 13 peaks. The use of MetFrag 
greatly improved the searches through thousands of compounds having the same 
empirical formula, in matching the predicted and experimental MSn fragments in 
database (e.g. Peak 213 in Chapter 4, Section 4.3.3.2). Thus, this computer program was 
rather efficient and helpful in the selection of the best candidates due to the ranking 
score and represents one of the strengths of the strategy applied here for the 
identification of compounds. Additionally, MetFrag is very user-friendly and freely 
available. However, even with strong software, the searches remain dependant on the 
databases and the compounds present. Thus, these databases need to be developed 
further, to help in the identification of unknown compounds. This dependence of 
databases is a limiting factor to non-target identification. For instance we saw that for 
many peaks of interest it was not possible to suggest any candidates. One of the likely 
reasons is the absence of the chemical from the databases. In GC-MS, structure 
generation proved to be an alternative strategy to overcome the absence of structures 
from database [156,157], but we saw in this work that the lack of fragmentation in LC-
MS/MS is a severe obstacle to the application of structure generation to LC-MS/MS 
data. The lack of fragmentation means that insufficient structural information is 
available to limit the number of candidates. Higher collision energies increase the 
fragmentation of chemicals and may provide more information. Another possibility is 
the in-source fragmentation. In most cases, negative ionisation provides very few 
fragments. However, in a recent study [158], Wu and co-workers used in-source 
fragmentation under negative APCI to provide intense fragments allowing the structural 
identification of triclosan. Improvement in negative ionisation mode could provide some 
more information regarding the fragmentation pattern of an unknown, and could be 
combined with the identified fragments obtained in positive mode, enabling the use of 
the structure generation.  
Failure in the determination of the correct empirical formula, leading to the lack 
of candidates for some peaks could be attributed to adduct formation.  Solvent adducts 
or adducts containing one or more alkali metals could be present as mentioned by Weiss 
et al. [101]. These adducts should be removed prior to determination of the molecular 
formula, which is the basis of the unknown strategy identification. It could be valuable 
to incorporate into the method a computer program enabling the determination of the 
nature of the adducts before proceeding to the determination of the elemental formula 
[103]. This feature is now being built into many workflows (e.g. [159]) that have not yet 
been evaluated fully (an evaluation was beyond the scope of work here). Another reason 
could be also due to the loss of a portion of the molecule during the ionisation process 
(e.g. loss of water or alkyl group). This results in the wrong molecular ion detection and 
hence to the wrong empirical formula. Thus, it would be worthwhile to further 
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investigate the role of in-source fragmentation and possible losses during ionisation and 
retry the database searches. 
 
Matching experimental with computational fragmentation spectra and physical-
chemical properties is a valid method for rapid discrimination of compounds with the 
same empirical formula. However, there are often several possible candidate structures 
for an individual peak. Thus, further classifiers are needed to exclude as many 
candidates as possible. In this work we proposed the use of two methods. The first one 
was based on the quantitative structure retention relationship (QSRR) approach, using 
the linear solvation-energy relationship (LSER) and was applied to fraction N-2-8. This 
method is based on the Abraham equation, which although developed in the 1990’s, has 
only recently been applied in in EDA studies. We proved here that it helps to drastically 
reduce the number of candidates. The proposed list of 92 candidates was reduced to 22 
using this approach. The chromatographic hydrophobicity index (CHI) equation 
proposed by Ulrich et al. [110] was easy to use and only requires a calibration of the 
LC-column with standards before application. In general, this approach can be easily 
included in EDA studies as a pre-step for confirmation. The LSER approach using CHI 
is of universal approach as is it nearly independent from gradient set-up and column 
dimension and thus can be used in any other EDA studies.  
The second approach was based on the quantitative structure activity 
relationship (QSAR), approach using the stability of nitrenium ion theory of aromatic 
amines. This method was easy to use to predict mutagenicity of compounds and did not 
require further experiments, only calculations. In comparison to the LSER approach, 
this method is specific to mutagenic compounds involving aromatic amines. However, 
in such EDA studies with BR sampling, this method can be easily applied to prioritise 
candidates for confirmation. Thus, it is really important to develop and apply new 
classifier in the selection of candidates during identification process.  
 
The combination of specific passive sampler, fractionation and novel candidate 
selection for unknown identification is a very promising method for the isolation and 
investigation of mutagenic compounds in water matrices. 
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